| GMP-Bios-ab-001 |
Pre-Made Abagovomab biosimilar,
Whole Mab: Anti-CA125/MUC16 therapeutic
antibody |
Abagovomab |
CA125/MUC16 |
Whole mAb |
 |
| GMP-Bios-ab-002 |
Pre-Made Abelacimab biosimilar,
Whole mAb, Anti-F11 Antibody: Anti-FXI/PTA
therapeutic antibody |
Abelacimab |
F11 |
Whole mAb |
 |
| GMP-Bios-ab-003 |
Pre-Made Abituzumab biosimilar,
Whole mAb, Anti-ITGAV Antibody:
Anti-CD51/MSK8/VNRA/VTNR therapeutic
antibody |
Abituzumab |
ITGAV |
Whole mAb |
 |
| GMP-Bios-ab-004 |
Pre-Made Abrezekimab biosimilar,
Fab, Anti-IL13 Antibody: Anti-IL-13/P600
therapeutic antibody |
Abrezekimab |
IL13 |
Fab |
 |
| GMP-Bios-ab-005 |
Pre-Made Abrilumab biosimilar,
Whole mAb, Anti-α4β7/Integrin alpha 4 beta 7
Antibody: Anti-LPAM‑1 therapeutic antibody
|
Abrilumab |
α4β7/ Integrin alpha 4
beta 7 |
Whole mAb |
 |
| GMP-Bios-ab-006 |
Pre-Made Acapatamab biosimilar,
Bispecific scFv, Anti-FOLH1/GCPII;CD3E Antibody:
Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18
therapeutic antibody |
Acapatamab |
FOLH1/GCPII;CD3E |
Bispecific scFv |
 |
| GMP-Bios-ab-007 |
Pre-Made Acasunlimab
biosimilar, Bispecific mAb,
Anti-CD274/PD-L1;TNFRSF9/CD137
Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1;ILA/4-1BB/CDw137
therapeutic antibody |
Acasunlimab |
CD274/PD-L1; TNFRSF9/CD137 |
Bispecific mAb |
 |
| GMP-Bios-ab-008 |
Pre-Made Actoxumab biosimilar,
Whole Mab: Anti-Toxin A therapeutic antibody
|
Actoxumab |
Toxin A |
Whole mAb |
 |
| GMP-Bios-ab-009 |
Pre-Made Adalimumab biosimilar,
Whole mAb, Anti-TNFA/TNF Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Adalimumab |
TNFA/TNF |
Whole mAb |
 |
| GMP-Bios-ab-010 |
Pre-Made Adebrelimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Adebrelimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-011 |
Pre-Made Aducanumab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Aducanumab |
APP |
Whole mAb |
 |
| GMP-Bios-ab-012 |
Pre-Made Afasevikumab
biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Afasevikumab |
IL17A/IL17 |
Whole mAb |
 |
| GMP-Bios-ab-013 |
Pre-Made Afutuzumab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Afutuzumab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-014 |
Pre-Made Alacizumab biosimilar,
di-Fab, Anti-KDR Antibody:
Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic
antibody |
Alacizumab |
KDR |
di-Fab |
 |
| GMP-Bios-ab-015 |
Pre-Made Alemtuzumab biosimilar,
Whole mAb, Anti-CD52 Antibody:
Anti-HE5/CDW52/EDDM5 therapeutic antibody
|
Alemtuzumab |
CD52 |
Whole mAb |
 |
| GMP-Bios-ab-016 |
Pre-Made Alirocumab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Alirocumab |
PCSK9 |
Whole mAb |
 |
| GMP-Bios-ab-017 |
Pre-Made Alomfilimab biosimilar,
Whole mAb, Anti-ICOS Antibody:
Anti-AILIM/CD278/CVID1 therapeutic antibody
|
Alomfilimab |
ICOS |
Whole mAb |
 |
| GMP-Bios-ab-018 |
Pre-Made Alnuctamab biosimilar,
Bispecific mAb with Domain Crossover,
Anti-TNFRSF17;CD3E Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18
therapeutic antibody |
Alnuctamab |
TNFRSF17;CD3E |
Bispecific mAb with Domain
Crossover |
 |
| GMP-Bios-ab-019 |
Pre-Made Alsevalimab biosimilar,
Whole mAb, Anti-VTCN1 Antibody:
Anti-B7-H4/B7H4/B7S1/B7X/B7h.5/PRO1291/VCTN1
therapeutic antibody |
Alsevalimab |
VTCN1 |
Whole mAb |
 |
| GMP-Bios-ab-020 |
Pre-Made Amatuximab biosimilar,
Whole mAb, Anti-MSLN Antibody: Anti-MPF/SMRP
therapeutic antibody |
Amatuximab |
MSLN |
Whole mAb |
 |
| GMP-Bios-ab-021 |
Pre-Made Amivantamab biosimilar,
Bispecific mAb, Anti-EGFR;MET Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;AUTS9/DFNB97/HGFR/RCCP2/c-Met
therapeutic antibody |
Amivantamab |
EGFR;MET |
Bispecific mAb |
 |
| GMP-Bios-ab-022 |
Pre-Made Amlitelimab biosimilar,
Whole mAb, Anti-TNFSF4/OX40 Antibody:
Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1
therapeutic antibody |
Amlitelimab |
TNFSF4/OX40 |
Whole mAb |
 |
| GMP-Bios-ab-023 |
Pre-Made Anbenitamab biosimilar,
Bispecific mAb: Anti-ERBB2 (Domain II);ERBB2
(Domain IV) therapeutic antibody |
Anbenitamab |
ERBB2 (Domain II); ERBB2
(Domain IV) |
Bispecific mAb |
 |
| GMP-Bios-ab-024 |
Pre-Made Andecaliximab
biosimilar, Whole mAb, Anti-MMP9/MMP-9 Antibody:
Anti-CLG4B/GELB/MANDP2 therapeutic antibody
|
Andecaliximab |
MMP9/MMP-9 |
Whole mAb |
 |
| GMP-Bios-ab-025 |
Pre-Made Anetumab biosimilar,
Whole mAb ADC, Anti-MSLN Antibody: Anti-MPF/SMRP
therapeutic antibody |
Anetumab |
MSLN |
Whole mAb ADC |
 |
| GMP-Bios-ab-026 |
Pre-Made Anifrolumab biosimilar,
Whole mAb, Anti-IFNAR1 Antibody:
Anti-AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC
therapeutic antibody |
Anifrolumab |
IFNAR1 |
Whole mAb |
 |
| GMP-Bios-ab-027 |
Pre-Made Anrukinzumab
biosimilar, Whole mAb, Anti-IL13 Antibody:
Anti-IL-13/P600 therapeutic antibody |
Anrukinzumab |
IL13 |
Whole mAb |
 |
| GMP-Bios-ab-028 |
Pre-Made Ansuvimab biosimilar,
Whole Mab: Anti-Zaire Ebolavirus GP1 therapeutic
antibody |
Ansuvimab |
Zaire Ebolavirus GP1 |
Whole mAb |
 |
| GMP-Bios-ab-029 |
Pre-Made Apamistamab biosimilar,
Whole mAb Radiolabelled, Anti-PTPRC Antibody:
Anti-B220/CD45/CD45R/GP180/L-CA/LCA/LY5/T200
therapeutic antibody |
Apamistamab |
PTPRC |
Whole mAb Radiolabelled |
 |
| GMP-Bios-ab-030 |
Pre-Made Apitegromab biosimilar,
Whole Mab: Anti-pro-GDF-8 therapeutic
antibody |
Apitegromab |
pro-GDF-8 |
Whole mAb |
 |
| GMP-Bios-ab-031 |
Pre-Made Aprutumab biosimilar,
Whole mAb ADC, Anti-FGFR2 Antibody:
Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25
therapeutic antibody |
Aprutumab |
FGFR2 |
Whole mAb ADC |
 |
| GMP-Bios-ab-032 |
Pre-Made Ascrinvacumab
biosimilar, Whole mAb, Anti-ACVRL1 Antibody:
Anti-ACVRLK1/ALK-1/ALK1/HHT/HHT2/ORW2/SKR3/TSR-I
therapeutic antibody |
Ascrinvacumab |
ACVRL1 |
Whole mAb |
 |
| GMP-Bios-ab-033 |
Pre-Made Astegolimab biosimilar,
Whole mAb, Anti-IL1RL1/ST2 Antibody:
Anti-DER4/FIT-1/IL33R/T1 therapeutic
antibody |
Astegolimab |
IL1RL1/ST2 |
Whole mAb |
 |
| GMP-Bios-ab-034 |
Pre-Made Atezolizumab
biosimilar, Whole mAb, Anti-CD274/PD-L1
Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1
therapeutic antibody |
Atezolizumab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-035 |
Pre-Made Atibuclimab biosimilar,
Whole Mab: Anti-CD14 therapeutic antibody
|
Atibuclimab |
CD14 |
Whole mAb |
 |
| GMP-Bios-ab-036 |
Pre-Made Atidortoxumab
biosimilar, Whole Mab: Anti-Toxin A therapeutic
antibody |
Atidortoxumab |
Toxin A |
Whole mAb |
 |
| GMP-Bios-ab-037 |
Pre-Made Atinumab biosimilar,
Whole mAb, Anti-RTN4 Antibody:
Anti-ASY/NI220/250/NOGO/NSP/NSP-CL/Nbla00271/Nbla10545/RTN-X-B1-B2
therapeutic antibody |
Atinumab |
RTN4 |
Whole mAb |
 |
| GMP-Bios-ab-038 |
Pre-Made Atoltivimab biosimilar,
Whole Mab: Anti-Zaire Ebolavirus GP therapeutic
antibody |
Atoltivimab |
Zaire Ebolavirus GP |
Whole mAb |
 |
| GMP-Bios-ab-039 |
Pre-Made Avdoralimab biosimilar,
Whole mAb, Anti-C5AR1 Antibody:
Anti-C5AR/C5R1/CD88 therapeutic antibody
|
Avdoralimab |
C5AR1 |
Whole mAb |
 |
| GMP-Bios-ab-040 |
Pre-Made Avelumab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Avelumab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-041 |
Pre-Made Avizakimab biosimilar,
Whole mAb, Anti-IL21 Antibody:
Anti-CVID11/IL-21/Za11 therapeutic antibody
|
Avizakimab |
IL21 |
Whole mAb |
 |
| GMP-Bios-ab-042 |
Pre-Made Axatilimab biosimilar,
Whole mAb, Anti-CSF1R Antibody:
Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R
therapeutic antibody |
Axatilimab |
CSF1R |
Whole mAb |
 |
| GMP-Bios-ab-043 |
Pre-Made Azintuxizumab
biosimilar, Whole mAb ADC, Anti-SLAMF7/CS1
Antibody: Anti-19A/CD319/CRACC therapeutic
antibody |
Azintuxizumab |
SLAMF7/CS1 |
Whole mAb ADC |
 |
| GMP-Bios-ab-044 |
Pre-Made Balstilimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Balstilimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-045 |
Pre-Made Bamlanivimab
biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike
therapeutic antibody |
Bamlanivimab |
SARS-CoV-2 Spike |
Whole mAb |
 |
| GMP-Bios-ab-046 |
Pre-Made Bapineuzumab
biosimilar, Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Bapineuzumab |
APP |
Whole mAb |
 |
| GMP-Bios-ab-047 |
Pre-Made Bapotulimab biosimilar,
Whole mAb, Anti-ILDR2 Antibody:
Anti-C1orf32/dJ782G3.1 therapeutic antibody
|
Bapotulimab |
ILDR2 |
Whole mAb |
 |
| GMP-Bios-ab-048 |
Pre-Made Barecetamab biosimilar,
Whole mAb, Anti-ERBB3/Erbb-3 Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Barecetamab |
ERBB3/Erbb-3 |
Whole mAb |
 |
| GMP-Bios-ab-049 |
Pre-Made Basiliximab biosimilar,
Whole mAb, Anti-IL2RA Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody |
Basiliximab |
IL2RA |
Whole mAb |
 |
| GMP-Bios-ab-050 |
Pre-Made Batoclimab biosimilar,
Whole mAb, Anti-FCGRT Antibody:
Anti-FCRN/FcgammaRn/alpha-chain therapeutic
antibody |
Batoclimab |
FCGRT |
Whole mAb |
 |
| GMP-Bios-ab-051 |
Pre-Made Bavituximab biosimilar,
Whole Mab: Anti-Phosphatidylserine therapeutic
antibody |
Bavituximab |
Phosphatidylserine |
Whole mAb |
 |
| GMP-Bios-ab-052 |
Pre-Made Bedinvetmab biosimilar,
Canine Whole Mab: Anti-Canine NGFB therapeutic
antibody |
Bedinvetmab |
Canine NGFB |
Canine Whole mAb |
 |
| GMP-Bios-ab-053 |
Pre-Made Befovacimab biosimilar,
Whole mAb, Anti-TFPI Antibody: Anti-EPI/LACI/TFI
therapeutic antibody |
Befovacimab |
TFPI |
Whole mAb |
 |
| GMP-Bios-ab-055 |
Pre-Made Belantamab biosimilar,
Whole mAb ADC, Anti-TNFRSF17 Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A therapeutic
antibody |
Belantamab |
TNFRSF17 |
Whole mAb ADC |
 |
| GMP-Bios-ab-056 |
Pre-Made Belimumab biosimilar,
Whole mAb, Anti-TNFSF13B Antibody:
Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4
therapeutic antibody |
Belimumab |
TNFSF13B |
Whole mAb |
 |
| GMP-Bios-ab-057 |
Pre-Made Bemarituzumab
biosimilar, Whole mAb, Anti-FGFR2 Antibody:
Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25
therapeutic antibody |
Bemarituzumab |
FGFR2 |
Whole mAb |
 |
| GMP-Bios-ab-058 |
Pre-Made Benralizumab
biosimilar, Whole mAb, Anti-IL5RA Antibody:
Anti-CD125/CDw125/HSIL5R3/IL5R therapeutic
antibody |
Benralizumab |
IL5RA |
Whole mAb |
 |
| GMP-Bios-ab-059 |
Pre-Made Bentracimab biosimilar,
Whole Mab: Anti-AR-C124910XX therapeutic
antibody |
Bentracimab |
AR-C124910XX |
Whole mAb |
 |
| GMP-Bios-ab-060 |
Pre-Made Benufutamab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Benufutamab |
TNFRSF10B/TRAIL-R2 |
Whole mAb |
 |
| GMP-Bios-ab-061 |
Pre-Made Bepranemab biosimilar,
Whole mAb, Anti-MAPT Antibody:
Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40
therapeutic antibody |
Bepranemab |
MAPT |
Whole mAb |
 |
| GMP-Bios-ab-062 |
Pre-Made Berlimatoxumab
biosimilar, Whole Mab: Anti-Toxin A therapeutic
antibody |
Berlimatoxumab |
Toxin A |
Whole mAb |
 |
| GMP-Bios-ab-063 |
Pre-Made Bermekimab biosimilar,
Whole mAb, Anti-IL1A Antibody:
Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1 alpha
therapeutic antibody |
Bermekimab |
IL1A |
Whole mAb |
 |
| GMP-Bios-ab-064 |
Pre-Made Bersanlimab biosimilar,
Whole mAb, Anti-ICAM1 Antibody:
Anti-BB2/CD54/P3.58 therapeutic antibody
|
Bersanlimab |
ICAM1 |
Whole mAb |
 |
| GMP-Bios-ab-065 |
Pre-Made Bevacizumab biosimilar,
Whole mAb, Anti-VEGFA Antibody:
Anti-VPF/VEGF/MVCD1 therapeutic antibody
|
Bevacizumab |
VEGFA |
Whole mAb |
 |
| GMP-Bios-ab-066 |
Pre-Made Bexmarilimab
biosimilar, Whole mAb, Anti-STAB1 Antibody:
Anti-CLEVER-1/FEEL-1/FEEL1/FELE-1/FEX1/SCARH2/STAB-1
therapeutic antibody |
Bexmarilimab |
STAB1 |
Whole mAb |
 |
| GMP-Bios-ab-067 |
Pre-Made Bezlotoxumab
biosimilar, Whole Mab: Anti-Toxin A therapeutic
antibody |
Bezlotoxumab |
Toxin A |
Whole mAb |
 |
| GMP-Bios-ab-068 |
Pre-Made Bifikafusp biosimilar,
Whole mAb Fusion: Anti-FN extra domain B
therapeutic antibody |
Bifikafusp |
FN extra domain B |
Whole mAb Fusion |
 |
| GMP-Bios-ab-069 |
Pre-Made Bimagrumab biosimilar,
Whole mAb, Anti-ACVR2B Antibody:
Anti-ACTRIIB/ActR-IIB/HTX4 therapeutic
antibody |
Bimagrumab |
ACVR2B |
Whole mAb |
 |
| GMP-Bios-ab-070 |
Pre-Made Bimekizumab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Bimekizumab |
IL17A/IL17 |
Whole mAb |
 |
| GMP-Bios-ab-071 |
Pre-Made Bintrafusp biosimilar,
Whole mAb Fusion, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Bintrafusp |
CD274/PD-L1 |
Whole mAb Fusion |
 |
| GMP-Bios-ab-072 |
Pre-Made Birtamimab biosimilar,
Whole mAb, Anti-SAA1 Antibody:
Anti-PIG4/SAA/SAA2/TP53I4 therapeutic
antibody |
Birtamimab |
SAA1 |
Whole mAb |
 |
| GMP-Bios-ab-073 |
Pre-Made Bleselumab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Bleselumab |
CD40 |
Whole mAb |
 |
| GMP-Bios-ab-074 |
Pre-Made Blinatumomab
biosimilar, Bispecific T-Cell Engager,
Anti-CD19;CD3E Antibody:
Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic
antibody |
Blinatumomab |
CD19;CD3E |
Bispecific T-Cell Engager
|
 |
| GMP-Bios-ab-075 |
Pre-Made Blontuvetmab
biosimilar, Canine Whole mAb, Anti-MS4A1/CD20
Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7
therapeutic antibody |
Blontuvetmab |
MS4A1/CD20 |
Canine Whole mAb |
 |
| GMP-Bios-ab-076 |
Pre-Made Blosozumab biosimilar,
Whole mAb, Anti-SOST Antibody:
Anti-CDD/DAND6/VBCH therapeutic antibody
|
Blosozumab |
SOST |
Whole mAb |
 |
| GMP-Bios-ab-077 |
Pre-Made Bococizumab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Bococizumab |
PCSK9 |
Whole mAb |
 |
| GMP-Bios-ab-078 |
Pre-Made Botensilimab
biosimilar, Whole mAb, Anti-CTLA4/CTLA-4
Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Botensilimab |
CTLA4/CTLA-4 |
Whole mAb |
 |
| GMP-Bios-ab-079 |
Pre-Made Brazikumab biosimilar,
Whole mAb, Anti-IL23A/IL23 Antibody:
Anti-IL23P19/P19/SGRF therapeutic antibody
|
Brazikumab |
IL23A/IL23 |
Whole mAb |
 |
| GMP-Bios-ab-080 |
Pre-Made Brentuximab biosimilar,
Whole mAb ADC, Anti-TNFRSF8 Antibody:
Anti-CD30/Ki-1/D1S166E therapeutic antibody
|
Brentuximab |
TNFRSF8 |
Whole mAb ADC |
 |
| GMP-Bios-ab-081 |
Pre-Made Briakinumab biosimilar,
Whole mAb, Anti-IL12B Antibody:
Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2
therapeutic antibody |
Briakinumab |
IL12B |
Whole mAb |
 |
| GMP-Bios-ab-082 |
Pre-Made Brodalumab biosimilar,
Whole mAb, Anti-IL17RA/IL17R Antibody:
Anti-CANDF5/CD217/CDw217RAR/IMD51/hIL-17R
therapeutic antibody |
Brodalumab |
IL17RA/IL17R |
Whole mAb |
 |
| GMP-Bios-ab-083 |
Pre-Made Brolucizumab
biosimilar, scFv, Anti-VEGFA Antibody:
Anti-VPF/VEGF/MVCD1 therapeutic antibody
|
Brolucizumab |
VEGFA |
scFv |
 |
| GMP-Bios-ab-084 |
Pre-Made Brontictuzumab
biosimilar, Whole mAb, Anti-NOTCH1 Antibody:
Anti-AOS5/AOVD1/TAN1/hN1 therapeutic
antibody |
Brontictuzumab |
NOTCH1 |
Whole mAb |
 |
| GMP-Bios-ab-085 |
Pre-Made Budigalimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Budigalimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-086 |
Pre-Made Burosumab biosimilar,
Whole mAb, Anti-FGF23 Antibody:
Anti-ADHR/FGFN/HFTC2/HPDR2/HYPF/PHPTC
therapeutic antibody |
Burosumab |
FGF23 |
Whole mAb |
 |
| GMP-Bios-ab-087 |
Pre-Made Cabiralizumab
biosimilar, Whole mAb, Anti-CSF1R Antibody:
Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R
therapeutic antibody |
Cabiralizumab |
CSF1R |
Whole mAb |
 |
| GMP-Bios-ab-088 |
Pre-Made Cadonilimab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-PDCD1/PD-1;CTLA4/CTLA-4 antibody:
Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Cadonilimab |
PDCD1/PD-1; CTLA4/CTLA-4
|
Bispecific Mixed mAb and
scFv |
 |
| GMP-Bios-ab-089 |
Pre-Made Camidanlumab
biosimilar, Whole mAb ADC, Anti-IL2RA Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody |
Camidanlumab |
IL2RA |
Whole mAb ADC |
 |
| GMP-Bios-ab-090 |
Pre-Made Camrelizumab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Camrelizumab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-091 |
Pre-Made Canakinumab biosimilar,
Whole mAb, Anti-IL1B Antibody:
Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic
antibody |
Canakinumab |
IL1B |
Whole mAb |
 |
| GMP-Bios-ab-092 |
Pre-Made Cantuzumab biosimilar,
Whole mAb ADC, Anti-MUC1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Cantuzumab |
MUC1 |
Whole mAb ADC |
 |
| GMP-Bios-ab-093 |
Pre-Made Caplacizumab
biosimilar, Nanobody, Anti-VWF Antibody:
Anti-F8VWF/VWD therapeutic antibody |
Caplacizumab |
VWF |
Nanobody |
 |
| GMP-Bios-ab-094 |
Pre-Made Carlumab biosimilar,
Whole mAb, Anti-CCL2 Antibody:
Anti-HC11/MCAF/MCP1/MCP-1/SCYA2/GDCF-2/SMC-CF/HSMCR30
therapeutic antibody |
Carlumab |
CCL2 |
Whole mAb |
 |
| GMP-Bios-ab-095 |
Pre-Made Carotuximab biosimilar,
Whole mAb, Anti-ENG Antibody: Anti-END/HHT1/ORW1
therapeutic antibody |
Carotuximab |
ENG |
Whole mAb |
 |
| GMP-Bios-ab-096 |
Pre-Made Casirivimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Casirivimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-097 |
Pre-Made Cemiplimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Cemiplimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-098 |
Pre-Made Cendakimab biosimilar,
Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600
therapeutic antibody |
Cendakimab |
IL13 |
Whole mAb |
 |
| GMP-Bios-ab-099 |
Pre-Made Cergutuzumab
biosimilar, Whole mAb Fusion, Anti-CEACAM5/CD66e
Antibody: Anti-CEA therapeutic antibody |
Cergutuzumab |
CEACAM5/CD66e |
Whole mAb Fusion |
 |
| GMP-Bios-ab-100 |
Pre-Made Certolizumab
biosimilar, Fab, Anti-TNFA/TNF Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Certolizumab |
TNFA/TNF |
Fab |
 |
| GMP-Bios-ab-101 |
Pre-Made Cetrelimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Cetrelimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-102 |
Pre-Made Cetuximab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Cetuximab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-103 |
Pre-Made Cevostamab biosimilar,
Bispecific mAb: Anti-FCRL5;CD3 therapeutic
antibody |
Cevostamab |
FCRL5;CD3 |
Bispecific mAb |
 |
| GMP-Bios-ab-104 |
Pre-Made Cibisatamab biosimilar,
Bispecific mAb with Domain Crossover:
Anti-CEACAM5;CD3E therapeutic antibody |
Cibisatamab |
CEACAM5;CD3E |
Bispecific mAb with Domain
Crossover |
 |
| GMP-Bios-ab-105 |
Pre-Made Cilgavimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Cilgavimab |
SARS-CoV-2 Spike RBD
|
Whole mAb |
 |
| GMP-Bios-ab-106 |
Pre-Made Cinpanemab biosimilar,
Whole mAb, Anti-SNCA Antibody:
Anti-NACP/PARK1/PARK4/PD1 therapeutic
antibody |
Cinpanemab |
SNCA |
Whole mAb |
 |
| GMP-Bios-ab-107 |
Pre-Made Citatuzumab biosimilar,
Fab Fusion, Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody |
Citatuzumab |
EPCAM |
Fab Fusion |
 |
| GMP-Bios-ab-108 |
Pre-Made Cixutumumab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Cixutumumab |
IGF1R |
Whole mAb |
 |
| GMP-Bios-ab-109 |
Pre-Made Claudiximab biosimilar,
Whole mAb, Anti-CLDN18 Antibody:
Anti-SFTA5/SFTPJ therapeutic antibody |
Claudiximab |
CLDN18 |
Whole mAb |
 |
| GMP-Bios-ab-110 |
Pre-Made Clazakizumab
biosimilar, Whole mAb, Anti-IL6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Clazakizumab |
IL6 |
Whole mAb |
 |
| GMP-Bios-ab-111 |
Pre-Made Clervonafusp
biosimilar, di-Fab Fusion, Anti-SLC29A2/ENT2
Antibody: Anti-DER12/HNP36 therapeutic
antibody |
Clervonafusp |
SLC29A2/ENT2 |
di-Fab Fusion |
 |
| GMP-Bios-ab-112 |
Pre-Made Clivatuzumab
biosimilar, Whole mAb Radiolabelled, Anti-MUC1
Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Clivatuzumab |
MUC1 |
Whole mAb Radiolabelled |
 |
| GMP-Bios-ab-113 |
Pre-Made Cobolimab biosimilar,
Whole mAb, Anti-HAVCR2/TIM3 Antibody:
Anti-CD366/KIM-3/SPTCL/TIMD3/Tim-3/TIMD-3/HAVcr-2
therapeutic antibody |
Cobolimab |
HAVCR2/TIM3 |
Whole mAb |
 |
| GMP-Bios-ab-114 |
Pre-Made Codrituzumab
biosimilar, Whole mAb, Anti-GPC3 Antibody:
Anti-DGSX/GTR2-2/MXR7/OCI-5/SDYS/SGB/SGBS/SGBS1
therapeutic antibody |
Codrituzumab |
GPC3 |
Whole mAb |
 |
| GMP-Bios-ab-115 |
Pre-Made Cofetuzumab biosimilar,
Whole mAb ADC, Anti-PTK7 Antibody:
Anti-CCK-4/CCK4 therapeutic antibody |
Cofetuzumab |
PTK7 |
Whole mAb ADC |
 |
| GMP-Bios-ab-116 |
Pre-Made Coltuximab biosimilar,
Whole mAb ADC, Anti-CD19 Antibody: Anti-B4/CVID3
therapeutic antibody |
Coltuximab |
CD19 |
Whole mAb ADC |
 |
| GMP-Bios-ab-117 |
Pre-Made Conatumumab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Conatumumab |
TNFRSF10B/ TRAIL-R2 |
Whole mAb |
 |
| GMP-Bios-ab-118 |
Pre-Made Concizumab biosimilar,
Whole mAb, Anti-TFPI Antibody: Anti-EPI/LACI/TFI
therapeutic antibody |
Concizumab |
TFPI |
Whole mAb |
 |
| GMP-Bios-ab-119 |
Pre-Made Coprelotamab
biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Coprelotamab |
ERBB2/HER2 |
Whole mAb |
 |
| GMP-Bios-ab-120 |
Pre-Made Cosfroviximab
biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP
therapeutic antibody |
Cosfroviximab |
Zaire Ebolavirus GP |
Whole mAb |
 |
| GMP-Bios-ab-121 |
Pre-Made Cosibelimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Cosibelimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-122 |
Pre-Made Crenezumab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Crenezumab |
APP |
Whole mAb |
 |
| GMP-Bios-ab-123 |
Pre-Made Crizanlizumab
biosimilar, Whole mAb, Anti-SELP Antibody:
Anti-CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL
therapeutic antibody |
Crizanlizumab |
SELP |
Whole mAb |
 |
| GMP-Bios-ab-124 |
Pre-Made Crotedumab biosimilar,
Whole mAb, Anti-GCGR Antibody:
Anti-GGR/GL-R/MVAH therapeutic antibody |
Crotedumab |
GCGR |
Whole mAb |
 |
| GMP-Bios-ab-125 |
Pre-Made Crovalimab biosimilar,
Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Crovalimab |
C5/CO5 |
Whole mAb |
 |
| GMP-Bios-ab-126 |
Pre-Made Cudarolimab biosimilar,
Whole mAb, Anti-TNFRSF4/CD134 Antibody:
Anti-ACT35/IMD16/OX40/TXGP1L therapeutic
antibody |
Cudarolimab |
TNFRSF4/CD134 |
Whole mAb |
 |
| GMP-Bios-ab-127 |
Pre-Made Cusatuzumab biosimilar,
Whole mAb, Anti-CD70/CD27-L Antibody:
Anti-CD27L/LPFS3/CD27LG/TNFSF7/TNLG8A
therapeutic antibody |
Cusatuzumab |
CD70/CD27-L |
Whole mAb |
 |
| GMP-Bios-ab-128 |
Pre-Made Dacetuzumab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Dacetuzumab |
CD40 |
Whole mAb |
 |
| GMP-Bios-ab-129 |
Pre-Made Daclizumab biosimilar,
Whole mAb, Anti-IL2RA Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody |
Daclizumab |
IL2RA |
Whole mAb |
 |
| GMP-Bios-ab-130 |
Pre-Made Dafsolimab biosimilar,
Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Dafsolimab |
CD3E |
Whole mAb |
 |
| GMP-Bios-ab-131 |
Pre-Made Dalotuzumab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Dalotuzumab |
IGF1R |
Whole mAb |
 |
| GMP-Bios-ab-132 |
Pre-Made Dapirolizumab
biosimilar, Fab, Anti-CD40LG Antibody:
Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L
therapeutic antibody |
Dapirolizumab |
CD40LG |
Fab |
 |
| GMP-Bios-ab-133 |
Pre-Made Daratumumab biosimilar,
Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC
1 therapeutic antibody |
Daratumumab |
CD38 |
Whole mAb |
 |
| GMP-Bios-ab-134 |
Pre-Made Datopotamab biosimilar,
Whole mAb, Anti-TACSTD2 Antibody:
Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2
therapeutic antibody |
Datopotamab |
TACSTD2 |
Whole mAb |
 |
| GMP-Bios-ab-135 |
Pre-Made Daxdilimab biosimilar,
Whole mAb, Anti-LILRA4/ILT7 Antibody: Anti-CD85g
therapeutic antibody |
Daxdilimab |
LILRA4/ILT7 |
Whole mAb |
 |
| GMP-Bios-ab-136 |
Pre-Made Dectrekumab biosimilar,
Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600
therapeutic antibody |
Dectrekumab |
IL13 |
Whole mAb |
 |
| GMP-Bios-ab-137 |
Pre-Made Demcizumab biosimilar,
Whole mAb, Anti-DLL4 Antibody:
Anti-AOS6/delta4/hdelta2 therapeutic
antibody |
Demcizumab |
DLL4 |
Whole mAb |
 |
| GMP-Bios-ab-138 |
Pre-Made Demupitamab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Demupitamab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-139 |
Pre-Made Denintuzumab
biosimilar, Whole mAb ADC, Anti-CD19 Antibody:
Anti-B4/CVID3 therapeutic antibody |
Denintuzumab |
CD19 |
Whole mAb ADC |
 |
| GMP-Bios-ab-140 |
Pre-Made Denosumab biosimilar,
Whole mAb, Anti-TNFSF11/ODF Antibody:
Anti-OPGL/sCD254/OPTB2/RANKL/TNLG6B/TRANCE/hRANKL2
therapeutic antibody |
Denosumab |
TNFSF11/ODF |
Whole mAb |
 |
| GMP-Bios-ab-141 |
Pre-Made Depatuxizumab
biosimilar, Whole mAb ADC, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Depatuxizumab |
EGFR |
Whole mAb ADC |
 |
| GMP-Bios-ab-142 |
Pre-Made Depemokimab biosimilar,
Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF
therapeutic antibody |
Depemokimab |
IL5 |
Whole mAb |
 |
| GMP-Bios-ab-143 |
Pre-Made Derlotuximab
biosimilar, Whole mAb Radiolabelled: Anti-DNA/H1
Complex therapeutic antibody |
Derlotuximab |
DNA/H1 Complex |
Whole mAb Radiolabelled |
 |
| GMP-Bios-ab-144 |
Pre-Made Dezamizumab biosimilar,
Whole mAb, Anti-APCS Antibody:
Anti-HEL-S-92n/PTX2/SAP therapeutic antibody
|
Dezamizumab |
APCS |
Whole mAb |
 |
| GMP-Bios-ab-145 |
Pre-Made Dilpacimab biosimilar,
Bispecific mAb, Anti-DLL4;VEGFA Antibody:
Anti-AOS6/delta4/hdelta2;VPF/VEGF/MVCD1
therapeutic antibody |
Dilpacimab |
DLL4;VEGFA |
Bispecific mAb |
 |
| GMP-Bios-ab-146 |
Pre-Made Dinutuximab biosimilar,
Whole Mab: Anti-Ganglioside GD2 therapeutic
antibody |
Dinutuximab |
Ganglioside GD2 |
Whole mAb |
 |
| GMP-Bios-ab-147 |
Pre-Made Diridavumab biosimilar,
Whole Mab: Anti-Influenza A HA2 therapeutic
antibody |
Diridavumab |
Influenza A HA2 |
Whole mAb |
 |
| GMP-Bios-ab-148 |
Pre-Made Disitamab biosimilar,
Whole mAb ADC, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Disitamab |
ERBB2/HER2 |
Whole mAb ADC |
 |
| GMP-Bios-ab-149 |
Pre-Made Divozilimab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Divozilimab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-150 |
Pre-Made Docaravimab biosimilar,
Whole mAb (Mouse): Anti-Rabies Virus Strain ERA
GP Ectodomain Epitope G-III therapeutic
antibody |
Docaravimab |
Rabies Virus Strain ERA
GP Ectodomain Epitope G-III |
Whole mAb (Mouse) |
 |
| GMP-Bios-ab-151 |
Pre-Made Domagrozumab
biosimilar, Whole mAb, Anti-MSTN/GDF-8 Antibody:
Anti-GDF8/MSLHP therapeutic antibody |
Domagrozumab |
MSTN/GDF-8 |
Whole mAb |
 |
| GMP-Bios-ab-152 |
Pre-Made Domvanalimab
biosimilar, Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Domvanalimab |
TIGIT |
Whole mAb |
 |
| GMP-Bios-ab-153 |
Pre-Made Donanemab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Donanemab |
APP |
Whole mAb |
 |
| GMP-Bios-ab-154 |
Pre-Made Dostarlimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Dostarlimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-155 |
Pre-Made Dovanvetmab biosimilar,
Feline Whole Mab: Anti-IL31 (Feline) therapeutic
antibody |
Dovanvetmab |
IL31 (Feline) |
Feline Whole mAb |
 |
| GMP-Bios-ab-156 |
Pre-Made Drozitumab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Drozitumab |
TNFRSF10B /TRAIL-R2 |
Whole mAb |
 |
| GMP-Bios-ab-157 |
Pre-Made Duligotuzumab
biosimilar, Whole mAb, Anti-ERBB3/Erbb-3
Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Duligotuzumab |
ERBB3/Erbb-3 |
Whole mAb |
 |
| GMP-Bios-ab-158 |
Pre-Made Dupilumab biosimilar,
Whole mAb, Anti-IL4R Antibody: Anti-CD124
therapeutic antibody |
Dupilumab |
IL4R |
Whole mAb |
 |
| GMP-Bios-ab-159 |
Pre-Made Durvalumab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Durvalumab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-160 |
Pre-Made Dusigitumab biosimilar,
Whole mAb, Anti-IGF1;IGF2 Antibody:
Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3
therapeutic antibody |
Dusigitumab |
IGF1;IGF2 |
Whole mAb |
 |
| GMP-Bios-ab-161 |
Pre-Made Duvortuxizumab
biosimilar, Bispecific scFv with Crossover,
Anti-CD19;CD3E antibody:
Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic
antibody |
Duvortuxizumab |
CD19;CD3E |
Bispecific scFv with
Crossover |
 |
| GMP-Bios-ab-162 |
Pre-Made Ebdarokimab biosimilar,
Whole mAb, Anti-IL12B Antibody:
Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2
therapeutic antibody |
Ebdarokimab |
IL12B |
Whole mAb |
 |
| GMP-Bios-ab-163 |
Pre-Made Ebronucimab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Ebronucimab |
PCSK9 |
Whole mAb |
 |
| GMP-Bios-ab-164 |
Pre-Made Eculizumab biosimilar,
Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Eculizumab |
C5/CO5 |
Whole mAb |
 |
| GMP-Bios-ab-165 |
Pre-Made Edrecolomab biosimilar,
Whole mAb, Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody |
Edrecolomab |
EPCAM |
Whole mAb |
 |
| GMP-Bios-ab-166 |
Pre-Made Efalizumab biosimilar,
Whole mAb, Anti-ITGAL Antibody:
Anti-CD11A/LFA-1/LFA1A therapeutic antibody
|
Efalizumab |
ITGAL |
Whole mAb |
 |
| GMP-Bios-ab-167 |
Pre-Made Efungumab biosimilar,
scFv: Anti-Heat Shock Protein 90 Homolog
therapeutic antibody |
Efungumab |
Heat Shock Protein 90
Homolog |
scFv |
 |
| GMP-Bios-ab-168 |
Pre-Made Eldelumab biosimilar,
Whole mAb, Anti-CXCL10 Antibody:
Anti-C7/IFI10/INP10/IP-10/SCYB10/crg-2/gIP-10/mob-1
therapeutic antibody |
Eldelumab |
CXCL10 |
Whole mAb |
 |
| GMP-Bios-ab-169 |
Pre-Made Elezanumab biosimilar,
Whole mAb, Anti-RGMA Antibody: Anti-RGM
therapeutic antibody |
Elezanumab |
RGMA |
Whole mAb |
 |
| GMP-Bios-ab-170 |
Pre-Made Elgemtumab biosimilar,
Whole mAb, Anti-ERBB3/Erbb-3 Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Elgemtumab |
ERBB3/Erbb-3 |
Whole mAb |
 |
| GMP-Bios-ab-171 |
Pre-Made Elipovimab biosimilar,
Whole Mab: Anti-HIV-1 gp120 therapeutic
antibody |
Elipovimab |
HIV-1 gp120 |
Whole mAb |
 |
| GMP-Bios-ab-172 |
Pre-Made Elotuzumab biosimilar,
Whole mAb, Anti-SLAMF7/CS1 Antibody:
Anti-19A/CD319/CRACC therapeutic antibody
|
Elotuzumab |
SLAMF7/CS1 |
Whole mAb |
 |
| GMP-Bios-ab-173 |
Pre-Made Eluvixtamab biosimilar,
Bispecific scFv, Anti-CD33;CD3E Antibody:
Anti-p67/SIGLEC3/SIGLEC-3;T3E/TCRE/IMD18
therapeutic antibody |
Eluvixtamab |
CD33;CD3E |
Bispecific scFv |
 |
| GMP-Bios-ab-174 |
Pre-Made Emactuzumab biosimilar,
Whole mAb, Anti-CSF1R Antibody:
Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R
therapeutic antibody |
Emactuzumab |
CSF1R |
Whole mAb |
 |
| GMP-Bios-ab-175 |
Pre-Made Emapalumab biosimilar,
Whole mAb, Anti-IFNG Antibody:
Anti-IFG/IFI/IMD69 therapeutic antibody |
Emapalumab |
IFNG |
Whole mAb |
 |
| GMP-Bios-ab-176 |
Pre-Made Emerfetamab biosimilar,
Bispecific scFv, Anti-CD33;CD3E Antibody:
Anti-p67/SIGLEC3/SIGLEC-3;T3E/TCRE/IMD18
therapeutic antibody |
Emerfetamab |
CD33;CD3E |
Bispecific scFv |
 |
| GMP-Bios-ab-177 |
Pre-Made Emicizumab biosimilar,
Bispecific mAb, Anti-F9;F10 Antibody:
Anti-FIX/HEMB/P19/PTC/THPH8;FX/FXA therapeutic
antibody |
Emicizumab |
F9;F10 |
Bispecific mAb |
 |
| GMP-Bios-ab-178 |
Pre-Made Emibetuzumab
biosimilar, Whole mAb, Anti-MET Antibody:
Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic
antibody |
Emibetuzumab |
MET |
Whole mAb |
 |
| GMP-Bios-ab-179 |
Pre-Made Enapotamab biosimilar,
Whole mAb ADC, Anti-AXL Antibody:
Anti-ARK/UFO/JTK11/Tyro7 therapeutic
antibody |
Enapotamab |
AXL |
Whole mAb ADC |
 |
| GMP-Bios-ab-180 |
Pre-Made Enavatuzumab
biosimilar, Whole mAb, Anti-TNFRSF12A Antibody:
Anti-CD2664/TWEAKR therapeutic antibody |
Enavatuzumab |
TNFRSF12A |
Whole mAb |
 |
| GMP-Bios-ab-181 |
Pre-Made Encelimab biosimilar,
Whole mAb, Anti-LAG3 Antibody: Anti-CD223
therapeutic antibody |
Encelimab |
LAG3 |
Whole mAb |
 |
| GMP-Bios-ab-182 |
Pre-Made Enfortumab biosimilar,
Whole mAb ADC, Anti-PVRL4/NECTIN4 Antibody:
Anti-EDSS1/LNIR/PRR4/nectin-4 therapeutic
antibody |
Enfortumab |
PVRL4/NECTIN4 |
Whole mAb ADC |
 |
| GMP-Bios-ab-183 |
Pre-Made Enibarcimab biosimilar,
Whole mAb, Anti-ADM Antibody: Anti-AM/PAMP
therapeutic antibody |
Enibarcimab |
ADM |
Whole mAb |
 |
| GMP-Bios-ab-184 |
Pre-Made Enoblituzumab
biosimilar, Whole mAb, Anti-CD276 Antibody:
Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic
antibody |
Enoblituzumab |
CD276 |
Whole mAb |
 |
| GMP-Bios-ab-185 |
Pre-Made Enokizumab biosimilar,
Whole mAb, Anti-IL9 Antibody: Anti-HP40/IL-9/P40
therapeutic antibody |
Enokizumab |
IL9 |
Whole mAb |
 |
| GMP-Bios-ab-186 |
Pre-Made Enoticumab biosimilar,
Whole mAb, Anti-DLL4 Antibody:
Anti-AOS6/delta4/hdelta2 therapeutic
antibody |
Enoticumab |
DLL4 |
Whole mAb |
 |
| GMP-Bios-ab-187 |
Pre-Made Ensituximab biosimilar,
Whole mAb, Anti-MUC5AC Antibody:
Anti-MUC5/TBM/leBin therapeutic antibody
|
Ensituximab |
MUC5AC |
Whole mAb |
 |
| GMP-Bios-ab-188 |
Pre-Made Envafolimab biosimilar,
Single Domain Variable Fragment;H,
Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PD-L1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1
therapeutic antibody |
Envafolimab |
CD274/PD-L1 |
Single Domain Variable
Fragment;H |
 |
| GMP-Bios-ab-189 |
Pre-Made Epcoritamab biosimilar,
Bispecific mAb, Anti-CD3E;MS4A1/CD20 Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7
therapeutic antibody |
Epcoritamab |
CD3E;MS4A1/CD20 |
Bispecific mAb |
 |
| GMP-Bios-ab-190 |
Pre-Made Epratuzumab biosimilar,
Whole mAb, Anti-CD22 Antibody:
Anti-SIGLEC2/SIGLEC-2 therapeutic antibody
|
Epratuzumab |
CD22 |
Whole mAb |
 |
| GMP-Bios-ab-191 |
Pre-Made Eptinezumab biosimilar,
Whole mAb, Anti-CALCA;CALCB Antibody:
Anti-CT/KC/PCT/CGRP/CALC1/CGRP1/CGRP-I/CGRP-alpha;CALC2/CGRP-II/CGRP2
therapeutic antibody |
Eptinezumab |
CALCA;CALCB |
Whole mAb |
 |
| GMP-Bios-ab-192 |
Pre-Made Eramkafusp biosimilar,
Whole mAb Fusion, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Eramkafusp |
MS4A1/CD20 |
Whole mAb Fusion |
 |
| GMP-Bios-ab-193 |
Pre-Made Erenumab biosimilar,
Whole mAb, Anti-CALCRL/CGRPR Antibody:
Anti-CRLR/LMPHM8 therapeutic antibody |
Erenumab |
CALCRL/CGRPR |
Whole mAb |
 |
| GMP-Bios-ab-194 |
Pre-made Erfonrilimab
biosimilar, Bispecific Single Domains
(VH-VH'-CH), Anti-CD274/PD-L1;CTLA4/CTLA-4
Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Erfonrilimab |
CD274/PD-L1;CTLA4/CTLA-4
|
Bispecific Single Domains
(VH-VH'-CH) |
 |
| GMP-Bios-ab-195 |
Pre-Made Etaracizumab
biosimilar, Whole mAb, Anti-ITGAV;ITGB3
Antibody:
Anti-CD51/MSK8/VNRA/VTNR;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2
therapeutic antibody |
Etaracizumab |
ITGAV;ITGB3 |
Whole mAb |
 |
| GMP-Bios-ab-196 |
Pre-Made Etesevimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Etesevimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-197 |
Pre-Made Etevritamab biosimilar,
Bispecific scFv, Anti-EGFR;CD3E Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;T3E/TCRE/IMD18
therapeutic antibody |
Etevritamab |
EGFR;CD3E |
Bispecific scFv |
 |
| GMP-Bios-ab-198 |
Pre-Made Etigilimab biosimilar,
Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Etigilimab |
TIGIT |
Whole mAb |
 |
| GMP-Bios-ab-199 |
Pre-Made Etokimab biosimilar,
Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600
therapeutic antibody |
Etokimab |
IL13 |
Whole mAb |
 |
| GMP-Bios-ab-200 |
Pre-Made Etrolizumab biosimilar,
Whole Mab: Anti-ITGA4;ITGB7;ITGAE;ITGB7
therapeutic antibody |
Etrolizumab |
ITGA4;ITGB7; ITGAE;ITGB7
|
Whole mAb |
 |
| GMP-Bios-ab-201 |
Pre-Made Evinacumab biosimilar,
Whole mAb, Anti-ANGPTL3 Antibody:
Anti-ANG-5/ANGPT5/ANL3/FHBL2 therapeutic
antibody |
Evinacumab |
ANGPTL3 |
Whole mAb |
 |
| GMP-Bios-ab-202 |
Pre-Made Evolocumab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Evolocumab |
PCSK9 |
Whole mAb |
 |
| GMP-Bios-ab-203 |
Pre-Made Ezabenlimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Ezabenlimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-204 |
Pre-Made Faricimab biosimilar,
Bispecific mAb, Anti-VEGFA;ANGPT2 Antibody:
Anti-VPF/VEGF/MVCD1;AGPT2/ANG2/LMPHM10
therapeutic antibody |
Faricimab |
VEGFA;ANGPT2 |
Bispecific mAb |
 |
| GMP-Bios-ab-205 |
Pre-Made Farletuzumab
biosimilar, Whole mAb, Anti-FOLR1 Antibody:
Anti-FBP/FOLR/FRalpha/NCFTD therapeutic
antibody |
Farletuzumab |
FOLR1 |
Whole mAb |
 |
| GMP-Bios-ab-206 |
Pre-Made Fasinumab biosimilar,
Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5
therapeutic antibody |
Fasinumab |
NGFB/NGF |
Whole mAb |
 |
| GMP-Bios-ab-207 |
Pre-Made Feladilimab biosimilar,
Whole mAb, Anti-ICOS Antibody:
Anti-AILIM/CD278/CVID1 therapeutic antibody
|
Feladilimab |
ICOS |
Whole mAb |
 |
| GMP-Bios-ab-208 |
Pre-Made Felzartamab biosimilar,
Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC
1 therapeutic antibody |
Felzartamab |
CD38 |
Whole mAb |
 |
| GMP-Bios-ab-209 |
Pre-Made Fezakinumab biosimilar,
Whole mAb, Anti-IL22 Antibody:
Anti-IL-21/IL-22/IL-D110/IL-TIF/ILTIF/TIFIL-23/TIFa/zcyto18
therapeutic antibody |
Fezakinumab |
IL22 |
Whole mAb |
 |
| GMP-Bios-ab-210 |
Pre-Made Fianlimab biosimilar,
Whole mAb, Anti-LAG3 Antibody: Anti-CD223
therapeutic antibody |
Fianlimab |
LAG3 |
Whole mAb |
 |
| GMP-Bios-ab-211 |
Pre-Made Fibatuzumab biosimilar,
Whole mAb, Anti-EPHA3 Antibody:
Anti-EK4/ETK/ETK1/HEK/HEK4/TYRO4 therapeutic
antibody |
Fibatuzumab |
EPHA3 |
Whole mAb |
 |
| GMP-Bios-ab-212 |
Pre-Made Ficlatuzumab
biosimilar, Whole mAb, Anti-HGF Antibody:
Anti-DFNB39/F-TCF/HPTA/SF therapeutic
antibody |
Ficlatuzumab |
HGF |
Whole mAb |
 |
| GMP-Bios-ab-213 |
Pre-Made Figitumumab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Figitumumab |
IGF1R |
Whole mAb |
 |
| GMP-Bios-ab-214 |
Pre-Made Firivumab biosimilar,
Whole Mab: Anti-Influenza A HA therapeutic
antibody |
Firivumab |
Influenza A HA |
Whole mAb |
 |
| GMP-Bios-ab-215 |
Pre-Made Finotonlimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Finotonlimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-216 |
Pre-Made Flanvotumab biosimilar,
Whole mAb, Anti-TYRP1 Antibody:
Anti-TRP/CAS2/CATB/GP75/OCA3/TRP1/TYRP/b-PROTEIN
therapeutic antibody |
Flanvotumab |
TYRP1 |
Whole mAb |
 |
| GMP-Bios-ab-217 |
Pre-Made Fletikumab biosimilar,
Whole mAb, Anti-IL20 Antibody:
Anti-IL-20/IL10D/ZCYTO10 therapeutic
antibody |
Fletikumab |
IL20 |
Whole mAb |
 |
| GMP-Bios-ab-218 |
Pre-Made Flotetuzumab
biosimilar, Bispecific scFv with Crossover,
Anti-IL3RA;CD3E Antibody:
Anti-CD123/IL3RX/IL3RY/IL3RAY/hIL-3Ra;T3E/TCRE/IMD18
therapeutic antibody |
Flotetuzumab |
IL3RA;CD3E |
Bispecific scFv with
Crossover |
 |
| GMP-Bios-ab-219 |
Pre-Made Fontolizumab
biosimilar, Whole mAb, Anti-IFNG Antibody:
Anti-IFG/IFI/IMD69 therapeutic antibody |
Fontolizumab |
IFNG |
Whole mAb |
 |
| GMP-Bios-ab-220 |
Pre-Made Foralumab biosimilar,
Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Foralumab |
CD3E |
Whole mAb |
 |
| GMP-Bios-ab-221 |
Pre-Made Foravirumab biosimilar,
Whole Mab: Anti-RV Antigenic Site III
therapeutic antibody |
Foravirumab |
RV Antigenic Site III |
Whole mAb |
 |
| GMP-Bios-ab-222 |
Pre-Made Fremanezumab
biosimilar, Whole mAb, Anti-CALCA;CALCB
Antibody:
Anti-CT/KC/PCT/CGRP/CALC1/CGRP1/CGRP-I/CGRP-alpha;CALC2/CGRP-II/CGRP2
therapeutic antibody |
Fremanezumab |
CALCA;CALCB |
Whole mAb |
 |
| GMP-Bios-ab-223 |
Pre-Made Fresolimumab
biosimilar, Whole mAb, Anti-TGFB/TGFB1 Antibody:
Anti-CED/DPD1/IBDIMDE/LAP therapeutic
antibody |
Fresolimumab |
TGFB/TGFB1 |
Whole mAb |
 |
| GMP-Bios-ab-224 |
Pre-Made Frovocimab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Frovocimab |
PCSK9 |
Whole mAb |
 |
| GMP-Bios-ab-225 |
Pre-Made Frunevetmab biosimilar,
Feline Whole mAb, Anti-NGFB/NGF Antibody:
Anti-HSAN5 therapeutic antibody |
Frunevetmab |
NGFB/NGF |
Feline Whole mAb |
 |
| GMP-Bios-ab-226 |
Pre-Made Fulranumab biosimilar,
Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5
therapeutic antibody |
Fulranumab |
NGFB/NGF |
Whole mAb |
 |
| GMP-Bios-ab-227 |
Pre-Made Futuximab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Futuximab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-228 |
Pre-Made Galcanezumab
biosimilar, Whole mAb, Anti-CALCA;CALCB
Antibody:
Anti-CT/KC/PCT/CGRP/CALC1/CGRP1/CGRP-I/CGRP-alpha;CALC2/CGRP-II/CGRP2
therapeutic antibody |
Galcanezumab |
CALCA;CALCB |
Whole mAb |
 |
| GMP-Bios-ab-229 |
Pre-Made Galiximab biosimilar,
Whole mAb, Anti-CD80 Antibody:
Anti-B7/BB1/B7-1/B7.1/LAB7/CD28LG/CD28LG1
therapeutic antibody |
Galiximab |
CD80 |
Whole mAb |
 |
| GMP-Bios-ab-230 |
Pre-Made Gancotamab biosimilar,
scFv, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Gancotamab |
ERBB2/HER2 |
scFv |
 |
| GMP-Bios-ab-231 |
Pre-Made Ganitumab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Ganitumab |
IGF1R |
Whole mAb |
 |
| GMP-Bios-ab-232 |
Pre-Made Gantenerumab
biosimilar, Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Gantenerumab |
APP |
Whole mAb |
 |
| GMP-Bios-ab-233 |
Pre-Made Garadacimab biosimilar,
Whole mAb, Anti-F12 Antibody: Anti-HAE3/HAEX/HAF
therapeutic antibody |
Garadacimab |
F12 |
Whole mAb |
 |
| GMP-Bios-ab-234 |
Pre-Made Garetosmab biosimilar,
Whole mAb, Anti-INHBA/ACT Antibody: Anti-EDF/FRP
therapeutic antibody |
Garetosmab |
INHBA/ACT |
Whole mAb |
 |
| GMP-Bios-ab-235 |
Pre-Made Garivulimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Garivulimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-236 |
Pre-Made Gatipotuzumab
biosimilar, Whole mAb, Anti-MUC1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Gatipotuzumab |
MUC1 |
Whole mAb |
 |
| GMP-Bios-ab-237 |
Pre-Made Gatralimab biosimilar,
Whole mAb, Anti-CD52 Antibody:
Anti-HE5/CDW52/EDDM5 therapeutic antibody
|
Gatralimab |
CD52 |
Whole mAb |
 |
| GMP-Bios-ab-238 |
Pre-Made Gedivumab biosimilar,
Whole Mab: Anti-Influenza A HA therapeutic
antibody |
Gedivumab |
Influenza A HA |
Whole mAb |
 |
| GMP-Bios-ab-239 |
Pre-Made Gemtuzumab biosimilar,
Whole mAb ADC, Anti-CD33 Antibody:
Anti-p67/SIGLEC3/SIGLEC-3 therapeutic
antibody |
Gemtuzumab |
CD33 |
Whole mAb ADC |
 |
| GMP-Bios-ab-240 |
Pre-Made Geptanolimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Geptanolimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-241 |
Pre-Made Gevokizumab biosimilar,
Whole mAb, Anti-IL1B Antibody:
Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic
antibody |
Gevokizumab |
IL1B |
Whole mAb |
 |
| GMP-Bios-ab-242 |
Pre-Made Giloralimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Giloralimab |
CD40 |
Whole mAb |
 |
| GMP-Bios-ab-243 |
Pre-Made Gilvetmab biosimilar,
Canine Whole Mab: Anti-PDCD1 (Canine)
therapeutic antibody |
Gilvetmab |
PDCD1 (Canine) |
Canine Whole mAb |
 |
| GMP-Bios-ab-244 |
Pre-Made Gimsilumab biosimilar,
Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF
therapeutic antibody |
Gimsilumab |
CSF2 |
Whole mAb |
 |
| GMP-Bios-ab-245 |
Pre-Made Girentuximab
biosimilar, Whole mAb Radiolabelled,
Anti-CA9/CA-IX Antibody: Anti-CAIX/MN
therapeutic antibody |
Girentuximab |
CA9/CA-IX |
Whole mAb Radiolabelled |
 |
| GMP-Bios-ab-246 |
Pre-Made Glembatumumab
biosimilar, Whole mAb ADC, Anti-GPNMB Antibody:
Anti-HGFIN/NMB/PLCA3 therapeutic antibody
|
Glembatumumab |
GPNMB |
Whole mAb ADC |
 |
| GMP-Bios-ab-247 |
Pre-Made Glenzocimab biosimilar,
Fab, Anti-GP6 Antibody: Anti-BDPLT11/GPIV/GPVI
therapeutic antibody |
Glenzocimab |
GP6 |
Fab |
 |
| GMP-Bios-ab-248 |
Pre-Made Glofitamab biosimilar,
Bispecific mAb with Domain Crossover,
Anti-CD3E;MS4A1/CD20 antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7therapeutic
antibody |
Glofitamab |
CD3E;MS4A1/CD20 |
Bispecific mAb with Domain
Crossover |
 |
| GMP-Bios-ab-249 |
Pre-Made Golimumab biosimilar,
Whole mAb, Anti-TNFA/TNF Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Golimumab |
TNFA/TNF |
Whole mAb |
 |
| GMP-Bios-ab-250 |
Pre-Made Gomiliximab biosimilar,
Whole mAb, Anti-FCER2/CD23 Antibody:
Anti-BLAST-2A/CLEC4J/FCE2/FCErII/IGEBF
therapeutic antibody |
Gomiliximab |
FCER2/CD23 |
Whole mAb |
 |
| GMP-Bios-ab-251 |
Pre-Made Gontivimab biosimilar,
Bispecific Single Domains (VH-VH'-VH’): Anti-RSV
gpF therapeutic antibody |
Gontivimab |
RSV gpF |
Bispecific Single Domains
(VH-VH'-VH’) |
 |
| GMP-Bios-ab-252 |
Pre-Made Gosuranemab biosimilar,
Whole mAb, Anti-MAPT Antibody:
Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40
therapeutic antibody |
Gosuranemab |
MAPT |
Whole mAb |
 |
| GMP-Bios-ab-253 |
Pre-Made Gremubamab biosimilar,
Bispecific mAb: Anti-PcrV type III secretion
system; Polysaccharide synthesis locus
(Pseudomonas) therapeutic antibody |
Gremubamab |
PcrV type III secretion
system; Polysaccharide synthesis
locus (Pseudomonas) |
Bispecific mAb |
 |
| GMP-Bios-ab-254 |
Pre-Made Grisnilimab biosimilar,
Whole mAb, Anti-CD7 Antibody:
Anti-GP40/TP41/Tp40/LEU-9 therapeutic
antibody |
Grisnilimab |
CD7 |
Whole mAb |
 |
| GMP-Bios-ab-255 |
Pre-Made Guselkumab biosimilar,
Whole mAb, Anti-IL23A/IL23 Antibody:
Anti-IL23P19/P19/SGRF therapeutic antibody
|
Guselkumab |
IL23A/IL23 |
Whole mAb |
 |
| GMP-Bios-ab-256 |
Pre-Made Ianalumab biosimilar,
Whole mAb, Anti-TNFRSF13C Antibody:
Anti-BAFF-R/BAFFR/BROMIX/CD268/CVID4/prolixin
therapeutic antibody |
Ianalumab |
TNFRSF13C |
Whole mAb |
 |
| GMP-Bios-ab-257 |
Pre-Made Ibalizumab biosimilar,
Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D
therapeutic antibody |
Ibalizumab |
CD4 |
Whole mAb |
 |
| GMP-Bios-ab-258 |
Pre-Made Icatolimab biosimilar,
Whole mAb, Anti-BTLA Antibody: Anti-CD272
therapeutic antibody |
Icatolimab |
BTLA |
Whole mAb |
 |
| GMP-Bios-ab-259 |
Pre-Made Icrucumab biosimilar,
Whole mAb, Anti-FLT1/FLT-1 Antibody:
Anti-VEGFR-1/VEGFR1 therapeutic antibody
|
Icrucumab |
FLT1/FLT-1 |
Whole mAb |
 |
| GMP-Bios-ab-260 |
Pre-Made Idactamab biosimilar,
Whole mAb, Anti-SLC1A5 Antibody:
Anti-AAAT/ASCT2/ATBO/M7V1/M7VS1/R16/RDRC
therapeutic antibody |
Idactamab |
SLC1A5 |
Whole mAb |
 |
| GMP-Bios-ab-261 |
Pre-Made Idarucizumab
biosimilar, Fab: Anti-Dabigatran therapeutic
antibody |
Idarucizumab |
Dabigatran |
Fab |
 |
| GMP-Bios-ab-262 |
Pre-Made Ieramilimab biosimilar,
Whole Mab: Anti-CD223/LAG3 therapeutic
antibody |
Ieramilimab |
CD223/LAG3 |
Whole mAb |
 |
| GMP-Bios-ab-263 |
Pre-Made Ifabotuzumab
biosimilar, Whole mAb, Anti-EPHA3 Antibody:
Anti-EK4/ETK/ETK1/HEK/HEK4/TYRO4 therapeutic
antibody |
Ifabotuzumab |
EPHA3 |
Whole mAb |
 |
| GMP-Bios-ab-264 |
Pre-Made Iladatuzumab
biosimilar, Whole mAb ADC, Anti-CD79B Antibody:
Anti-AGM6/B29/IGB therapeutic antibody |
Iladatuzumab |
CD79B |
Whole mAb ADC |
 |
| GMP-Bios-ab-265 |
Pre-Made Imalumab biosimilar,
Whole mAb, Anti-MIF Antibody: Anti-GIF/GLIF/MMIF
therapeutic antibody |
Imalumab |
MIF |
Whole mAb |
 |
| GMP-Bios-ab-266 |
Pre-Made Imaprelimab biosimilar,
Whole mAb, Anti-MCAM Antibody:
Anti-CD146/HEMCAM/METCAM8/MelCAM therapeutic
antibody |
Imaprelimab |
MCAM |
Whole mAb |
 |
| GMP-Bios-ab-267 |
Pre-Made Imdevimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Imdevimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-268 |
Pre-Made Imgatuzumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Imgatuzumab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-269 |
Pre-Made Imsidolimab biosimilar,
Whole mAb, Anti-IL36R/IL1RL2 Antibody:
Anti-IL1RRP2/IL-1Rrp2/IL1R-rp2 therapeutic
antibody |
Imsidolimab |
IL36R/IL1RL2 |
Whole mAb |
 |
| GMP-Bios-ab-270 |
Pre-Made Inclacumab biosimilar,
Whole mAb, Anti-SELP Antibody:
Anti-CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL
therapeutic antibody |
Inclacumab |
SELP |
Whole mAb |
 |
| GMP-Bios-ab-271 |
Pre-Made Indatuximab biosimilar,
Whole mAb ADC, Anti-SDC1 Antibody:
Anti-SDC/CD138/SYND1/syndecan therapeutic
antibody |
Indatuximab |
SDC1 |
Whole mAb ADC |
 |
| GMP-Bios-ab-272 |
Pre-Made Indusatumab biosimilar,
Whole mAb ADC, Anti-GUCY2C Antibody:
Anti-DIAR6/GC-C/GUC2C/MECILIL/STAR therapeutic
antibody |
Indusatumab |
GUCY2C |
Whole mAb ADC |
 |
| GMP-Bios-ab-273 |
Pre-Made Inebilizumab
biosimilar, Whole mAb, Anti-CD19 Antibody:
Anti-B4/CVID3 therapeutic antibody |
Inebilizumab |
CD19 |
Whole mAb |
 |
| GMP-Bios-ab-274 |
Pre-Made Infliximab biosimilar,
Whole mAb, Anti-TNFA/TNF Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Infliximab |
TNFA/TNF |
Whole mAb |
 |
| GMP-Bios-ab-275 |
Pre-Made Inotuzumab biosimilar,
Whole mAb ADC, Anti-CD22 Antibody:
Anti-SIGLEC2/SIGLEC-2 therapeutic antibody
|
Inotuzumab |
CD22 |
Whole mAb ADC |
 |
| GMP-Bios-ab-276 |
Pre-Made Intetumumab biosimilar,
Whole mAb, Anti-ITGAV;ITGB3 Antibody:
Anti-CD51/MSK8/VNRA/VTNR;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2
therapeutic antibody |
Intetumumab |
ITGAV;ITGB3 |
Whole mAb |
 |
| GMP-Bios-ab-277 |
Pre-Made Ipilimumab biosimilar,
Whole mAb, Anti-CTLA4/CTLA-4 Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Ipilimumab |
CTLA4/CTLA-4 |
Whole mAb |
 |
| GMP-Bios-ab-278 |
Pre-Made Iratumumab biosimilar,
Whole mAb, Anti-TNFRSF8 Antibody:
Anti-CD30/Ki-1/D1S166E therapeutic antibody
|
Iratumumab |
TNFRSF8 |
Whole mAb |
 |
| GMP-Bios-ab-279 |
Pre-Made Isatuximab biosimilar,
Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC
1 therapeutic antibody |
Isatuximab |
CD38 |
Whole mAb |
 |
| GMP-Bios-ab-280 |
Pre-Made Iscalimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Iscalimab |
CD40 |
Whole mAb |
 |
| GMP-Bios-ab-281 |
Pre-Made Isecarosmab biosimilar,
Bispecific Single Domains (VH-VH'),
Anti-ADAMTSL5;ALB Antibody:
Anti-THSD6;FDAHT/HSA/PRO0883/PRO0903/PRO1341
therapeutic antibody |
Isecarosmab |
ADAMTSL5;ALB |
Bispecific Single Domains
(VH-VH') |
 |
| GMP-Bios-ab-282 |
Pre-Made Istiratumab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-IGF1R;ERBB3/Erbb-3 Antibody:
Anti-IGFR/CD221/IGFIR/JTK13;FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-c-erbB3/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Istiratumab |
IGF1R;ERBB3/Erbb-3 |
Bispecific Mixed mAb and
scFv |
 |
| GMP-Bios-ab-283 |
Pre-Made Itepekimab biosimilar,
Whole mAb, Anti-IL33 Antibody:
Anti-C9orf26/DVS27/IL1F11/NF-HEV/NFEHEV
therapeutic antibody |
Itepekimab |
IL33 |
Whole mAb |
 |
| GMP-Bios-ab-284 |
Pre-Made Itolizumab biosimilar,
Whole Mab: Anti-CD6/TP120 therapeutic
antibody |
Itolizumab |
CD6/TP120 |
Whole mAb |
 |
| GMP-Bios-ab-285 |
Pre-Made Ivuxolimab biosimilar,
Whole mAb, Anti-TNFRSF4/CD134 Antibody:
Anti-ACT35/IMD16/OX40/TXGP1L therapeutic
antibody |
Ivuxolimab |
TNFRSF4/CD134 |
Whole mAb |
 |
| GMP-Bios-ab-286 |
Pre-Made Ixekizumab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Ixekizumab |
IL17A/IL17 |
Whole mAb |
 |
| GMP-Bios-ab-287 |
Pre-Made Izuralimab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-ICOS;PDCD1/PD-1 antibody:
Anti-AILIM/CD278/CVID1;CD279/SLEB2/hPD-1/hPD-l/hSLE1
therapeutic antibody |
Izuralimab |
ICOS;PDCD1/PD-1 |
Bispecific Mixed mAb and
scFv |
 |
| GMP-Bios-ab-288 |
Pre-Made Labetuzumab biosimilar,
Whole mAb ADC, Anti-CEACAM5/CD66e Antibody:
Anti-CEA therapeutic antibody |
Labetuzumab |
CEACAM5/CD66e |
Whole mAb ADC |
 |
| GMP-Bios-ab-289 |
Pre-Made Lacnotuzumab
biosimilar, Whole mAb, Anti-CSF1 Antibody:
Anti-MCSF/CSF-1 therapeutic antibody |
Lacnotuzumab |
CSF1 |
Whole mAb |
 |
| GMP-Bios-ab-290 |
Pre-Made Lacutamab biosimilar,
Whole mAb, Anti-KIR3DL2/CD158k Antibody:
Anti-3DL2/CD158K/KIR-3DL2/NKAT-4/NKAT4/NKAT4B/p140
therapeutic antibody |
Lacutamab |
KIR3DL2/CD158k |
Whole mAb |
 |
| GMP-Bios-ab-291 |
Pre-Made Ladiratuzumab
biosimilar, Whole mAb ADC, Anti-SLC39A6
Antibody: Anti-LIV-1/LIV1/ZIP6 therapeutic
antibody |
Ladiratuzumab |
SLC39A6 |
Whole mAb ADC |
 |
| GMP-Bios-ab-292 |
Pre-Made Lambrolizumab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Lambrolizumab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-293 |
Pre-Made Lampalizumab
biosimilar, Fab, Anti-CFD Antibody:
Anti-ADIPSIN/ADN/DF/PFD therapeutic antibody
|
Lampalizumab |
CFD |
Fab |
 |
| GMP-Bios-ab-294 |
Pre-Made Lanadelumab biosimilar,
Whole mAb, Anti-KLKB1 Antibody:
Anti-KLK3/PKK/PKKD/PPK therapeutic antibody
|
Lanadelumab |
KLKB1 |
Whole mAb |
 |
| GMP-Bios-ab-295 |
Pre-Made Landogrozumab
biosimilar, Whole mAb, Anti-MSTN/GDF-8 Antibody:
Anti-GDF8/MSLHP therapeutic antibody |
Landogrozumab |
MSTN/GDF-8 |
Whole mAb |
 |
| GMP-Bios-ab-296 |
Pre-Made Laprituximab
biosimilar, Whole mAb ADC, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Laprituximab |
EGFR |
Whole mAb ADC |
 |
| GMP-Bios-ab-297 |
Pre-Made Larcaviximab
biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP
therapeutic antibody |
Larcaviximab |
Zaire Ebolavirus GP |
Whole mAb |
 |
| GMP-Bios-ab-298 |
Pre-Made Latozinemab biosimilar,
Whole mAb, Anti-SORT1 Antibody:
Anti-Gp95/LDLCQ6/NT3/NTR3 therapeutic
antibody |
Latozinemab |
SORT1 |
Whole mAb |
 |
| GMP-Bios-ab-299 |
Pre-Made Lebrikizumab
biosimilar, Whole mAb, Anti-IL13 Antibody:
Anti-IL-13/P600 therapeutic antibody |
Lebrikizumab |
IL13 |
Whole mAb |
 |
| GMP-Bios-ab-300 |
Pre-Made Lecanemab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Lecanemab |
APP |
Whole mAb |
 |
| GMP-Bios-ab-301 |
Pre-Made Lemzoparlimab
biosimilar, Whole mAb, Anti-CD47 Antibody:
Anti-IAP/OA3/MER6 therapeutic antibody |
Lemzoparlimab |
CD47 |
Whole mAb |
 |
| GMP-Bios-ab-302 |
Pre-Made Lenvervimab biosimilar,
Whole Mab: Anti-HBV therapeutic antibody
|
Lenvervimab |
HBV |
Whole mAb |
 |
| GMP-Bios-ab-303 |
Pre-Made Lenzilumab biosimilar,
Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF
therapeutic antibody |
Lenzilumab |
CSF2 |
Whole mAb |
 |
| GMP-Bios-ab-304 |
Pre-Made Leronlimab biosimilar,
Whole mAb, Anti-CCR5 Antibody:
Anti-CKR5/CCR-5/CD195/CKR-5/CCCKR5/CMKBR5/IDDM22/CC-CKR-5
therapeutic antibody |
Leronlimab |
CCR5 |
Whole mAb |
 |
| GMP-Bios-ab-305 |
Pre-Made Lesofavumab biosimilar,
Whole Mab: Anti-Influenza B Virus therapeutic
antibody |
Lesofavumab |
Influenza B Virus |
Whole mAb |
 |
| GMP-Bios-ab-306 |
Pre-Made Letaplimab biosimilar,
Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6
therapeutic antibody |
Letaplimab |
CD47 |
Whole mAb |
 |
| GMP-Bios-ab-307 |
Pre-Made Letolizumab biosimilar,
Single Domain Variable Fragment;H, Anti-CD40LG
Antibody:
Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L
therapeutic antibody |
Letolizumab |
CD40LG |
Single Domain Variable
Fragment;H |
 |
| GMP-Bios-ab-308 |
Pre-Made Levilimab biosimilar,
Whole mAb, Anti-IL6R Antibody:
Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80
therapeutic antibody |
Levilimab |
IL6R |
Whole mAb |
 |
| GMP-Bios-ab-309 |
Pre-Made Lexatumumab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Lexatumumab |
TNFRSF10B/TRAIL-R2 |
Whole mAb |
 |
| GMP-Bios-ab-310 |
Pre-Made Licaminlimab
biosimilar, scFv, Anti-TNFA/TNF Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Licaminlimab |
TNFA/TNF |
scFv |
 |
| GMP-Bios-ab-311 |
Pre-Made Lifastuzumab
biosimilar, Whole mAb ADC, Anti-SLC34A2
Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM
therapeutic antibody |
Lifastuzumab |
SLC34A2 |
Whole mAb ADC |
 |
| GMP-Bios-ab-312 |
Pre-Made Ligelizumab biosimilar,
Whole Mab: Anti-IGHE/IgE therapeutic
antibody |
Ligelizumab |
IGHE/IgE |
Whole mAb |
 |
| GMP-Bios-ab-313 |
Pre-Made Lilotomab biosimilar,
Whole mAb ADC, Anti-CD37 Antibody:
Anti-GP52-40/TSPAN26 therapeutic antibody
|
Lilotomab |
CD37 |
Whole mAb ADC |
 |
| GMP-Bios-ab-314 |
Pre-Made Lintuzumab biosimilar,
Whole mAb Radiolabelled, Anti-CD33 Antibody:
Anti-p67/SIGLEC3/SIGLEC-3 therapeutic
antibody |
Lintuzumab |
CD33 |
Whole mAb Radiolabelled |
 |
| GMP-Bios-ab-315 |
Pre-Made Lirentelimab
biosimilar, Whole mAb, Anti-SIGLEC8/Siglec-8
Antibody: Anti-SAF2 therapeutic antibody
|
Lirentelimab |
SIGLEC8/Siglec-8 |
Whole mAb |
 |
| GMP-Bios-ab-316 |
Pre-Made Lirilumab biosimilar,
Whole Mab: Anti-KIRD2 therapeutic antibody
|
Lirilumab |
KIRD2 |
Whole mAb |
 |
| GMP-Bios-ab-317 |
Pre-Made Lodapolimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Lodapolimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-318 |
Pre-Made Lodelcizumab
biosimilar, Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Lodelcizumab |
PCSK9 |
Whole mAb |
 |
| GMP-Bios-ab-319 |
Pre-Made Lokivetmab biosimilar,
Canine Whole Mab: Anti-IL31 therapeutic
antibody |
Lokivetmab |
IL31 |
Canine Whole mAb |
 |
| GMP-Bios-ab-320 |
Pre-Made Loncastuximab
biosimilar, Whole mAb ADC, Anti-CD19 Antibody:
Anti-B4/CVID3 therapeutic antibody |
Loncastuximab |
CD19 |
Whole mAb ADC |
 |
| GMP-Bios-ab-321 |
Pre-Made Lonigutamab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Lonigutamab |
IGF1R |
Whole mAb |
 |
| GMP-Bios-ab-322 |
Pre-Made Lorukafusp biosimilar,
Whole mAb Fusion: Anti-Ganglioside GD2
therapeutic antibody |
Lorukafusp |
Ganglioside GD2 |
Whole mAb Fusion |
 |
| GMP-Bios-ab-323 |
Pre-Made Lorvotuzumab
biosimilar, Whole mAb ADC, Anti-NCAM1 Antibody:
Anti-CD56/NCAM/MSK39 therapeutic antibody
|
Lorvotuzumab |
NCAM1 |
Whole mAb ADC |
 |
| GMP-Bios-ab-324 |
Pre-Made Losatuxizumab
biosimilar, Whole mAb ADC, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Losatuxizumab |
EGFR |
Whole mAb ADC |
 |
| GMP-Bios-ab-325 |
Pre-Made Lucatumumab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Lucatumumab |
CD40 |
Whole mAb |
 |
| GMP-Bios-ab-326 |
Pre-Made Lulizumab biosimilar,
Single Domain Variable Fragment;L, Anti-CD28
Antibody: Anti-Tp44 therapeutic antibody
|
Lulizumab |
CD28 |
Single Domain Variable
Fragment;L |
 |
| GMP-Bios-ab-327 |
Pre-Made Lumiliximab biosimilar,
Whole mAb, Anti-FCER2/CD23 Antibody:
Anti-BLAST-2A/CLEC4J/FCE2/FCErII/IGEBF
therapeutic antibody |
Lumiliximab |
FCER2/CD23 |
Whole mAb |
 |
| GMP-Bios-ab-328 |
Pre-Made Lumretuzumab
biosimilar, Whole mAb, Anti-ERBB3/Erbb-3
Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Lumretuzumab |
ERBB3/Erbb-3 |
Whole mAb |
 |
| GMP-Bios-ab-329 |
Pre-Made Lupartumab biosimilar,
Whole mAb ADC, Anti-LYPD3 Antibody: Anti-C4.4A
therapeutic antibody |
Lupartumab |
LYPD3 |
Whole mAb ADC |
 |
| GMP-Bios-ab-330 |
Pre-Made Lusvertikimab
biosimilar, Whole mAb, Anti-IL7R Antibody:
Anti-CD127/CDW127 therapeutic antibody |
Lusvertikimab |
IL7R |
Whole mAb |
 |
| GMP-Bios-ab-331 |
Pre-Made Lutikizumab biosimilar,
Bispecific Dual Variable Domain IG,
Anti-IL1A;IL1B Antibody:
Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1
alpha;IL-1/IL1-BETA/IL1F2/IL1beta therapeutic
antibody |
Lutikizumab |
IL1A;IL1B |
Bispecific Dual Variable
Domain IG |
 |
| GMP-Bios-ab-332 |
Pre-Made Maftivimab biosimilar,
Whole Mab: Anti-Zaire Ebolavirus GP therapeutic
antibody |
Maftivimab |
Zaire Ebolavirus GP |
Whole mAb |
 |
| GMP-Bios-ab-333 |
Pre-Made Magrolimab biosimilar,
Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6
therapeutic antibody |
Magrolimab |
CD47 |
Whole mAb |
 |
| GMP-Bios-ab-334 |
Pre-Made Manelimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Manelimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-335 |
Pre-Made Margetuximab
biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Margetuximab |
ERBB2/HER2 |
Whole mAb |
 |
| GMP-Bios-ab-336 |
Pre-Made Marstacimab biosimilar,
Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Marstacimab |
ERBB2/HER2 |
Whole mAb |
 |
| GMP-Bios-ab-337 |
Pre-Made Matuzumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Matuzumab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-338 |
Pre-Made Mavezelimab biosimilar,
Whole mAb, Anti-LAG3 Antibody: Anti-CD223
therapeutic antibody |
Mavezelimab |
LAG3 |
Whole mAb |
 |
| GMP-Bios-ab-339 |
Pre-Made Mavrilimumab
biosimilar, Whole mAb, Anti-CSF2RA Antibody:
Anti-GMR/CD116/CSF2R/SMDP4/CDw116GMR-alpha/GMCSFR-alpha/GM-CSF-R-alpha
therapeutic antibody |
Mavrilimumab |
CSF2RA |
Whole mAb |
 |
| GMP-Bios-ab-340 |
Pre-Made Melrilimab biosimilar,
Whole mAb, Anti-IL1RL1/ST2 Antibody:
Anti-DER4/FIT-1/IL33R/T1 therapeutic
antibody |
Melrilimab |
IL1RL1/ST2 |
Whole mAb |
 |
| GMP-Bios-ab-341 |
Pre-Made Mepolizumab biosimilar,
Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF
therapeutic antibody |
Mepolizumab |
IL5 |
Whole mAb |
 |
| GMP-Bios-ab-342 |
Pre-Made Mezagitamab biosimilar,
Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC
1 therapeutic antibody |
Mezagitamab |
CD38 |
Whole mAb |
 |
| GMP-Bios-ab-343 |
Pre-Made Mibavademab biosimilar,
Whole mAb, Anti-LEPR Antibody:
Anti-CD295/OB-R/OBR therapeutic antibody
|
Mibavademab |
LEPR |
Whole mAb |
 |
| GMP-Bios-ab-344 |
Pre-Made Milatuzumab biosimilar,
Whole mAb, Anti-CD74 Antibody:
Anti-CLIP/DHLAG/HLADG/II/Ia-GAMMA/p33
therapeutic antibody |
Milatuzumab |
CD74 |
Whole mAb |
 |
| GMP-Bios-ab-345 |
Pre-Made Mipasetamab biosimilar,
Whole mAb, Anti-AXL Antibody:
Anti-ARK/UFO/JTK11/Tyro7 therapeutic
antibody |
Mipasetamab |
AXL |
Whole mAb |
 |
| GMP-Bios-ab-346 |
Pre-Made Miptenalimab
biosimilar, Whole mAb, Anti-LAG3 Antibody:
Anti-CD223 therapeutic antibody |
Miptenalimab |
LAG3 |
Whole mAb |
 |
| GMP-Bios-ab-347 |
Pre-Made Mirikizumab biosimilar,
Whole mAb, Anti-IL23A/IL23 Antibody:
Anti-IL23P19/P19/SGRF therapeutic antibody
|
Mirikizumab |
IL23A/IL23 |
Whole mAb |
 |
| GMP-Bios-ab-348 |
Anti-Rabies Virus Strain ERA GP
Ectodomain Epitope G-II therapeutic antibody
(Pre-made Miromavimab biosimilar,Whole mAb
(Mouse)) |
Miromavimab |
Rabies Virus Strain ERA
GP Ectodomain Epitope G-II |
Whole mAb (Mouse) |
 |
| GMP-Bios-ab-349 |
Pre-Made Mirvetuximab
biosimilar, Whole mAb ADC, Anti-FOLR1 Antibody:
Anti-FBP/FOLR/FRalpha/NCFTD therapeutic
antibody |
Mirvetuximab |
FOLR1 |
Whole mAb ADC |
 |
| GMP-Bios-ab-350 |
Pre-Made Mirzotamab biosimilar,
Whole mAb, Anti-CD276 Antibody:
Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic
antibody |
Mirzotamab |
CD276 |
Whole mAb |
 |
| GMP-Bios-ab-351 |
Pre-Made Mitazalimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Mitazalimab |
CD40 |
Whole mAb |
 |
| GMP-Bios-ab-352 |
Pre-Made Modakafusp biosimilar,
Whole mAb Fusion: Anti-ADPRC therapeutic
antibody |
Modakafusp |
ADPRC |
Whole mAb Fusion |
 |
| GMP-Bios-ab-353 |
Pre-Made Modotuximab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Modotuximab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-354 |
Pre-Made Mogamulizumab
biosimilar, Whole mAb, Anti-CCR4 Antibody:
Anti-CKR4/K5-5/CD194/CMKBR4/ChemR13/CC-CKR-4/HGCN:14099
therapeutic antibody |
Mogamulizumab |
CCR4 |
Whole mAb |
 |
| GMP-Bios-ab-355 |
Pre-Made Monalizumab biosimilar,
Whole mAb, Anti-KLRC1/NKG2A Antibody:
Anti-CD159A/NKG2 therapeutic antibody |
Monalizumab |
KLRC1/NKG2A |
Whole mAb |
 |
| GMP-Bios-ab-356 |
Pre-Made Mosunetuzumab
biosimilar, Bispecific mAb, Anti-CD3E;MS4A1/CD20
Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7
therapeutic antibody |
Mosunetuzumab |
CD3E;MS4A1/CD20 |
Bispecific mAb |
 |
| GMP-Bios-ab-357 |
Pre-Made Motavizumab biosimilar,
Whole Mab: Anti-RSV gpF therapeutic antibody
|
Motavizumab |
RSV gpF |
Whole mAb |
 |
| GMP-Bios-ab-358 |
Pre-Made Moxetumomab biosimilar,
Fv Fusion, Anti-CD22 Antibody:
Anti-SIGLEC2/SIGLEC-2 therapeutic antibody
|
Moxetumomab |
CD22 |
Fv Fusion |
 |
| GMP-Bios-ab-359 |
Pre-Made Murlentamab biosimilar,
Whole mAb, Anti-AMHR2 Antibody:
Anti-AMHR/MISR2/MISRII/MRII therapeutic
antibody |
Murlentamab |
AMHR2 |
Whole mAb |
 |
| GMP-Bios-ab-360 |
Pre-Made Muromonab biosimilar,
Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Muromonab |
CD3E |
Whole mAb |
 |
| GMP-Bios-ab-361 |
Pre-Made Nadecnemab biosimilar,
Whole mAb, Anti-GFRA3 Antibody: Anti-GDNFR3
therapeutic antibody |
Nadecnemab |
GFRA3 |
Whole mAb |
 |
| GMP-Bios-ab-362 |
Pre-Made Namilumab biosimilar,
Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF
therapeutic antibody |
Namilumab |
CSF2 |
Whole mAb |
 |
| GMP-Bios-ab-363 |
Pre-Made Naptumomab biosimilar,
Fab Fusion, Anti-TPBG Antibody:
Anti-5T4/M6P1/5T4AG/WAIF1 therapeutic
antibody |
Naptumomab |
TPBG |
Fab Fusion |
 |
| GMP-Bios-ab-364 |
Pre-Made Naratuximab biosimilar,
Whole mAb ADC, Anti-CD37 Antibody:
Anti-GP52-40/TSPAN26 therapeutic antibody
|
Naratuximab |
CD37 |
Whole mAb ADC |
 |
| GMP-Bios-ab-365 |
Pre-Made Narnatumab biosimilar,
Whole mAb, Anti-MST1R/RON Antibody:
Anti-RON/SEA/PTK8/CD136/NPCA3/CDw136 therapeutic
antibody |
Narnatumab |
MST1R/RON |
Whole mAb |
 |
| GMP-Bios-ab-366 |
Pre-Made Narsoplimab biosimilar,
Whole mAb, Anti-MASP2 Antibody:
Anti-MAP-2/MAP19/MASP-2/MASP1P1/sMAP therapeutic
antibody |
Narsoplimab |
MASP2 |
Whole mAb |
 |
| GMP-Bios-ab-367 |
Pre-Made Natalizumab biosimilar,
Whole mAb, Anti-ITGA4 Antibody: Anti-CD49D/IA4
therapeutic antibody |
Natalizumab |
ITGA4 |
Whole mAb |
 |
| GMP-Bios-ab-368 |
Pre-Made Navivumab biosimilar,
Whole Mab: Anti-Influenza A HA therapeutic
antibody |
Navivumab |
Influenza A HA |
Whole mAb |
 |
| GMP-Bios-ab-369 |
Pre-Made Navicixizumab
biosimilar, Bispecific mAb, Anti-DLL4;VEGFA
Antibody:
Anti-AOS6/delta4/hdelta2;VPF/VEGF/MVCD1
therapeutic antibody |
Navicixizumab |
DLL4;VEGFA |
Bispecific mAb |
 |
| GMP-Bios-ab-370 |
Pre-Made Naxitamab biosimilar,
Whole Mab: Anti-Ganglioside GD2 therapeutic
antibody |
Naxitamab |
Ganglioside GD2 |
Whole mAb |
 |
| GMP-Bios-ab-371 |
Pre-Made Necitumumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Necitumumab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-372 |
Pre-Made Nemolizumab biosimilar,
Whole mAb, Anti-IL31RA/IL31R Antibody:
Anti-CRL/CRL3/GLM-R/GLMR/GPL/IL-31RA/PLCA2/PRO21384/hGLM-R/zcytoR17
therapeutic antibody |
Nemolizumab |
IL31RA/IL31R |
Whole mAb |
 |
| GMP-Bios-ab-373 |
Pre-Made Nesvacumab biosimilar,
Whole mAb, Anti-ANGPT2 Antibody:
Anti-AGPT2/ANG2/LMPHM10 therapeutic antibody
|
Nesvacumab |
ANGPT2 |
Whole mAb |
 |
| GMP-Bios-ab-374 |
Pre-Made Netakimab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Netakimab |
IL17A/IL17 |
Whole mAb |
 |
| GMP-Bios-ab-375 |
Pre-Made Nidanilimab biosimilar,
Whole mAb, Anti-IL1RAP Antibody:
Anti-C3orf13/IL-1RAcP/IL1R3 therapeutic
antibody |
Nidanilimab |
IL1RAP |
Whole mAb |
 |
| GMP-Bios-ab-377 |
Pre-Made Nimotuzumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Nimotuzumab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-378 |
Pre-Made Nipocalimab biosimilar,
Whole mAb, Anti-FCGRT Antibody:
Anti-FCRN/FcgammaRn/alpha-chain therapeutic
antibody |
Nipocalimab |
FCGRT |
Whole mAb |
 |
| GMP-Bios-ab-379 |
Pre-Made Nirsevimab biosimilar,
Whole Mab: Anti-RSV therapeutic antibody
|
Nirsevimab |
RSV |
Whole mAb |
 |
| GMP-Bios-ab-380 |
Pre-Made Nivatrotamab
biosimilar, Bispecific Mixed mAb and scFv,
Anti-GD2;CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Nivatrotamab |
GD2;CD3E |
Bispecific Mixed mAb and
scFv |
 |
| GMP-Bios-ab-381 |
Pre-Made Nivolumab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Nivolumab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-382 |
Pre-Made Nurulimab biosimilar,
Whole mAb, Anti-CTLA4/CTLA-4 Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Nurulimab |
CTLA4/CTLA-4 |
Whole mAb |
 |
| GMP-Bios-ab-383 |
Pre-Made Obexelimab biosimilar,
Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3
therapeutic antibody |
Obexelimab |
CD19 |
Whole mAb |
 |
| GMP-Bios-ab-384 |
Pre-Made Obiltoxaximab
biosimilar, Whole Mab: Anti-Anthrax Protective
Antigen therapeutic antibody |
Obiltoxaximab |
Anthrax Protective
Antigen |
Whole mAb |
 |
| GMP-Bios-ab-385 |
Pre-Made Obinutuzumab
biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Obinutuzumab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-386 |
Pre-Made Obrindatamab
biosimilar, Bispecific scFv with Domain
Crossover, Anti-CD276;CD3E Antibody:
Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2;T3E/TCRE/IMD18
therapeutic antibody |
Obrindatamab |
CD276;CD3E |
Bispecific scFv with Domain
Crossover |
 |
| GMP-Bios-ab-387 |
Pre-Made Ocaratuzumab
biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ocaratuzumab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-388 |
Pre-Made Ociperlimab biosimilar,
Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Ociperlimab |
TIGIT |
Whole mAb |
 |
| GMP-Bios-ab-389 |
Pre-Made Ocrelizumab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ocrelizumab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-390 |
Pre-Made Odesivimab biosimilar,
Whole Mab: Anti-Zaire Ebolavirus GP therapeutic
antibody |
Odesivimab |
Zaire Ebolavirus GP |
Whole mAb |
 |
| GMP-Bios-ab-391 |
Pre-Made Odronextamab
biosimilar, Bispecific mAb, Anti-MS4A1/CD20;CD3E
Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18
therapeutic antibody |
Odronextamab |
MS4A1/CD20;CD3E |
Bispecific mAb |
 |
| GMP-Bios-ab-392 |
Pre-Made Ofatumumab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ofatumumab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-393 |
Pre-Made Olaratumab biosimilar,
Whole mAb, Anti-PDGFRA Antibody:
Anti-CD140A/PDGFR-2/PDGFR2 therapeutic
antibody |
Olaratumab |
PDGFRA |
Whole mAb |
 |
| GMP-Bios-ab-394 |
Pre-Made Oleclumab biosimilar,
Whole mAb, Anti-NT5E/CD73 Antibody:
Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic
antibody |
Oleclumab |
NT5E/CD73 |
Whole mAb |
 |
| GMP-Bios-ab-395 |
Pre-Made Olendalizumab
biosimilar, Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Olendalizumab |
C5/CO5 |
Whole mAb |
 |
| GMP-Bios-ab-396 |
Pre-Made Olinvacimab biosimilar,
Whole mAb, Anti-KDR Antibody:
Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic
antibody |
Olinvacimab |
KDR |
Whole mAb |
 |
| GMP-Bios-ab-397 |
Pre-Made Olokizumab biosimilar,
Whole mAb, Anti-IL6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Olokizumab |
IL6 |
Whole mAb |
 |
| GMP-Bios-ab-398 |
Pre-Made Omalizumab biosimilar,
Whole Mab: Anti-IGHE/IgE therapeutic
antibody |
Omalizumab |
IGHE/IgE |
Whole mAb |
 |
| GMP-Bios-ab-399 |
Pre-Made Omburtamab biosimilar,
Whole mAb Radiolabelled, Anti-CD276 Antibody:
Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic
antibody |
Omburtamab |
CD276 |
Whole mAb Radiolabelled |
 |
| GMP-Bios-ab-400 |
Pre-Made Omodenbamab biosimilar,
Whole Mab: Anti-SpA therapeutic antibody
|
Omodenbamab |
SpA |
Whole mAb |
 |
| GMP-Bios-ab-401 |
Pre-Made Onartuzumab biosimilar,
Fab + di-Fc, Anti-MET Antibody:
Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic
antibody |
Onartuzumab |
MET |
Fab + di-Fc |
 |
| GMP-Bios-ab-402 |
Pre-Made Onfekafusp biosimilar,
Whole mAb Fusion: Anti-FN extra domain B
therapeutic antibody |
Onfekafusp |
FN extra domain B |
Whole mAb Fusion |
 |
| GMP-Bios-ab-403 |
Pre-Made Ongericimab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Ongericimab |
PCSK9 |
Whole mAb |
 |
| GMP-Bios-ab-404 |
Pre-Made Ontamalimab biosimilar,
Whole Mab: Anti-MADCAM1 therapeutic antibody
|
Ontamalimab |
MADCAM1 |
Whole mAb |
 |
| GMP-Bios-ab-405 |
Pre-Made Ontuxizumab biosimilar,
Whole mAb, Anti-CD248 Antibody:
Anti-CD164L1/TEM1 therapeutic antibody |
Ontuxizumab |
CD248 |
Whole mAb |
 |
| GMP-Bios-ab-406 |
Pre-Made Onvatilimab biosimilar,
Whole mAb, Anti-VSIR Antibody:
Anti-B7-H5/B7H5/C10orf54/DD1alpha/Dies1/GI24/PD-1H/PP2135/SISP1/VISTA
therapeutic antibody |
Onvatilimab |
VSIR |
Whole mAb |
 |
| GMP-Bios-ab-407 |
Pre-Made Opicinumab biosimilar,
Whole mAb, Anti-LINGO1 Antibody:
Anti-LERN1/LRRN6A/MRT64/UNQ201 therapeutic
antibody |
Opicinumab |
LINGO1 |
Whole mAb |
 |
| GMP-Bios-ab-408 |
Pre-Made Oportuzumab biosimilar,
scFv, Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody |
Oportuzumab |
EPCAM |
scFv |
 |
| GMP-Bios-ab-409 |
Pre-Made Opucolimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Opucolimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-410 |
Pre-Made Ordesekimab biosimilar,
Whole Mab: Anti-IL15 therapeutic antibody
|
Ordesekimab |
IL15 |
Whole mAb |
 |
| GMP-Bios-ab-411 |
Pre-Made Orilanolimab
biosimilar, Whole mAb, Anti-FCGRT Antibody:
Anti-FCRN/FcgammaRn/alpha-chain therapeutic
antibody |
Orilanolimab |
FCGRT |
Whole mAb |
 |
| GMP-Bios-ab-412 |
Pre-Made Orticumab biosimilar,
Whole Mab: Anti-OxLDL therapeutic antibody
|
Orticumab |
OxLDL |
Whole mAb |
 |
| GMP-Bios-ab-413 |
Pre-Made Osocimab biosimilar,
Whole mAb, Anti-F11 Antibody: Anti-FXI/PTA
therapeutic antibody |
Osocimab |
F11 |
Whole mAb |
 |
| GMP-Bios-ab-414 |
Pre-Made Otelixizumab
biosimilar, Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Otelixizumab |
CD3E |
Whole mAb |
 |
| GMP-Bios-ab-415 |
Pre-Made Otilimab biosimilar,
Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF
therapeutic antibody |
Otilimab |
CSF2 |
Whole mAb |
 |
| GMP-Bios-ab-416 |
Pre-Made Otlertuzumab
biosimilar, di-scFv+Fc, Anti-CD37 Antibody:
Anti-GP52-40/TSPAN26 therapeutic antibody
|
Otlertuzumab |
CD37 |
di-scFv+Fc |
 |
| GMP-Bios-ab-417 |
Pre-Made Oxelumab biosimilar,
Whole mAb, Anti-TNFSF4/OX40 Antibody:
Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1
therapeutic antibody |
Oxelumab |
TNFSF4/OX40 |
Whole mAb |
 |
| GMP-Bios-ab-418 |
Pre-Made Ozanezumab biosimilar,
Whole mAb, Anti-RTN4 Antibody:
Anti-ASY/NI220/250/NOGO/NSP/NSP-CL/Nbla00271/Nbla10545/RTN-X-B1-B2
therapeutic antibody |
Ozanezumab |
RTN4 |
Whole mAb |
 |
| GMP-Bios-ab-419 |
Pre-Made Ozoralizumab
biosimilar, Bispecific Single Domains
(VH-VH'-VH), Anti-TNFA/TNF;ALB Antibody:
Anti-DIF/TNF-alpha/TNFSF2/TNLG1F;FDAHT/HSA/PRO0883/PRO0903/PRO1341
therapeutic antibody |
Ozoralizumab |
TNFA/TNF;ALB |
Bispecific Single Domains
(VH-VH'-VH) |
 |
| GMP-Bios-ab-420 |
Pre-Made Pabinafusp biosimilar,
Whole mAb Fusion, Anti-TFRC Antibody:
Anti-CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90
therapeutic antibody |
Pabinafusp |
TFRC |
Whole mAb Fusion |
 |
| GMP-Bios-ab-421 |
Pre-Made Pacanalotamab
biosimilar, Bispecific scFv, Anti-TNFRSF17;CD3E
Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18
therapeutic antibody |
Pacanalotamab |
TNFRSF17; CD3E |
Bispecific scFv |
 |
| GMP-Bios-ab-422 |
Pre-Made Pacmilimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Pacmilimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-423 |
Pre-Made Palivizumab biosimilar,
Whole Mab: Anti-RSV gpF therapeutic antibody
|
Palivizumab |
RSV gpF |
Whole mAb |
 |
| GMP-Bios-ab-424 |
Pre-Made Pamrevlumab biosimilar,
Whole mAb, Anti-CTGF/CCN2 Antibody:
Anti-HCS24/IGFBP8/NOV2 therapeutic antibody
|
Pamrevlumab |
CTGF/CCN2 |
Whole mAb |
 |
| GMP-Bios-ab-425 |
Pre-Made Panitumumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Panitumumab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-426 |
Pre-Made PankoMab biosimilar,
Whole mAb, Anti-MUC1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
PankoMab |
MUC1 |
Whole mAb |
 |
| GMP-Bios-ab-427 |
Pre-Made Panobacumab biosimilar,
Whole Mab: Anti-Serotype IATS O11 therapeutic
antibody |
Panobacumab |
Serotype IATS O11 |
Whole mAb |
 |
| GMP-Bios-ab-428 |
Pre-Made Parsatuzumab
biosimilar, Whole mAb, Anti-EGFL7 Antibody:
Anti-NEU1/VE-STATIN/ZNEU1 therapeutic
antibody |
Parsatuzumab |
EGFL7 |
Whole mAb |
 |
| GMP-Bios-ab-429 |
Pre-Made Pasotuxizumab
biosimilar, Bispecific scFv,
Anti-FOLH1/GCPII;CD3E Antibody:
Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18
therapeutic antibody |
Pasotuxizumab |
FOLH1/GCPII;CD3E |
Bispecific scFv |
 |
| GMP-Bios-ab-430 |
Pre-Made Pateclizumab
biosimilar, Whole mAb, Anti-LTA Antibody:
Anti-LT/TNFB/TNFSF1/TNLG1E therapeutic
antibody |
Pateclizumab |
LTA |
Whole mAb |
 |
| GMP-Bios-ab-431 |
Pre-Made Patritumab biosimilar,
Whole mAb, Anti-ERBB3/Erbb-3 Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Patritumab |
ERBB3/Erbb-3 |
Whole mAb |
 |
| GMP-Bios-ab-432 |
Pre-Made Pavunalimab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-LAG3;CTLA4/CTLA-4 Antibody:
Anti-CD223;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Pavunalimab |
LAG3;CTLA4/CTLA-4 |
Bispecific Mixed mAb and
scFv |
 |
| GMP-Bios-ab-433 |
Pre-Made Pavurutamab biosimilar,
Bispecific scFv, Anti-TNFRSF17;CD3E Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18
therapeutic antibody |
Pavurutamab |
TNFRSF17; CD3E |
Bispecific scFv |
 |
| GMP-Bios-ab-434 |
Pre-Made Pelgifatamab
biosimilar, Whole mAb ADC, Anti-FOLH1/GCPII
Antibody:
Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP
therapeutic antibody |
Pelgifatamab |
FOLH1/GCPII |
Whole mAb ADC |
 |
| GMP-Bios-ab-435 |
Pre-Made Pembrolizumab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Pembrolizumab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-436 |
Pre-Made Penpulimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Penpulimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-437 |
Pre-Made Pepinemab biosimilar,
Whole mAb, Anti-SEMA4D Antibody:
Anti-A8/BB18/C9orf164/CD100/COLL4/GR3/M-sema-G/SEMAJ/coll-4
therapeutic antibody |
Pepinemab |
SEMA4D |
Whole mAb |
 |
| GMP-Bios-ab-438 |
Pre-Made Perakizumab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Perakizumab |
IL17A/IL17 |
Whole mAb |
 |
| GMP-Bios-ab-439 |
Pre-Made Pertuzumab biosimilar,
Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Pertuzumab |
ERBB2/HER2 |
Whole mAb |
 |
| GMP-Bios-ab-440 |
Pre-Made Petosemtamab
biosimilar, Bispecific mAb, Anti-EGFR;LGR5
Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;FEX/GPR49/GPR67/GRP49/HG38
therapeutic antibody |
Petosemtamab |
EGFR;LGR5 |
Bispecific mAb |
 |
| GMP-Bios-ab-441 |
Pre-Made Pidilizumab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Pidilizumab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-442 |
Pre-Made Pimivalimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Pimivalimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-443 |
Pre-Made Pimurutamab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Pimurutamab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-444 |
Pre-Made Pinatuzumab biosimilar,
Whole mAb ADC, Anti-CD22 Antibody:
Anti-SIGLEC2/SIGLEC-2 therapeutic antibody
|
Pinatuzumab |
CD22 |
Whole mAb ADC |
 |
| GMP-Bios-ab-445 |
Pre-Made Placulumab biosimilar,
Single Domain Variable Fragment (VL + Fc),
Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F
therapeutic antibody |
Placulumab |
TNFA/TNF |
Single Domain Variable
Fragment (VL) + Fc |
 |
| GMP-Bios-ab-446 |
Pre-Made Plamotamab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-MS4A1/CD20;CD3E Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18
therapeutic antibody |
Plamotamab |
MS4A1/CD20;CD3E |
Bispecific Mixed mAb and
scFv |
 |
| GMP-Bios-ab-447 |
Pre-Made Plozalizumab
biosimilar, Whole mAb, Anti-CCR2 Antibody:
Anti-CKR2/CD192/CKR2A/CKR2B/CMKBR2/MCP-1-R/CC-CKR-2
therapeutic antibody |
Plozalizumab |
CCR2 |
Whole mAb |
 |
| GMP-Bios-ab-448 |
Pre-Made Pogalizumab biosimilar,
Whole mAb, Anti-TNFRSF4/CD134 Antibody:
Anti-ACT35/IMD16/OX40/TXGP1L therapeutic
antibody |
Pogalizumab |
TNFRSF4/CD134 |
Whole mAb |
 |
| GMP-Bios-ab-449 |
Pre-Made Polatuzumab biosimilar,
Whole mAb ADC, Anti-CD79B Antibody:
Anti-AGM6/B29/IGB therapeutic antibody |
Polatuzumab |
CD79B |
Whole mAb ADC |
 |
| GMP-Bios-ab-450 |
Pre-Made Ponezumab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Ponezumab |
APP |
Whole mAb |
 |
| GMP-Bios-ab-451 |
Pre-Made Ponsegromab biosimilar,
Whole mAb, Anti-GDF15 Antibody:
Anti-GDF-15/MIC-1/MIC1/NAG-1/PDF/PLAB/PTGFB
therapeutic antibody |
Ponsegromab |
GDF15 |
Whole mAb |
 |
| GMP-Bios-ab-452 |
Pre-Made Porgaviximab
biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP
therapeutic antibody |
Porgaviximab |
Zaire Ebolavirus GP |
Whole mAb |
 |
| GMP-Bios-ab-453 |
Pre-Made Plonmarlimab
biosimilar, Whole mAb, Anti-CSF2 Antibody:
Anti-CSF/GMCSF therapeutic antibody |
Plonmarlimab |
CSF2 |
Whole mAb |
 |
| GMP-Bios-ab-454 |
Pre-Made Praluzatamab
biosimilar, Whole mAb, Anti-CD166/ALCAM
Antibody: Anti-MEMD therapeutic antibody
|
Praluzatamab |
CD166/ALCAM |
Whole mAb |
 |
| GMP-Bios-ab-455 |
Pre-Made Prasinezumab
biosimilar, Whole mAb, Anti-SNCA Antibody:
Anti-NACP/PARK1/PARK4/PD1 therapeutic
antibody |
Prasinezumab |
SNCA |
Whole mAb |
 |
| GMP-Bios-ab-456 |
Pre-Made Prezalumab biosimilar,
Whole mAb, Anti-ICOSLG/B7RP1 Antibody:
Anti-B7-H2/B7H2/B7h/CD275/GL50/ICOS-L/ICOSL/LICOS
therapeutic antibody |
Prezalumab |
ICOSLG/B7RP1 |
Whole mAb |
 |
| GMP-Bios-ab-457 |
Pre-Made Pritoxaximab
biosimilar, Whole Mab: Anti-Shiga Toxin Type 1
therapeutic antibody |
Pritoxaximab |
Shiga Toxin Type 1 |
Whole mAb |
 |
| GMP-Bios-ab-458 |
Pre-Made Prolgolimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Prolgolimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-459 |
Pre-Made Pucotenlimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Pucotenlimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-460 |
Pre-Made Quavonlimab biosimilar,
Whole mAb, Anti-CTLA4/CTLA-4 Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Quavonlimab |
CTLA4/CTLA-4 |
Whole mAb |
 |
| GMP-Bios-ab-461 |
Pre-Made Quetmolimab biosimilar,
Whole mAb, Anti-CX3CL1 Antibody:
Anti-ABCD-3/C3Xkine/CXC3/CXC3C/NTN/NTT/SCYD1/fractalkine/neurotactin
therapeutic antibody |
Quetmolimab |
CX3CL1 |
Whole mAb |
 |
| GMP-Bios-ab-462 |
Pre-Made Quilizumab biosimilar,
Whole Mab: Anti-IGHE/IgE therapeutic
antibody |
Quilizumab |
IGHE/IgE |
Whole mAb |
 |
| GMP-Bios-ab-463 |
Pre-Made Racotumomab biosimilar,
Whole Mab: Anti-Idiotope of
Anti-NeuGc-ganliosides therapeutic antibody
|
Racotumomab |
Idiotope of
anti-NeuGc-ganliosides |
Whole mAb |
 |
| GMP-Bios-ab-464 |
Pre-Made Radretumab biosimilar,
di-scFv + CH4: Anti-FN extra domain B
therapeutic antibody |
Radretumab |
FN extra domain B |
di-scFv + CH4 |
 |
| GMP-Bios-ab-465 |
Pre-Made Rafivirumab biosimilar,
Whole Mab: Anti-RV Antigenic Site III
therapeutic antibody |
Rafivirumab |
RV Antigenic Site III |
Whole mAb |
 |
| GMP-Bios-ab-466 |
Pre-Made Ragifilimab biosimilar,
Whole mAb, Anti-TNFRSF18 Antibody:
Anti-AITR/CD357/ENERGEN/GITR/GITR-D therapeutic
antibody |
Ragifilimab |
TNFRSF18 |
Whole mAb |
 |
| GMP-Bios-ab-467 |
Pre-Made Ralpancizumab
biosimilar, Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Ralpancizumab |
PCSK9 |
Whole mAb |
 |
| GMP-Bios-ab-468 |
Pre-Made Ramucirumab biosimilar,
Whole mAb, Anti-KDR Antibody:
Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic
antibody |
Ramucirumab |
KDR |
Whole mAb |
 |
| GMP-Bios-ab-469 |
Pre-Made Ranevetmab biosimilar,
Canine Whole mAb, Anti-NGFB/NGF Antibody:
Anti-HSAN5 therapeutic antibody |
Ranevetmab |
NGFB/NGF |
Canine Whole mAb |
 |
| GMP-Bios-ab-470 |
Pre-Made Ranibizumab biosimilar,
Fab, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1
therapeutic antibody |
Ranibizumab |
VEGFA |
Fab |
 |
| GMP-Bios-ab-471 |
Pre-Made Ravagalimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Ravagalimab |
CD40 |
Whole mAb |
 |
| GMP-Bios-ab-472 |
Pre-Made Ravulizumab biosimilar,
Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Ravulizumab |
C5/CO5 |
Whole mAb |
 |
| GMP-Bios-ab-473 |
Pre-Made Recaticimab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Recaticimab |
PCSK9 |
Whole mAb |
 |
| GMP-Bios-ab-474 |
Pre-Made Refanezumab biosimilar,
Whole mAb, Anti-MAG Antibody:
Anti-GMA/S-MAG/SIGLEC-4A/SIGLEC4A/SPG75
therapeutic antibody |
Refanezumab |
MAG |
Whole mAb |
 |
| GMP-Bios-ab-476 |
Pre-Made Relatlimab biosimilar,
Whole mAb, Anti-LAG3 Antibody: Anti-CD223
therapeutic antibody |
Relatlimab |
LAG3 |
Whole mAb |
 |
| GMP-Bios-ab-477 |
Pre-Made Relfovetmab biosimilar,
Feline Whole mAb, Anti-NGFB/NGF Antibody:
Anti-HSAN5 therapeutic antibody |
Relfovetmab |
NGFB/NGF |
Feline Whole mAb |
 |
| GMP-Bios-ab-478 |
Pre-Made Remtolumab biosimilar,
Bispecific Dual Variable Domain IG:
Anti-IL17A/IL17;TNFA/TNF therapeutic
antibody |
Remtolumab |
IL17A/IL17; TNFA/TNF |
Bispecific Dual Variable
Domain IG |
 |
| GMP-Bios-ab-479 |
Pre-Made Reslizumab biosimilar,
Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF
therapeutic antibody |
Reslizumab |
IL5 |
Whole mAb |
 |
| GMP-Bios-ab-480 |
Pre-Made Retifanlimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Retifanlimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-481 |
Pre-Made Retlirafusp biosimilar,
Whole mAb Fusion, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Retlirafusp |
CD274/PD-L1 |
Whole mAb Fusion |
 |
| GMP-Bios-ab-482 |
Pre-Made Revdofilimab
biosimilar, Whole mAb, Anti-TNFRSF4/CD134
Antibody: Anti-ACT35/IMD16/OX40/TXGP1L
therapeutic antibody |
Revdofilimab |
TNFRSF4/CD134 |
Whole mAb |
 |
| GMP-Bios-ab-483 |
Pre-Made Rilotumumab biosimilar,
Whole mAb, Anti-HGF Antibody:
Anti-DFNB39/F-TCF/HPTA/SF therapeutic
antibody |
Rilotumumab |
HGF |
Whole mAb |
 |
| GMP-Bios-ab-484 |
Pre-Made Rinucumab biosimilar,
Whole mAb, Anti-PDGFRB Antibody:
Anti-IMF1/KOGS/IBGC4/JTK12/PDGFR/PENTT/CD140B/PDGFR1/PDGFR-1
therapeutic antibody |
Rinucumab |
PDGFRB |
Whole mAb |
 |
| GMP-Bios-ab-485 |
Pre-Made Ripertamab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ripertamab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-486 |
Pre-Made Risankizumab
biosimilar, Whole mAb, Anti-IL23A/IL23 Antibody:
Anti-IL23P19/P19/SGRF therapeutic antibody
|
Risankizumab |
IL23A/IL23 |
Whole mAb |
 |
| GMP-Bios-ab-487 |
Pre-Made Rituximab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Rituximab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-488 |
Pre-Made Rivabazumab biosimilar,
Fab: Anti-PcrV type III secretion system
therapeutic antibody |
Rivabazumab |
PcrV type III secretion
system |
Fab |
 |
| GMP-Bios-ab-489 |
Pre-Made Robatumumab biosimilar,
Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Robatumumab |
IGF1R |
Whole mAb |
 |
| GMP-Bios-ab-490 |
Pre-Made Roledumab biosimilar,
Whole mAb, Anti-RHD Antibody:
Anti-CD240D/DIIIc/HDFNRH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhII/RhK562-II/RhPI
therapeutic antibody |
Roledumab |
RHD |
Whole mAb |
 |
| GMP-Bios-ab-491 |
Pre-Made Rolinsatamab
biosimilar, Whole mAb ADC, Anti-PRLR Antibody:
Anti-HPRL/MFAB/RI-PRLR/hPRLrI therapeutic
antibody |
Rolinsatamab |
PRLR |
Whole mAb ADC |
 |
| GMP-Bios-ab-492 |
Pre-Made Romilkimab biosimilar,
Bispecific Dual Variable Domain IG,
Anti-IL13;IL4 Antibody:
Anti-IL-13/P600;BCGF-1/BCGF1/BSF-1/BSF1/IL-4
therapeutic antibody |
Romilkimab |
IL13;IL4 |
Bispecific Dual Variable
Domain IG |
 |
| GMP-Bios-ab-493 |
Pre-Made Romosozumab biosimilar,
Whole mAb, Anti-SOST Antibody:
Anti-CDD/DAND6/VBCH therapeutic antibody
|
Romosozumab |
SOST |
Whole mAb |
 |
| GMP-Bios-ab-494 |
Pre-Made Rontalizumab
biosimilar, Whole mAb, Anti-IFNA1 Antibody:
Anti-IFL/IFN3/leIF DD therapeutic antibody
|
Rontalizumab |
IFNA1 |
Whole mAb |
 |
| GMP-Bios-ab-495 |
Pre-Made Rosmantuzumab
biosimilar, Whole mAb, Anti-RSPO3 Antibody:
Anti-CRISTIN1/PWTSR/THSD2 therapeutic
antibody |
Rosmantuzumab |
RSPO3 |
Whole mAb |
 |
| GMP-Bios-ab-496 |
Pre-Made Rosopatamab biosimilar,
Whole mAb, Anti-FOLH1/GCPII Antibody:
Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP
therapeutic antibody |
Rosopatamab |
FOLH1/GCPII |
Whole mAb |
 |
| GMP-Bios-ab-497 |
Pre-Made Rovalpituzumab
biosimilar, Whole mAb ADC, Anti-DLL3 Antibody:
Anti-SCDO1 therapeutic antibody |
Rovalpituzumab |
DLL3 |
Whole mAb ADC |
 |
| GMP-Bios-ab-498 |
Pre-Made Rozanolixizumab
biosimilar, Whole mAb, Anti-FCGRT Antibody:
Anti-FCRN/FcgammaRn/alpha-chain therapeutic
antibody |
Rozanolixizumab |
FCGRT |
Whole mAb |
 |
| GMP-Bios-ab-499 |
Pre-Made Rozibafusp biosimilar,
Whole mAb Fusion, Anti-ICOS Antibody:
Anti-AILIM/CD278/CVID1 therapeutic antibody
|
Rozibafusp |
ICOS |
Whole mAb Fusion |
 |
| GMP-Bios-ab-500 |
Pre-Made Runimotamab biosimilar,
Bispecific mAb, Anti-ERBB2/HER2;CD3E Antibody:
Anti-CD340/MLN
19/NEU/NGL/TKR1/VSCN2;T3E/TCRE/IMD18 therapeutic
antibody |
Runimotamab |
ERBB2/HER2;CD3E |
Bispecific mAb |
 |
| GMP-Bios-ab-501 |
Pre-Made Ruplizumab biosimilar,
Whole mAb, Anti-CD40LG Antibody:
Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L
therapeutic antibody |
Ruplizumab |
CD40LG |
Whole mAb |
 |
| GMP-Bios-ab-502 |
Pre-Made Sabatolimab biosimilar,
Whole mAb, Anti-HAVCR2/TIM3 Antibody:
Anti-CD366/KIM-3/SPTCL/TIMD3/Tim-3/TIMD-3/HAVcr-2
therapeutic antibody |
Sabatolimab |
HAVCR2/TIM3 |
Whole mAb |
 |
| GMP-Bios-ab-503 |
Pre-Made Sacituzumab biosimilar,
Whole mAb ADC, Anti-TACSTD2 Antibody:
Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2
therapeutic antibody |
Sacituzumab |
TACSTD2 |
Whole mAb ADC |
 |
| GMP-Bios-ab-504 |
Pre-Made Samalizumab biosimilar,
Whole mAb, Anti-CD200 Antibody:
Anti-MRC/MOX1/MOX2/OX-2 therapeutic antibody
|
Samalizumab |
CD200 |
Whole mAb |
 |
| GMP-Bios-ab-505 |
Pre-Made Samrotamab biosimilar,
Whole mAb ADC, Anti-LRRC15 Antibody: Anti-LIB
therapeutic antibody |
Samrotamab |
LRRC15 |
Whole mAb ADC |
 |
| GMP-Bios-ab-506 |
Pre-Made Sapelizumab biosimilar,
Whole mAb, Anti-IL6R Antibody:
Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80
therapeutic antibody |
Sapelizumab |
IL6R |
Whole mAb |
 |
| GMP-Bios-ab-507 |
Pre-Made Sarilumab biosimilar,
Whole mAb, Anti-IL6R Antibody:
Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80
therapeutic antibody |
Sarilumab |
IL6R |
Whole mAb |
 |
| GMP-Bios-ab-508 |
Pre-Made Sasanlimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Sasanlimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-509 |
Pre-Made Satralizumab
biosimilar, Whole mAb, Anti-IL6R Antibody:
Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80
therapeutic antibody |
Satralizumab |
IL6R |
Whole mAb |
 |
| GMP-Bios-ab-510 |
Pre-Made Secukinumab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Secukinumab |
IL17A/IL17 |
Whole mAb |
 |
| GMP-Bios-ab-511 |
Pre-Made Selicrelumab
biosimilar, Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Selicrelumab |
CD40 |
Whole mAb |
 |
| GMP-Bios-ab-512 |
Pre-Made Semorinemab biosimilar,
Whole mAb, Anti-MAPT Antibody:
Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40
therapeutic antibody |
Semorinemab |
MAPT |
Whole mAb |
 |
| GMP-Bios-ab-513 |
Pre-Made Serclutamab biosimilar,
Whole mAb ADC, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Serclutamab |
EGFR |
Whole mAb ADC |
 |
| GMP-Bios-ab-514 |
Pre-Made Seribantumab
biosimilar, Whole mAb, Anti-ERBB3/Erbb-3
Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody |
Seribantumab |
ERBB3/Erbb-3 |
Whole mAb |
 |
| GMP-Bios-ab-515 |
Pre-Made Serplulimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Serplulimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-516 |
Pre-Made Setoxaximab biosimilar,
Whole Mab: Anti-Shiga Toxin Type 2 therapeutic
antibody |
Setoxaximab |
Shiga Toxin Type 2 |
Whole mAb |
 |
| GMP-Bios-ab-517 |
Pre-Made Setrusumab biosimilar,
Whole mAb, Anti-SOST Antibody:
Anti-CDD/DAND6/VBCH therapeutic antibody
|
Setrusumab |
SOST |
Whole mAb |
 |
| GMP-Bios-ab-518 |
Pre-Made Sibeprenlimab
biosimilar, Whole mAb, Anti-TNFSF13/APRIL
Antibody:
Anti-CD256/TALL-2/TALL2/TNLG7B/TRDL-1/UNQ383/PRO715/ZTNF2
therapeutic antibody |
Sibeprenlimab |
TNFSF13/APRIL |
Whole mAb |
 |
| GMP-Bios-ab-519 |
Pre-Made Sifalimumab biosimilar,
Whole mAb, Anti-IFNA1 Antibody:
Anti-IFL/IFN3/leIF DD therapeutic antibody
|
Sifalimumab |
IFNA1 |
Whole mAb |
 |
| GMP-Bios-ab-520 |
Pre-Made Siltuximab biosimilar,
Whole mAb, Anti-IL6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Siltuximab |
IL6 |
Whole mAb |
 |
| GMP-Bios-ab-521 |
Pre-Made Simlukafusp biosimilar,
Whole mAb Fusion, Anti-FAP Antibody:
Anti-FAPA/SIMP/DPPIV/FAPalpha therapeutic
antibody |
Simlukafusp |
FAP |
Whole mAb Fusion |
 |
| GMP-Bios-ab-522 |
Pre-Made Simtuzumab biosimilar,
Whole mAb, Anti-LOXL2 Antibody:
Anti-LOR/LOR2/WS9-14 therapeutic antibody
|
Simtuzumab |
LOXL2 |
Whole mAb |
 |
| GMP-Bios-ab-523 |
Pre-Made Sintilimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Sintilimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-524 |
Pre-Made Sirtratumab biosimilar,
Whole mAb ADC, Anti-SLITRK6 Antibody:
Anti-DFNMYP therapeutic antibody |
Sirtratumab |
SLITRK6 |
Whole mAb ADC |
 |
| GMP-Bios-ab-525 |
Pre-Made Sirukumab biosimilar,
Whole mAb, Anti-IL6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Sirukumab |
IL6 |
Whole mAb |
 |
| GMP-Bios-ab-526 |
Pre-Made Sofituzumab biosimilar,
Whole mAb ADC, Anti-MUC16 Antibody: Anti-CA125
therapeutic antibody |
Sofituzumab |
MUC16 |
Whole mAb ADC |
 |
| GMP-Bios-ab-527 |
Pre-Made Solanezumab biosimilar,
Whole mAb, Anti-APP Antibody:
Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma
therapeutic antibody |
Solanezumab |
APP |
Whole mAb |
 |
| GMP-Bios-ab-528 |
Pre-Made Solitomab biosimilar,
Bispecific scFv, Anti-EPCAM;CD3E Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1;T3E/TCRE/IMD18
therapeutic antibody |
Solitomab |
EPCAM;CD3E |
Bispecific scFv |
 |
| GMP-Bios-ab-529 |
Pre-Made Sotigalimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Sotigalimab |
CD40 |
Whole mAb |
 |
| GMP-Bios-ab-530 |
Pre-Made Sotrovimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Sotrovimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-531 |
Pre-Made Spartalizumab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Spartalizumab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-532 |
Pre-Made Spesolimab biosimilar,
Whole mAb, Anti-IL36RN/IL-36R Antibody:
Anti-FIL1/FIL1(DELTA)/FIL1D/IL1F5/IL1HY1/IL1L1/IL1RP3/IL36RA/PSORP/PSORS14
therapeutic antibody |
Spesolimab |
IL36RN/IL-36R |
Whole mAb |
 |
| GMP-Bios-ab-533 |
Pre-Made Sudubrilimab
biosimilar, Whole mAb, Anti-CD274/PD-L1
Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1
therapeutic antibody |
Sudubrilimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-534 |
Pre-Made Sugemalimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Sugemalimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-535 |
Pre-Made Suptavumab biosimilar,
Whole Mab: Anti-RSV gpF therapeutic antibody
|
Suptavumab |
RSV gpF |
Whole mAb |
 |
| GMP-Bios-ab-536 |
Pre-Made Surzebiclimab
biosimilar, Whole mAb, Anti-HAVCR2/TIM3
Antibody:
Anti-CD366/KIM-3/SPTCL/TIMD3/Tim-3/TIMD-3/HAVcr-2
therapeutic antibody |
Surzebiclimab |
HAVCR2/TIM3 |
Whole mAb |
 |
| GMP-Bios-ab-537 |
Pre-Made Sutimlimab biosimilar,
Whole mAb, Anti-C1S Antibody: Anti-EDSPD2
therapeutic antibody |
Sutimlimab |
C1S |
Whole mAb |
 |
| GMP-Bios-ab-538 |
Pre-Made Suvizumab biosimilar,
Whole Mab: Anti-HIV-1 gp120 therapeutic
antibody |
Suvizumab |
HIV-1 gp120 |
Whole mAb |
 |
| GMP-Bios-ab-539 |
Pre-Made Suvratoxumab
biosimilar, Whole Mab: Anti-Toxin A therapeutic
antibody |
Suvratoxumab |
Toxin A |
Whole mAb |
 |
| GMP-Bios-ab-540 |
Pre-Made Tabalumab biosimilar,
Whole mAb, Anti-TNFSF13B Antibody:
Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4
therapeutic antibody |
Tabalumab |
TNFSF13B |
Whole mAb |
 |
| GMP-Bios-ab-541 |
Pre-Made Tabituximab biosimilar,
Whole mAb ADC, Anti-FZD10 Antibody:
Anti-CD350/FZ-10/Fz10/FzE7/hFz10 therapeutic
antibody |
Tabituximab |
FZD10 |
Whole mAb ADC |
 |
| GMP-Bios-ab-542 |
Pre-Made Tadocizumab biosimilar,
Fab, Anti-ITGA2B;ITGB3 Antibody:
Anti-BDPLT16/BDPLT2/CD41/CD41B/GP2B/GPIIb/GT/GT1/GTA/HPA3/PPP1R93;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2
therapeutic antibody |
Tadocizumab |
ITGA2B;ITGB3 |
Fab |
 |
| GMP-Bios-ab-543 |
Pre-Made Tafasitamab biosimilar,
Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3
therapeutic antibody |
Tafasitamab |
CD19 |
Whole mAb |
 |
| GMP-Bios-ab-544 |
Pre-Made Tafolecimab biosimilar,
Whole mAb, Anti-PCSK9 Antibody:
Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
therapeutic antibody |
Tafolecimab |
PCSK9 |
Whole mAb |
 |
| GMP-Bios-ab-545 |
Pre-Made Talacotuzumab
biosimilar, Whole mAb, Anti-IL3RA Antibody:
Anti-IL3R/CD123/IL3RX/IL3RY/hIL-3Ra therapeutic
antibody |
Talacotuzumab |
IL3RA |
Whole mAb |
 |
| GMP-Bios-ab-546 |
Pre-Made Talquetamab biosimilar,
Bispecific mAb, Anti-GPRC5D;CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Talquetamab |
GPRC5D;CD3E |
Bispecific mAb |
 |
| GMP-Bios-ab-547 |
Pre-Made Tamrintamab biosimilar,
Whole mAb ADC, Anti-DPEP3 Antibody: Anti-MBD3
therapeutic antibody |
Tamrintamab |
DPEP3 |
Whole mAb ADC |
 |
| GMP-Bios-ab-548 |
Pre-Made Tamtuvetmab biosimilar,
Canine Whole mAb, Anti-CD52 Antibody:
Anti-HE5/CDW52/EDDM5 therapeutic antibody
|
Tamtuvetmab |
CD52 |
Canine Whole mAb |
 |
| GMP-Bios-ab-549 |
Pre-Made Tanezumab biosimilar,
Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5
therapeutic antibody |
Tanezumab |
NGFB/NGF |
Whole mAb |
 |
| GMP-Bios-ab-550 |
Pre-Made Tanibirumab biosimilar,
Whole mAb, Anti-KDR Antibody:
Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic
antibody |
Tanibirumab |
KDR |
Whole mAb |
 |
| GMP-Bios-ab-551 |
Pre-Made Tarextumab biosimilar,
Whole mAb, Anti-NOTCH2&3 Antibody:
Anti-AGS2/HJCYS/hN2;CADASIL/CADASIL1/CASIL/IMF2/LMNS
therapeutic antibody |
Tarextumab |
NOTCH2&3 |
Whole mAb |
 |
| GMP-Bios-ab-552 |
Pre-Made Tarlatamab biosimilar,
Bispecific scFv, Anti-DLL3;CD3E Antibody:
Anti-SCDO1;T3E/TCRE/IMD18 therapeutic
antibody |
Tarlatamab |
DLL3;CD3E |
Bispecific scFv |
 |
| GMP-Bios-ab-553 |
Pre-Made Tavolimab biosimilar,
Whole mAb, Anti-TNFSF4/OX40 Antibody:
Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1
therapeutic antibody |
Tavolimab |
TNFSF4/OX40 |
Whole mAb |
 |
| GMP-Bios-ab-554 |
Pre-Made Tavolixizumab
biosimilar, Whole mAb, Anti-TNFSF4/OX40
Antibody:
Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1
therapeutic antibody |
Tavolixizumab |
TNFSF4/OX40 |
Whole mAb |
 |
| GMP-Bios-ab-555 |
Pre-Made Tebentafusp biosimilar,
scFv Fusion, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Tebentafusp |
CD3E |
scFv Fusion |
 |
| GMP-Bios-ab-556 |
Pre-Made Tebotelimab biosimilar,
Bispecific scFv with Crossover,
Anti-PDCD1/PD-1;LAG3 Antibody:
Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD223
therapeutic antibody |
Tebotelimab |
PDCD1/PD-1;LAG3 |
Bispecific scFv with
Crossover |
 |
| GMP-Bios-ab-557 |
Pre-Made Teclistamab biosimilar,
Bispecific mAb, Anti-TNFRSF17;CD3E Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18
therapeutic antibody |
Teclistamab |
TNFRSF17;CD3E |
Bispecific mAb |
 |
| GMP-Bios-ab-558 |
Pre-Made Telazorlimab
biosimilar, Whole mAb, Anti-TNFRSF4/CD134
Antibody: Anti-ACT35/IMD16/OX40/TXGP1L
therapeutic antibody |
Telazorlimab |
TNFRSF4/CD134 |
Whole mAb |
 |
| GMP-Bios-ab-559 |
Pre-Made Telisotuzumab
biosimilar, Whole mAb ADC, Anti-MET Antibody:
Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic
antibody |
Telisotuzumab |
MET |
Whole mAb ADC |
 |
| GMP-Bios-ab-561 |
Pre-Made Tenatumomab biosimilar,
Whole mAb Radiolabelled, Anti-TNC Antibody:
Anti-150-225/DFNA56/GMEM/GP/HXB/JI/TN/TN-C
therapeutic antibody |
Tenatumomab |
TNC |
Whole mAb Radiolabelled |
 |
| GMP-Bios-ab-562 |
Pre-Made Teplizumab biosimilar,
Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Teplizumab |
CD3E |
Whole mAb |
 |
| GMP-Bios-ab-563 |
Pre-Made Tepoditamab biosimilar,
Bispecific mAb, Anti-CLEC12A/CD371;CD3E
Antibody:
Anti-CLL-1/CLL1/DCAL-2/MICL;T3E/TCRE/IMD18
therapeutic antibody |
Tepoditamab |
CLEC12A/CD371;CD3E |
Bispecific mAb |
 |
| GMP-Bios-ab-564 |
Pre-Made Teprotumumab
biosimilar, Whole mAb, Anti-IGF1R Antibody:
Anti-IGFR/CD221/IGFIR/JTK13 therapeutic
antibody |
Teprotumumab |
IGF1R |
Whole mAb |
 |
| GMP-Bios-ab-565 |
Pre-Made Tesidolumab biosimilar,
Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Tesidolumab |
C5/CO5 |
Whole mAb |
 |
| GMP-Bios-ab-566 |
Pre-Made Tesnatilimab
biosimilar, Whole mAb, Anti-KLRK1 Antibody:
Anti-CD314/D12S2489E/KLR/NKG2-D/NKG2D
therapeutic antibody |
Tesnatilimab |
KLRK1 |
Whole mAb |
 |
| GMP-Bios-ab-567 |
Pre-Made Tezepelumab biosimilar,
Whole Mab: Anti-TSLP therapeutic antibody
|
Tezepelumab |
TSLP |
Whole mAb |
 |
| GMP-Bios-ab-568 |
Pre-Made Tibulizumab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-TNFSF13B;IL17A/IL17 Antibody:
Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4;CTLA-8/CTLA8A
therapeutic antibody |
Tibulizumab |
TNFSF13B;IL17A/IL17 |
Bispecific Mixed mAb and
scFv |
 |
| GMP-Bios-ab-569 |
Pre-Made Ticilimumab biosimilar,
Whole mAb, Anti-CTLA4/CTLA-4 Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Ticilimumab |
CTLA4/CTLA-4 |
Whole mAb |
 |
| GMP-Bios-ab-570 |
Pre-Made Tidutamab biosimilar,
Bispecific Mixed mAb and scFv, Anti-SSTR2;CD3E
Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon
therapeutic antibody |
Tidutamab |
SSTR2;CD3E |
Bispecific Mixed mAb and
scFv |
 |
| GMP-Bios-ab-571 |
Pre-Made Tigatuzumab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Tigatuzumab |
TNFRSF10B/TRAIL-R2 |
Whole mAb |
 |
| GMP-Bios-ab-572 |
Pre-Made Tilavonemab biosimilar,
Whole mAb, Anti-MAPT Antibody:
Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40
therapeutic antibody |
Tilavonemab |
MAPT |
Whole mAb |
 |
| GMP-Bios-ab-573 |
Pre-Made Tildrakizumab
biosimilar, Whole mAb, Anti-IL23A/IL23 Antibody:
Anti-IL23P19/P19/SGRF therapeutic antibody
|
Tildrakizumab |
IL23A/IL23 |
Whole mAb |
 |
| GMP-Bios-ab-574 |
Pre-Made Tilogotamab biosimilar,
Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody:
Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5
therapeutic antibody |
Tilogotamab |
TNFRSF10B/TRAIL-R2 |
Whole mAb |
 |
| GMP-Bios-ab-575 |
Pre-Made Tilvestamab biosimilar,
Whole mAb, Anti-AXL Antibody:
Anti-ARK/UFO/JTK11/Tyro7 therapeutic
antibody |
Tilvestamab |
AXL |
Whole mAb |
 |
| GMP-Bios-ab-576 |
Pre-Made Timigutuzumab
biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Timigutuzumab |
ERBB2/HER2 |
Whole mAb |
 |
| GMP-Bios-ab-577 |
Pre-Made Timolumab biosimilar,
Whole mAb, Anti-AOC3 Antibody:
Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic
antibody |
Timolumab |
AOC3 |
Whole mAb |
 |
| GMP-Bios-ab-578 |
Pre-Made Tinurilimab biosimilar,
Whole mAb, Anti-CEACAM6/CD66c Antibody:
Anti-CEAL/NCA therapeutic antibody |
Tinurilimab |
CEACAM6/CD66c |
Whole mAb |
 |
| GMP-Bios-ab-579 |
Pre-Made Tiragolumab biosimilar,
Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Tiragolumab |
TIGIT |
Whole mAb |
 |
| GMP-Bios-ab-580 |
Pre-Made Tirnovetmab biosimilar,
Whole mAb (Canine): Anti-IL31 (Canine)
therapeutic antibody |
Tirnovetmab |
IL31 (Canine) |
Whole mAb (Canine) |
 |
| GMP-Bios-ab-581 |
Pre-Made Tislelizumab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Tislelizumab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-582 |
Pre-Made Tisotumab biosimilar,
Whole mAb, Anti-F3 Antibody: Anti-CD142/TF/TFA
therapeutic antibody |
Tisotumab |
F3 |
Whole mAb |
 |
| GMP-Bios-ab-583 |
Pre-Made Tixagevimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Tixagevimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-584 |
Pre-Made Tocilizumab biosimilar,
Whole mAb, Anti-IL6R Antibody:
Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80
therapeutic antibody |
Tocilizumab |
IL6R |
Whole mAb |
 |
| GMP-Bios-ab-585 |
Pre-Made Tomaralimab biosimilar,
Whole mAb, Anti-TLR2 Antibody: Anti-CD282/TIL4
therapeutic antibody |
Tomaralimab |
TLR2 |
Whole mAb |
 |
| GMP-Bios-ab-586 |
Pre-Made Tomuzotuximab
biosimilar, Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Tomuzotuximab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-587 |
Pre-Made Toripalimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Toripalimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-588 |
Pre-Made Torudokimab biosimilar,
Whole mAb, Anti-IL33 Antibody:
Anti-C9orf26/DVS27/IL1F11/NF-HEV/NFEHEV
therapeutic antibody |
Torudokimab |
IL33 |
Whole mAb |
 |
| GMP-Bios-ab-589 |
Pre-Made Tosatoxumab biosimilar,
Whole Mab: Anti-Toxin A therapeutic antibody
|
Tosatoxumab |
Toxin A |
Whole mAb |
 |
| GMP-Bios-ab-590 |
Pre-Made Tovetumab biosimilar,
Whole mAb, Anti-PDGFRA Antibody:
Anti-CD140A/PDGFR-2/PDGFR2 therapeutic
antibody |
Tovetumab |
PDGFRA |
Whole mAb |
 |
| GMP-Bios-ab-591 |
Pre-Made Tozorakimab biosimilar,
Whole mAb, Anti-IL33 Antibody:
Anti-C9orf26/DVS27/IL1F11/NF-HEV/NFEHEV
therapeutic antibody |
Tozorakimab |
IL33 |
Whole mAb |
 |
| GMP-Bios-ab-592 |
Pre-Made Tralokinumab
biosimilar, Whole mAb, Anti-IL13 Antibody:
Anti-IL-13/P600 therapeutic antibody |
Tralokinumab |
IL13 |
Whole mAb |
 |
| GMP-Bios-ab-593 |
Pre-Made Trastuzumab biosimilar,
Whole mAb, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2
therapeutic antibody |
Trastuzumab |
ERBB2/HER2 |
Whole mAb |
 |
| GMP-Bios-ab-594 |
Pre-Made Tregalizumab
biosimilar, Whole mAb, Anti-CD4 Antibody:
Anti-IMD79/OKT4D therapeutic antibody |
Tregalizumab |
CD4 |
Whole mAb |
 |
| GMP-Bios-ab-595 |
Pre-Made Tremelimumab
biosimilar, Whole mAb, Anti-CTLA4/CTLA-4
Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Tremelimumab |
CTLA4/CTLA-4 |
Whole mAb |
 |
| GMP-Bios-ab-596 |
Pre-Made Trevogrumab biosimilar,
Whole mAb, Anti-MSTN/GDF-8 Antibody:
Anti-GDF8/MSLHP therapeutic antibody |
Trevogrumab |
MSTN/GDF-8 |
Whole mAb |
 |
| GMP-Bios-ab-597 |
Pre-Made Tusamitamab biosimilar,
Whole mAb, Anti-CEACAM5/CD66e Antibody: Anti-CEA
therapeutic antibody |
Tusamitamab |
CEACAM5/CD66e |
Whole mAb |
 |
| GMP-Bios-ab-598 |
Pre-Made Ublituximab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ublituximab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-599 |
Pre-Made Uliledlimab biosimilar,
Whole mAb, Anti-NT5E/CD73 Antibody:
Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic
antibody |
Uliledlimab |
NT5E/CD73 |
Whole mAb |
 |
| GMP-Bios-ab-600 |
Pre-Made Ulocuplumab biosimilar,
Whole mAb, Anti-CXCR4 Antibody:
Anti-FB22/HM89/LAP3/LCR1/NPYR/WHIM/CD184/LAP-3/LESTR/NPY3R/NPYRL/WHIMS/HSY3RR/NPYY3R/WHIMS1/D2S201E
therapeutic antibody |
Ulocuplumab |
CXCR4 |
Whole mAb |
 |
| GMP-Bios-ab-602 |
Pre-Made Upifitamab biosimilar,
Whole mAb, Anti-SLC34A2 Antibody:
Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM therapeutic
antibody |
Upifitamab |
SLC34A2 |
Whole mAb |
 |
| GMP-Bios-ab-603 |
Pre-Made Urabrelimab biosimilar,
Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6
therapeutic antibody |
Urabrelimab |
CD47 |
Whole mAb |
 |
| GMP-Bios-ab-604 |
Pre-Made Urelumab biosimilar,
Whole mAb, Anti-TNFRSF9/CD137 Antibody:
Anti-ILA/4-1BB/CDw137 therapeutic antibody
|
Urelumab |
TNFRSF9/CD137 |
Whole mAb |
 |
| GMP-Bios-ab-605 |
Pre-Made Ustekinumab biosimilar,
Whole mAb, Anti-IL12B Antibody:
Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2
therapeutic antibody |
Ustekinumab |
IL12B |
Whole mAb |
 |
| GMP-Bios-ab-606 |
Pre-Made Utomilumab biosimilar,
Whole mAb, Anti-TNFRSF9/CD137 Antibody:
Anti-ILA/4-1BB/CDw137 therapeutic antibody
|
Utomilumab |
TNFRSF9/CD137 |
Whole mAb |
 |
| GMP-Bios-ab-607 |
Pre-Made Vadastuximab
biosimilar, Whole mAb ADC, Anti-CD33 Antibody:
Anti-p67/SIGLEC3/SIGLEC-3 therapeutic
antibody |
Vadastuximab |
CD33 |
Whole mAb ADC |
 |
| GMP-Bios-ab-608 |
Pre-Made Valanafusp biosimilar,
Whole mAb Fusion, Anti-INSR Antibody:
Anti-CD220/HHF5 therapeutic antibody |
Valanafusp |
INSR |
Whole mAb Fusion |
 |
| GMP-Bios-ab-609 |
Pre-Made Vanalimab biosimilar,
Whole mAb, Anti-CD40 Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic
antibody |
Vanalimab |
CD40 |
Whole mAb |
 |
| GMP-Bios-ab-610 |
Pre-Made Vandortuzumab
biosimilar, Whole mAb ADC, Anti-STEAP1 Antibody:
Anti-PRSS24/STEAP therapeutic antibody |
Vandortuzumab |
STEAP1 |
Whole mAb ADC |
 |
| GMP-Bios-ab-611 |
Pre-Made Vantictumab biosimilar,
Whole Mab: Anti-FZD Family therapeutic
antibody |
Vantictumab |
FZD Family |
Whole mAb |
 |
| GMP-Bios-ab-612 |
Pre-Made Vanucizumab biosimilar,
Bispecific mAb, Anti-ANGPT2;VEGFA Antibody:
Anti-AGPT2/ANG2/LMPHM10;VPF/VEGF/MVCD1
therapeutic antibody |
Vanucizumab |
ANGPT2;VEGFA |
Bispecific mAb |
 |
| GMP-Bios-ab-613 |
Pre-Made Varisacumab biosimilar,
Whole mAb, Anti-VEGFA Antibody:
Anti-VPF/VEGF/MVCD1 therapeutic antibody
|
Varisacumab |
VEGFA |
Whole mAb |
 |
| GMP-Bios-ab-614 |
Pre-Made Varlilumab biosimilar,
Whole mAb, Anti-CD27 Antibody:
Anti-T14/S152/Tp55/TNFRSF7/S152. LPFS2
therapeutic antibody |
Varlilumab |
CD27 |
Whole mAb |
 |
| GMP-Bios-ab-615 |
Pre-Made Vatelizumab biosimilar,
Whole mAb, Anti-ITGA2 Antibody:
Anti-BR/CD49B/GPIa/HPA-5/VLA-2/VLAA2 therapeutic
antibody |
Vatelizumab |
ITGA2 |
Whole mAb |
 |
| GMP-Bios-ab-616 |
Pre-Made Vedolizumab biosimilar,
Whole mAb, Anti-ITGA4;ITGB7 Antibody:
Anti-CD49D/IA4 therapeutic antibody |
Vedolizumab |
ITGA4;ITGB7 |
Whole mAb |
 |
| GMP-Bios-ab-617 |
Pre-Made Veltuzumab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Veltuzumab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-618 |
Pre-Made Vesencumab biosimilar,
Whole mAb, Anti-NRP1 Antibody:
Anti-BDCA4/CD304/NP1/NRP/VEGF165R therapeutic
antibody |
Vesencumab |
NRP1 |
Whole mAb |
 |
| GMP-Bios-ab-619 |
Pre-Made Vibecotamab biosimilar,
Bispecific Mixed mAb and scFv, Anti-IL3RA;CD3E
Antibody:
Anti-CD123/IL3RX/IL3RY/IL3RAY/hIL-3Ra;T3E/TCRE/IMD18
therapeutic antibody |
Vibecotamab |
IL3RA;CD3E |
Bispecific Mixed mAb and
scFv |
 |
| GMP-Bios-ab-620 |
Pre-Made Vibostolimab
biosimilar, Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Vibostolimab |
TIGIT |
Whole mAb |
 |
| GMP-Bios-ab-621 |
Pre-Made Vilobelimab biosimilar,
Whole mAb, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Vilobelimab |
C5/CO5 |
Whole mAb |
 |
| GMP-Bios-ab-622 |
Pre-Made Visilizumab biosimilar,
Whole mAb, Anti-CD3E Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Visilizumab |
CD3E |
Whole mAb |
 |
| GMP-Bios-ab-623 |
Pre-Made Vixarelimab biosimilar,
Whole mAb, Anti-OSMR Antibody:
Anti-IL-31R-beta/IL-31RB/OSMRB/OSMRbeta/PLCA1
therapeutic antibody |
Vixarelimab |
OSMR |
Whole mAb |
 |
| GMP-Bios-ab-624 |
Pre-Made Vixtimotamab
biosimilar, Bispecific Homodimer (VK-VH-VL'-VH',
Tandem diabody)), Anti-CD3E;CD33 Antibody:
Anti-T3E/TCRE/IMD18;p67/SIGLEC3/SIGLEC-3
therapeutic antibody |
Vixtimotamab |
CD3E;CD33 |
Bispecific Homodimer
(VK-VH-VL'-VH', Tandem diabody) |
 |
| GMP-Bios-ab-625 |
Pre-Made Vobarilizumab
biosimilar, Bispecific Single Domains (VH-VH'),
Anti-IL6R;ALB Antibody:
Anti-CD126/HIES5/IL-1Ra/IL-6R/IL-6R-1/IL-6RA/IL6Q/IL6QTL/IL6RA/IL6RQ/gp80;FDAHT/HSA/PRO0883/PRO0903/PRO1341
therapeutic antibody |
Vobarilizumab |
IL6R;ALB |
Bispecific Single Domains
(VH-VH') |
 |
| GMP-Bios-ab-626 |
Pre-Made Vofatamab biosimilar,
Whole mAb, Anti-FGFR3 Antibody:
Anti-ACH/CEK2/JTK4/CD333/HSFGFR3EX therapeutic
antibody |
Vofatamab |
FGFR3 |
Whole mAb |
 |
| GMP-Bios-ab-627 |
Pre-Made Volagidemab biosimilar,
Whole mAb, Anti-GCCR/NR3C1 Antibody:
Anti-GCR/GCRST/GR/GRL therapeutic antibody
|
Volagidemab |
GCCR/NR3C1 |
Whole mAb |
 |
| GMP-Bios-ab-628 |
Pre-Made Vonlerolizumab
biosimilar, Whole mAb, Anti-TNFRSF4/CD134
Antibody: Anti-ACT35/IMD16/OX40/TXGP1L
therapeutic antibody |
Vonlerolizumab |
TNFRSF4/CD134 |
Whole mAb |
 |
| GMP-Bios-ab-629 |
Pre-Made Vopratelimab
biosimilar, Whole mAb, Anti-ICOS Antibody:
Anti-AILIM/CD278/CVID1 therapeutic antibody
|
Vopratelimab |
ICOS |
Whole mAb |
 |
| GMP-Bios-ab-630 |
Pre-Made Vorsetuzumab
biosimilar, Whole mAb ADC, Anti-CD70/CD27-L
Antibody: Anti-CD27L/LPFS3/CD27LG/TNFSF7/TNLG8A
therapeutic antibody |
Vorsetuzumab |
CD70/CD27-L |
Whole mAb ADC |
 |
| GMP-Bios-ab-631 |
Pre-Made Vudalimab biosimilar,
Bispecific Mixed mAb and scFv,
Anti-CTLA4/CTLA-4;PDCD1/PD-1 Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3;CD279/SLEB2/hPD-1/hPD-l/hSLE1
therapeutic antibody |
Vudalimab |
CTLA4/CTLA-4; PDCD1/PD-1
|
Bispecific Mixed mAb and
scFv |
 |
| GMP-Bios-ab-632 |
Pre-Made Vulinacimab biosimilar,
Whole mAb, Anti-VEGFR2/KDR Antibody:
Anti-CD309/FLK1/VEGFR therapeutic antibody
|
Vulinacimab |
VEGFR2/KDR |
Whole mAb |
 |
| GMP-Bios-ab-633 |
Pre-Made Vunakizumab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Vunakizumab |
IL17A/IL17 |
Whole mAb |
 |
| GMP-Bios-ab-634 |
Pre-Made Xentuzumab biosimilar,
Whole mAb, Anti-IGF1;IGF2 Antibody:
Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3
therapeutic antibody |
Xentuzumab |
IGF1;IGF2 |
Whole mAb |
 |
| GMP-Bios-ab-635 |
Pre-Made Zagotenemab biosimilar,
Whole mAb, Anti-MAPT Antibody:
Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40
therapeutic antibody |
Zagotenemab |
MAPT |
Whole mAb |
 |
| GMP-Bios-ab-636 |
Pre-Made Zalifrelimab
biosimilar, Whole mAb, Anti-CTLA4/CTLA-4
Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Zalifrelimab |
CTLA4/CTLA-4 |
Whole mAb |
 |
| GMP-Bios-ab-637 |
Pre-Made Zalutumumab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Zalutumumab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-638 |
Pre-Made Zampilimab biosimilar,
Whole mAb, Anti-TGM2/TG2 Antibody:
Anti-G(h)/TG(C)/TGC/hTG2/tTG therapeutic
antibody |
Zampilimab |
TGM2/TG2 |
Whole mAb |
 |
| GMP-Bios-ab-639 |
Pre-Made Zanidatamab biosimilar,
Bispecific mAb, Anti-ERBB2/HER2;ERBB2/HER2
Antibody: Anti-CD340/HER-2/MLN
19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2 therapeutic antibody
|
Zanidatamab |
ERBB2/HER2; ERBB2/HER2
|
Bispecific mAb |
 |
| GMP-Bios-ab-640 |
Pre-Made Zanolimumab biosimilar,
Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D
therapeutic antibody |
Zanolimumab |
CD4 |
Whole mAb |
 |
| GMP-Bios-ab-641 |
Pre-Made Zansecimab biosimilar,
Whole mAb, Anti-ANGPT2 Antibody:
Anti-AGPT2/ANG2/LMPHM10 therapeutic antibody
|
Zansecimab |
ANGPT2 |
Whole mAb |
 |
| GMP-Bios-ab-642 |
Pre-Made Zatuximab biosimilar,
Whole mAb, Anti-EGFR Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2
therapeutic antibody |
Zatuximab |
EGFR |
Whole mAb |
 |
| GMP-Bios-ab-643 |
Pre-Made Zelminemab biosimilar,
Whole mAb, Anti-ADCYAP1R1/PAC1R Antibody:
Anti-PAC1/PACAPR/PACAPRI therapeutic
antibody |
Zelminemab |
ADCYAP1R1/PAC1R |
Whole mAb |
 |
| GMP-Bios-ab-644 |
Pre-Made Zeluvalimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Zeluvalimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-645 |
Pre-Made Zenocutuzumab
biosimilar, Bispecific mAb,
Anti-ERBB3/Erbb-3;ERBB2/HER2 Antibody:
Anti-FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3;CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2 therapeutic antibody
|
Zenocutuzumab |
ERBB3/Erbb-3; ERBB2/HER2
|
Bispecific mAb |
 |
| GMP-Bios-ab-646 |
Pre-Made Ziltivekimab
biosimilar, Whole mAb, Anti-IL6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Ziltivekimab |
IL6 |
Whole mAb |
 |
| GMP-Bios-ab-647 |
Pre-Made Zilovertamab
biosimilar, Whle mAb, Anti-ROR1 Antibody:
Anti-NTRKR1/dJ537F10.1 therapeutic antibody
|
Zilovertamab |
ROR1 |
Whle mAb |
 |
| GMP-Bios-ab-648 |
Pre-Made Zimberelimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Zimberelimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-649 |
Pre-Made Zolbetuximab
biosimilar, Whole mAb, Anti-CLDN18 Antibody:
Anti-SFTA5/SFTPJ therapeutic antibody |
Zolbetuximab |
CLDN18 |
Whole mAb |
 |
| GMP-Bios-ab-650 |
Pre-Made Zolimomab biosimilar,
Whole mAb, Anti-CD5 Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic
antibody |
Zolimomab |
CD5 |
Whole mAb |
 |
| GMP-Bios-ab-651 |
Pre-Made Zuberitamab biosimilar,
Whole mAb, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Zuberitamab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-ab-652 |
Pre-Made Adintrevimab
biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike
therapeutic antibody |
Adintrevimab |
SARS-CoV-2 Spike |
Whole mAb |
 |
| GMP-Bios-ab-653 |
Pre-Made Amubarvimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Amubarvimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-654 |
Pre-Made Anselamimab biosimilar,
Whole mAb, Anti-SAA1 Antibody:
Anti-PIG4/SAA/SAA2/TP53I4 therapeutic
antibody |
Anselamimab |
SAA1 |
Whole mAb |
 |
| GMP-Bios-ab-655 |
Pre-Made Anumigilimab
biosimilar, Whole mAb, Anti-CSF3R/G-CSF-R
Antibody: Anti-CD114/GCSFR/SCN7 therapeutic
antibody |
Anumigilimab |
CSF3R/G-CSF-R |
Whole mAb |
 |
| GMP-Bios-ab-656 |
Pre-Made Bafisontamab
biosimilar, Whole mAb, Anti-EGFR;MET Antibody:
Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;AUTS9/DFNB97/HGFR/RCCP2/c-Met
therapeutic antibody |
Bafisontamab |
EGFR;MET |
Bispecific Mixed mAb and Fab
|
 |
| GMP-Bios-ab-657 |
Pre-Made Barzolvolimab
biosimilar, Whole mAb, Anti-KIT Antibody:
Anti-C-Kit/CD117/MASTC/PBT/SCFR therapeutic
antibody |
Barzolvolimab |
KIT |
Whole mAb |
 |
| GMP-Bios-ab-658 |
Pre-Made Beludavimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Beludavimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-659 |
Pre-Made Dalutrafusp biosimilar,
Whole mAb, Anti-TGFBR2 Antibody:
Anti-AAT3/FAA3/LDS1B/LDS2/LDS2B/MFS2/RIIC/TAAD2/TBR-ii/TBRII/TGFR-2-RII
therapeutic antibody |
Dalutrafusp |
TGFBR2 |
Whole mAb Fusion |
 |
| GMP-Bios-ab-660 |
Pre-Made Dresbuxelimab
biosimilar, Whole mAb, Anti-NT5E/CD73 Antibody:
Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic
antibody |
Dresbuxelimab |
NT5E/CD73 |
Whole mAb |
 |
| GMP-Bios-ab-661 |
Pre-Made Eblasakimab biosimilar,
Whole mAb, Anti-IL13RA1 Antibody:
Anti-CD213A1/CT19/IL-13Ra/NR4 therapeutic
antibody |
Eblasakimab |
IL13RA1 |
Whole mAb |
 |
| GMP-Bios-ab-662 |
Pre-Made Ecleralimab biosimilar,
Whole Mab: Anti-TSLP therapeutic antibody
|
Ecleralimab |
TSLP |
Whole mAb |
 |
| GMP-Bios-ab-663 |
Pre-Made Elranatamab biosimilar,
Whole mAb, Anti-TNFRSF17;CD3E Antibody:
Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18
therapeutic antibody |
Elranatamab |
TNFRSF17;CD3E |
Bispecific Whole mAb |
 |
| GMP-Bios-ab-664 |
Pre-Made Ensomafusp Biosimilar,
Fusion Protein targeting CD19: Recombinant
therapeutic protein targeting B4/CVID3 |
Ensomafusp |
CD19 |
Fusion Protein |
 |
| GMP-Bios-ab-665 |
Pre-Made Enuzovimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Enuzovimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-667 |
Pre-Made Fidasimtamab
biosimilar, Whole mAb,
Anti-PDCD1/PD-1;ERBB2/HER2 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1;CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2 therapeutic antibody
|
Fidasimtamab |
PDCD1/PD-1; ERBB2/HER2
|
Bispecific Whole mAb |
 |
| GMP-Bios-ab-668 |
Pre-Made Galegenimab biosimilar,
Whole mAb, Anti-HTRA1 Antibody:
Anti-ARMD7/CADASIL2/CARASIL/HtrA/L56/ORF480/PRSS11
therapeutic antibody |
Galegenimab |
HTRA1 |
Whole mAb |
 |
| GMP-Bios-ab-669 |
Pre-Made Ginisortamab
biosimilar, Whole mAb, Anti-GREM1/Gremlin-1
Antibody:
Anti-C15DUPq/CKTSF1B1/CRAC1/CRCS4/DAND2/DRM/DUP15q/GREMLIN/HMPS/HMPS1/IHG-2/MPSH/PIG2
therapeutic antibody |
Ginisortamab |
GREM1/Gremlin-1 |
Whole mAb |
 |
| GMP-Bios-ab-670 |
Pre-Made Gresonitamab
biosimilar, Whole mAb, Anti-CLDN18;CD3E
Antibody: Anti-SFTA5/SFTPJ;T3E/TCRE/IMD18
therapeutic antibody |
Gresonitamab |
CLDN18;CD3E |
Bispecific scFv-scFv-scFc
|
 |
| GMP-Bios-ab-671 |
Pre-Made Gumokimab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Gumokimab |
IL17A/IL17 |
Whole mAb |
 |
| GMP-Bios-ab-672 |
Pre-Made Iparomlimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Iparomlimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-673 |
Pre-Made Ivicentamab biosimilar,
Whole mAb, Anti-CD37;CD37 Antibody:
Anti-GP52-40/TSPAN26;GP52-40/TSPAN26 therapeutic
antibody |
Ivicentamab |
CD37;CD37 |
Bispecific Whole mAb |
 |
| GMP-Bios-ab-674 |
Pre-Made Ivonescimab biosimilar,
Whole mAb, Anti-VEGFA Antibody:
Anti-VPF/VEGF/MVCD1 therapeutic antibody
|
Ivonescimab |
VEGFA |
scFv-IGHC |
 |
| GMP-Bios-ab-675 |
Pre-Made Lepunafusp biosimilar,
Whole mAb, Anti-TfR1/TFRC Antibody:
Anti-CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90
therapeutic antibody |
Lepunafusp |
TfR1/TFRC |
Whole mAb Fusion |
 |
| GMP-Bios-ab-676 |
Pre-Made Ligufalimab biosimilar,
Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6
therapeutic antibody |
Ligufalimab |
CD47 |
Whole mAb |
 |
| GMP-Bios-ab-677 |
Pre-Made Livmoniplimab
biosimilar, Whole mAb, Anti-LRRC32 Antibody:
Anti-CPPRDD/D11S833E/GARP therapeutic
antibody |
Livmoniplimab |
LRRC32 |
Whole mAb |
 |
| GMP-Bios-ab-678 |
Pre-Made Lomtegovimab
biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD
therapeutic antibody |
Lomtegovimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-679 |
Pre-Made Lorigerlimab
biosimilar, Whole mAb,
Anti-PDCD1/PD-1;CTLA4/CTLA-4 Antibody:
Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Lorigerlimab |
PDCD1/PD-1; CTLA4/CTLA-4
|
Bispecific Mixed scFv
(scFv-CH2-CH3-scFv) |
 |
| GMP-Bios-ab-680 |
Pre-Made Manfidokimab
biosimilar, Whole mAb, Anti-IL4R Antibody:
Anti-CD124 therapeutic antibody |
Manfidokimab |
IL4R |
Whole mAb |
 |
| GMP-Bios-ab-681 |
Pre-Made Mazorelvimab
biosimilar, Whole Mab: Anti-Rabies Virus Spike
Glycoprotein G therapeutic antibody |
Mazorelvimab |
Rabies Virus Spike
Glycoprotein G |
Whole mAb |
 |
| GMP-Bios-ab-682 |
Pre-Made Melredableukin
biosimilar, Whole Mab: Anti-Non-Binding
therapeutic antibody |
Melredableukin |
Non-Binding |
Whole mAb Fusion |
 |
| GMP-Bios-ab-683 |
Pre-Made Mupadolimab biosimilar,
Whole mAb, Anti-NT5E/CD73 Antibody:
Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic
antibody |
Mupadolimab |
NT5E/CD73 |
Whole mAb |
 |
| GMP-Bios-ab-684 |
Pre-Made Nofazinlimab
biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Nofazinlimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-685 |
Pre-Made Ormutivimab biosimilar,
Whole Mab: Anti-Rabies Virus Surface
Glycoprotein 4 (gp4) Epitope 1 therapeutic
antibody |
Ormutivimab |
Rabies Virus Surface
Glycoprotein 4 (gp4) Epitope 1 |
Whole mAb |
 |
| GMP-Bios-ab-686 |
Pre-Made Pivekimab biosimilar,
Whole mAb, Anti-IL3RA Antibody:
Anti-IL3R/CD123/IL3RX/IL3RY/hIL-3Ra therapeutic
antibody |
Pivekimab |
IL3RA |
Whole mAb |
 |
| GMP-Bios-ab-687 |
Pre-Made Pulocimab biosimilar,
Whole mAb, Anti-VEGFR2/KDR Antibody:
Anti-CD309/FLK1/VEGFR therapeutic antibody
|
Pulocimab |
VEGFR2/KDR |
Whole mAb |
 |
| GMP-Bios-ab-688 |
Pre-Made Quisovalimab
biosimilar, Whole mAb, Anti-TNFSF14/CD258
Antibody: Anti-HVEML/LIGHT/LTg therapeutic
antibody |
Quisovalimab |
TNFSF14/CD258 |
Whole mAb |
 |
| GMP-Bios-ab-689 |
Pre-Made Rimteravimab
biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD
therapeutic antibody |
Rimteravimab |
SARS-CoV-2 Spike RBD |
Mixed Nanobody (VHH-CH2-CH3
dimer) |
 |
| GMP-Bios-ab-690 |
Pre-Made Rocatinlimab
biosimilar, Whole mAb, Anti-TNFRSF4/CD134
Antibody: Anti-ACT35/IMD16/OX40/TXGP1L
therapeutic antibody |
Rocatinlimab |
TNFRSF4/CD134 |
Whole mAb |
 |
| GMP-Bios-ab-691 |
Pre-Made Romlusevimab
biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD
therapeutic antibody |
Romlusevimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-692 |
Pre-Made Rulonilimab biosimilar,
Whole mAb, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Rulonilimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-ab-693 |
Pre-Made Simridarlimab
biosimilar, Whole mAb, Anti-CD47;CD274/PD-L1
Antibody:
Anti-IAP/OA3/MER6;B7-H/B7H1/PD-L1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1
therapeutic antibody |
Simridarlimab |
CD47;CD274/PD-L1 |
Bispecific Mixed
mAb/VH-VH-CH2-CH3 |
 |
| GMP-Bios-ab-694 |
Pre-Made Sirexatamab biosimilar,
Whole mAb, Anti-DKK1 Antibody: Anti-SK/DKK-1
therapeutic antibody |
Sirexatamab |
DKK1 |
Whole mAb |
 |
| GMP-Bios-ab-695 |
Pre-Made Socazolimab biosimilar,
Whole mAb, Anti-CD274/PD-L1 Antibody:
Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic
antibody |
Socazolimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-696 |
Pre-Made Sotevtamab biosimilar,
Whole mAb, Anti-CLU/Clusterinm Antibody:
Anti-AAG4/APO-J/APOJ/CLI/KUB1/NA1/NA2/SGP-2/SGP2/SP-40/TRPM-2/TRPM2
therapeutic antibody |
Sotevtamab |
CLU/Clusterin |
Whole mAb |
 |
| GMP-Bios-ab-697 |
Pre-Made Suciraslimab
biosimilar, Whole mAb, Anti-CD22 Antibody:
Anti-SIGLEC2/SIGLEC-2 therapeutic antibody
|
Suciraslimab |
CD22 |
Whole mAb |
 |
| GMP-Bios-ab-698 |
Pre-Made Tagitanlimab
biosimilar, Whole mAb, Anti-CD274/PD-L1
Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1
therapeutic antibody |
Tagitanlimab |
CD274/PD-L1 |
Whole mAb |
 |
| GMP-Bios-ab-699 |
Pre-Made Tamgiblimab biosimilar,
Whole mAb, Anti-TIGIT Antibody:
Anti-VSIG9/VSTM3/WUCAM therapeutic antibody
|
Tamgiblimab |
TIGIT |
Whole mAb |
 |
| GMP-Bios-ab-700 |
Pre-Made Tarcolimab biosimilar,
Whole mAb, Anti-VEGFA Antibody:
Anti-VPF/VEGF/MVCD1 therapeutic antibody
|
Tarcolimab |
VEGFA |
Whole mAb |
 |
| GMP-Bios-ab-701 |
Pre-Made Tecaginlimab
biosimilar, Whole mAb, Anti-CD40;TNFRSF9/CD137
Antibody:
Anti-p50/Bp50/CDW40/TNFRSF5;ILA/4-1BB/CDw137
therapeutic antibody |
Tecaginlimab |
CD40;TNFRSF9/CD137 |
Bispecific Whole mAb |
 |
| GMP-Bios-ab-702 |
Pre-Made Teropavimab biosimilar,
Whole Mab: Anti-HIV-1 gp120 CD4bs therapeutic
antibody |
Teropavimab |
HIV-1 gp120 CD4bs |
Whole mAb |
 |
| GMP-Bios-ab-703 |
Pre-Made Trinbelimab biosimilar,
Whole mAb, Anti-RhD Antibody:
Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI
therapeutic antibody |
Trinbelimab |
RhD |
Whole mAb |
 |
| GMP-Bios-ab-704 |
Pre-Made Tuvonralimab
biosimilar, Whole mAb, Anti-CTLA4/CTLA-4
Antibody:
Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3
therapeutic antibody |
Tuvonralimab |
CTLA4/CTLA-4 |
Whole mAb |
 |
| GMP-Bios-ab-705 |
Pre-Made Ubamatamab biosimilar,
Whole mAb, Anti-MUC16;CD3E Antibody:
Anti-CA125;T3E/TCRE/IMD18 therapeutic
antibody |
Ubamatamab |
MUC16;CD3E |
Bispecific Whole mAb |
 |
| GMP-Bios-ab-706 |
Pre-Made Ulenistamab biosimilar,
Whole Mab: Anti-PAUF therapeutic antibody
|
Ulenistamab |
PAUF |
Whole mAb |
 |
| GMP-Bios-ab-707 |
Pre-Made Upanovimab biosimilar,
Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic
antibody |
Upanovimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-ab-708 |
Pre-Made Vepsitamab biosimilar,
Whole mAb, Anti-MUC17;CD3E Antibody:
Anti-MUC-17/MUC-3/MUC3;T3E/TCRE/IMD18
therapeutic antibody |
Vepsitamab |
MUC17;CD3E |
Bispecific scFv-scFv-scFc
|
 |
| GMP-Bios-ab-709 |
Pre-Made Voxalatamab biosimilar,
Whole mAb, Anti-FOLH1/GCPII;CD3E Antibody:
Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18
therapeutic antibody |
Voxalatamab |
FOLH1/GCPII;CD3E |
Bispecific Whole mAb |
 |
| GMP-Bios-ab-710 |
Pre-Made Xeligekimab biosimilar,
Whole mAb, Anti-IL17A/IL17 Antibody:
Anti-CTLA-8/CTLA8A/ILA17 therapeutic
antibody |
Xeligekimab |
IL17A/IL17 |
Whole mAb |
 |
| GMP-Bios-ab-711 |
Pre-Made Zamerovimab biosimilar,
Whole Mab: Anti-Rabies Virus Spike Glycoprotein
G therapeutic antibody |
Zamerovimab |
Rabies Virus Spike
Glycoprotein G |
Whole mAb |
 |
| GMP-Bios-INN-712 |
Pre-Made Abatacept Biosimilar,
Fusion Protein targeting CTLA4/CTLA-4 fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 |
Abatacept |
CTLA-4 |
Fusion Protein |
 |
| GMP-Bios-INN-713 |
Pre-Made Abciximab Biosimilar,
Fab Fusion, Anti-Itga2B/Itgb3 Antibody:
Anti-BDPLT16/BDPLT2/CD41/CD41B/GP2B/GPIIb/GT/GT1/GTA/HPA3/PPP1R93;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2
therapeutic antibody |
Abciximab |
ITGA2B;ITGB3 |
Fab Fusion |
 |
| GMP-Bios-INN-715 |
Pre-Made Acazicolcept
Biosimilar, Fusion Protein targeting CD28 fused
with human IGHG1 Fc (Fragment constant) via a
peptidyl linker: Recombinant therapeutic protein
targeting Tp44 |
Acazicolcept |
CD28 |
Fusion Protein |
 |
| GMP-Bios-INN-717 |
Pre-Made Actinium (225Ac)
Lintuzumab Satetraxetan Biosimilar, Whole Mab
Adc, Anti-Cd33 Antibody:
Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody
Drug Conjugate |
Actinium (225Ac) Lintuzumab
Satetraxetan |
CD33 |
Whole mAb ADC |
 |
| GMP-Bios-INN-718 |
Pre-Made Adalimumab Beta
Biosimilar, Whole Mab, Anti-Tnf Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Adalimumab Beta |
TNF |
Whole mAb |
 |
| GMP-Bios-INN-719 |
Pre-Made Adecatumumab
Biosimilar, Whole Mab, Anti-Epcam Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody |
Adecatumumab |
EPCAM |
Whole mAb |
 |
| GMP-Bios-INN-721 |
Pre-Made Afelimomab Biosimilar,
Fab Fusion, Anti-Tnf Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Afelimomab |
TNF |
Fab Fusion |
 |
| GMP-Bios-INN-722 |
Pre-Made Aflibercept Biosimilar,
Fusion Protein targeting VEGFA fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting MVCD1/VEGF/VPF
|
Aflibercept |
VEGFA |
Fusion Protein |
 |
| GMP-Bios-INN-724 |
Pre-Made Albiglutide Biosimilar,
Peptide Protein Fusion targeting GLP1R: (Glp-1)2
Peptide-Albumin(Alb) Fusion Protein
targetingGLP-1-R/GLP-1R |
Albiglutide |
GLP1R |
Peptide Protein fusion |
 |
| GMP-Bios-INN-725 |
Pre-Made Albinterferon Alfa- 2B
Biosimilar, Fusion Protein targeting IFNAR1
fused with ALB (albumin, human serum albumin,
HSA): Recombinant therapeutic protein targeting
AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC |
Albinterferon Alfa- 2B |
IFNAR1 |
Fusion Protein |
 |
| GMP-Bios-INN-726 |
Pre-Made Albutrepenonacog Alfa
Biosimilar, Fusion Protein targeting F9 fused
with ALB (albumin, human serum albumin, HSA):
Recombinant therapeutic protein targeting
FIX/P19/PTC/HEMB/THPH8 |
Albutrepenonacog Alfa |
F9 |
Fusion Protein |
 |
| GMP-Bios-INN-727 |
Pre-Made Aldafermin Biosimilar,
Recombinant Protein targeting FGFR4: Recombinant
therapeutic protein targeting CD334/JTK2/TKF
|
Aldafermin |
FGFR4 |
Recombinant Protein |
 |
| GMP-Bios-INN-728 |
Pre-Made Aldesleukin biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting IL2 |
Aldesleukin |
IL2
|
Recombinant Protein |
 |
| GMP-Bios-INN-729 |
Pre-Made Alefacept Biosimilar,
Fusion Protein targeting CD2 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting LFA-2/SRBC/T11
|
Alefacept |
CD2 |
Fusion Protein |
 |
| GMP-Bios-INN-730 |
Pre-Made Altumomab Biosimilar,
Radiolabelled Antibody, Anti-CEACAM5/CD66e
Antibody: Anti-CEA therapeutic antibody |
Altumomab |
CEACAM5/CD66e |
Radiolabelled antibody |
 |
| GMP-Bios-INN-731 |
Pre-Made Alvircept Sudotox
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting HIV-1 gp120 fused
with Pseudomonas aeruginosa exotoxin A |
Alvircept Sudotox |
HIV-1 gp120 |
Fusion Protein |
 |
| GMP-Bios-INN-732 |
Pre-Made Anakinra Biosimilar,
Recombinant Protein targeting IL1R1: Recombinant
therapeutic protein targeting
CD121A/D2S1473/IL-1R-alpha/IL1R/IL1RA/P80
|
Anakinra |
IL1R1 |
Recombinant Protein |
 |
| GMP-Bios-INN-733 |
Anatumomab-Anti-TAG-72
therapeutic antibody fused with Staphylococcus
aureus
enterotoxin A (Pre-made Anatumomab Mafenatox
biosimilar, Fusion Protein) |
Anatumomab Mafenatox |
TAG-72 |
Fusion Protein |
 |
| GMP-Bios-INN-734 |
Pre-Made Anetumab Corixetan
Biosimilar, Whole Mab Adc, Anti-Msln Antibody:
Anti-MPF/SMRP therapeutic antibody Drug
Conjugate |
Anetumab Corixetan |
MSLN |
Whole mAb ADC |
 |
| GMP-Bios-INN-735 |
Pre-Made Anetumab Ravtansine
Biosimilar, Whole Mab Adc, Anti-Msln Antibody:
Anti-MPF/SMRP therapeutic antibody Drug
Conjugate |
Anetumab Ravtansine |
MSLN |
Whole mAb ADC |
 |
| GMP-Bios-INN-736 |
Pre-Made Apolizumab Biosimilar,
Whole Mab, Anti-HLA-DRB/HLA-DRB1 Antibody:
Anti-DRB1/SS1 therapeutic antibody |
Apolizumab |
HLA-DRB/HLA-DRB1 |
Whole mAb |
 |
| GMP-Bios-INN-737 |
Pre-Made Aprutumab Ixadotin
Biosimilar, Whole Mab Adc, Anti-Fgfr2 Antibody:
Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25
therapeutic antibody Drug Conjugate |
Aprutumab Ixadotin |
FGFR2 |
Whole mAb ADC |
 |
| GMP-Bios-INN-738 |
Pre-Made Arcitumomab Biosimilar,
Radiolabelled Antibody, Anti-CEACAM5/CD66e
Antibody: Anti-CEA therapeutic antibody |
Arcitumomab |
CEACAM5/CD66e |
Radiolabelled antibody |
 |
| GMP-Bios-INN-739 |
Pre-Made Aselizumab Biosimilar,
Whole Mab, Anti-Sell Antibody:
Anti-CD62L/LAM1/LECAM1/LEU8/LNHR/LSEL/LYAM1/PLNHR/TQ1
therapeutic antibody |
Aselizumab |
SELL |
Whole mAb |
 |
| GMP-Bios-INN-740 |
Pre-Made Asfotase Alfa
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting Enzyme fused with
human IGHG1 Fc (Fragment constant) |
Asfotase Alfa |
Enzyme |
Fusion Protein |
 |
| GMP-Bios-INN-741 |
Pre-Made Asunercept Biosimilar,
Fusion Protein targeting FASLG/CD178 fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
ALPS1B/APT1LG1/APTL/CD95-L/CD95L/FASL/TNFSF6/TNLG1A
|
Asunercept |
FASLG/CD178 |
Fusion Protein |
 |
| GMP-Bios-INN-742 |
Pre-Made Atacicept Biosimilar,
Fusion Protein targeting TNFSF13/APRIL fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
CD256/TALL-2/TALL2/TNLG7B/TRDL-1/UNQ383/PRO715/ZTNF2
|
Atacicept |
TNFSF13/APRIL |
Fusion Protein |
 |
| GMP-Bios-INN-743 |
Pre-Made Atorolimumab
Biosimilar, Whole Mab, Anti-Rhd Antibody:
Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI
therapeutic antibody |
Atorolimumab |
RHD |
Whole mAb |
 |
| GMP-Bios-INN-746 |
Pre-Made Azintuxizumab Vedotin
Biosimilar, Whole Mab Adc, Anti-SLAMF7/CS1
Antibody: Anti-19A/CD319/CRACC therapeutic
antibody Drug Conjugate |
Azintuxizumab Vedotin |
SLAMF7/CS1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-748 |
Pre-Made Balugrastim Biosimilar,
Fusion Protein targeting CSF3R/G-CSF-R fused
with ALB (albumin, human serum albumin, HSA):
Recombinant therapeutic protein targeting
CD114/GCSFR/SCN7 |
Balugrastim |
CSF3R/G-CSF-R |
Fusion Protein |
 |
| GMP-Bios-INN-749 |
Pre-Made Baminercept Biosimilar,
Fusion Protein targeting LTA fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
LT/TNFB/TNFSF1/TNLG1E |
Baminercept |
LTA |
Fusion Protein |
 |
| GMP-Bios-INN-750 |
Pre-Made Batiraxcept Biosimilar,
Fusion Protein targeting GAS6 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting AXLLG/AXSF
|
Batiraxcept |
GAS6 |
Fusion Protein |
 |
| GMP-Bios-INN-751 |
Pre-Made Bectumomab Biosimilar,
Fab Fusion, Anti-Cd22 Antibody:
Anti-SIGLEC-2/SIGLEC2 therapeutic antibody
|
Bectumomab |
CD22 |
Fab Fusion |
 |
| GMP-Bios-INN-752 |
Pre-Made Belantamab Mafodotin
Biosimilar, Whole Mab Adc, Anti-Tnfrsf17
Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A
therapeutic antibody Drug Conjugate |
Belantamab Mafodotin |
TNFRSF17 |
Whole mAb ADC |
 |
| GMP-Bios-INN-753 |
Pre-Made Belatacept Biosimilar,
Fusion Protein targeting CD80 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
B7/B7-1/B7.1/BB1/CD28LG/CD28LG1/LAB7 |
Belatacept |
CD80 |
Fusion Protein |
 |
| GMP-Bios-INN-755 |
Pre-Made Bertilimumab
Biosimilar, Whole Mab, Anti-Ccl11 Antibody:
Anti-SCYA11 therapeutic antibody |
Bertilimumab |
CCL11 |
Whole mAb |
 |
| GMP-Bios-INN-756 |
Pre-Made Besilesomab Biosimilar,
Radiolabelled Antibody, Anti-Ceacam8/NCA-95
Antibody: Anti-CD66b/CD67/CGM6 therapeutic
antibody |
Besilesomab |
CEACAM8/NCA-95 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-757 |
Pre-Made Bevacizumab Beta
Biosimilar, Whole Mab, Anti-Vegfa Antibody:
Anti-MVCD1/VEGF/VPF therapeutic antibody
|
Bevacizumab Beta |
VEGFA |
Whole mAb |
 |
| GMP-Bios-INN-758 |
Pre-Made Bevifimod biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting Staphylococcal protein A
|
Bevifimod |
Staphylococcal protein A
|
Recombinant Protein |
 |
| GMP-Bios-INN-759 |
Pre-Made Biciromab Biosimilar,
Radiolabelled Antibody: Anti-Fibrin Ii
therapeutic antibody |
Biciromab |
fibrin II |
Radiolabelled antibody |
 |
| GMP-Bios-INN-760 |
Pre-Made Bifarcept Biosimilar,
Recombinant Protein targeting IFNA1: Recombinant
therapeutic protein targeting
IFL/IFN/IFN-ALPHA/IFN-alphaD/IFNA13/leIF D
|
Bifarcept |
IFNA1 |
Recombinant Protein |
 |
| GMP-Bios-INN-761 |
Pre-Made Bifikafusp Alfa
Biosimilar, Fusion Protein targeting FN/FN1
fused with human IL2 (interleukin 2, IL-2)
Pr21-153 (100%) (1:1), noncovalent dimer:
Recombinant therapeutic protein targeting
CIG/ED-B/FINCZ/GFND/GFND2/LETS/MSF/SMDCF
|
Bifikafusp Alfa |
FN/FN1 |
Fusion Protein |
 |
| GMP-Bios-INN-762 |
Pre-Made Bintrafusp Alfa
Biosimilar, Fusion Protein targeting CD274/PD-L1
fused with human TGFBR2 (transforming growth
factor beta receptor 2) (1:2) via a peptidyl
linker: Recombinant therapeutic protein
targeting B7-H/B7H1/PDCD1L1/PDCD1LG1 |
Bintrafusp Alfa |
CD274/PD-L1 |
Fusion Protein |
 |
| GMP-Bios-INN-763 |
Pre-Made Bivatuzumab Biosimilar,
Whole Mab, Anti-Cd44 Antibody:
Anti-CDW44/CSPG8/ECMR-III/HCELL/HUTCH-I/IN/LHR/MC56/MDU2/MDU3/MIC4/Pgp1
therapeutic antibody |
Bivatuzumab |
CD44 |
Whole mAb |
 |
| GMP-Bios-INN-764 |
Pre-Made Blisibimod Biosimilar,
Fusion Protein targeting TNFSF13B fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4
|
Blisibimod |
TNFSF13B |
Fusion Protein |
 |
| GMP-Bios-INN-765 |
Pre-Made Brentuximab Vedotin
Biosimilar, Whole Mab Adc, Anti-Tnfrsf8
Antibody: Anti-CD30/D1S166E/Ki-1 therapeutic
antibody Drug Conjugate |
Brentuximab Vedotin |
TNFRSF8 |
Whole mAb ADC |
 |
| GMP-Bios-INN-767 |
Pre-Made Briobacept Biosimilar,
Fusion Protein targeting TNFSF13B fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4
|
Briobacept |
TNFSF13B |
Fusion Protein |
 |
| GMP-Bios-INN-768 |
Pre-Made Camidanlumab Tesirine
Biosimilar, Whole Mab Adc, Anti-Il2Ra Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody Drug Conjugate |
Camidanlumab Tesirine |
IL2RA |
Whole mAb ADC |
 |
| GMP-Bios-INN-769 |
Pre-Made Cantuzumab Mertansine
Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody Drug Conjugate |
Cantuzumab Mertansine |
MUC1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-770 |
Pre-Made Cantuzumab Ravtansine
Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody Drug Conjugate |
Cantuzumab Ravtansine |
MUC1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-771 |
Pre-Made Capromab Biosimilar,
Radiolabelled Antibody, Anti-FOLH1/GCPII
Antibody:
Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP
therapeutic antibody |
Capromab |
FOLH1/GCPII |
Radiolabelled antibody |
 |
| GMP-Bios-INN-772 |
Pre-Made Catumaxomab Biosimilar,
Bispecific, Anti-Cd3E; Epcam Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon;Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody |
Catumaxomab |
CD3E;EPCAM |
Bispecific |
 |
| GMP-Bios-INN-773 |
Pre-Made Cedelizumab Biosimilar,
Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D
therapeutic antibody |
Cedelizumab |
CD4 |
Whole mAb |
 |
| GMP-Bios-INN-775 |
Pre-Made Cergutuzumab
Amunaleukin biosimilar, Fusion Protein,
Cergutuzumab-Anti-CEACAM5/CD66e Antibody:
Anti-CEA therapeutic antibody fused with human
IL2 (interleukin 2, IL-2) Pr21-153 |
Cergutuzumab Amunaleukin
|
CEACAM5/CD66e |
Fusion Protein |
 |
| GMP-Bios-INN-777 |
Pre-Made Cetuximab Sarotalocan
Biosimilar, Whole Mab Adc, Anti-Egfr Antibody:
Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA
therapeutic antibody Drug Conjugate |
Cetuximab Sarotalocan |
EGFR |
Whole mAb ADC |
 |
| GMP-Bios-INN-778 |
Pre-Made Choriogonadotropin Beta
Biosimilar, Recombinant Protein targeting LHCGR:
Recombinant therapeutic protein targeting
HHG/LCGR/LGR2/LH/CG-R/LH/CGR/LHR/LHRHR/LSH-R/ULG5
|
Choriogonadotropin Beta |
LHCGR |
Recombinant Protein |
 |
| GMP-Bios-INN-780 |
Pre-Made Cinrebafusp Alfa P
Alfaiosimilar, Bispecific,
Anti-ERBB2/HER2;TNFRSF9 Antibody: Anti-CD340/MLN
19/NEU/NGL/TKR1/VSCN2;ILA/4-1BB/CDw137
therapeutic antibody |
Cinrebafusp Alfa |
ERBB2/HER2; TNFRSF9 |
Bispecific |
 |
| GMP-Bios-INN-781 |
Pre-Made Citatuzumab Bogatox
biosimilar, Fusion Protein,
Citatuzumab-Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody fused with Bougainvillea
spectabilis Willd bouganin |
Citatuzumab Bogatox |
EPCAM |
Fusion Protein |
 |
| GMP-Bios-INN-782 |
Pre-Made Clenoliximab
Biosimilar, Whole Mab, Anti-Cd4 Antibody:
Anti-IMD79/OKT4D therapeutic antibody |
Clenoliximab |
CD4 |
Whole mAb |
 |
| GMP-Bios-INN-783 |
Pre-Made Clervonafusp Alfa
Biosimilar, Fusion Protein targeting
SLC29A2/ENT2 fused with human GAA (glucosidase
alpha, acid, lysosomal alpha-glucosidase
)(Pr67-952) (1:2) Enzyme substitute: Recombinant
therapeutic protein targeting DER12/HNP36
|
Clervonafusp Alfa |
SLC29A2/ENT2 |
Fusion Protein |
 |
| GMP-Bios-INN-784 |
Pre-Made Clivatuzumab Tetraxetan
Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody Drug Conjugate |
Clivatuzumab Tetraxetan |
MUC1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-785 |
Pre-Made Cofetuzumab Pelidotin
Biosimilar, Whole Mab Adc, Anti-Ptk7 Antibody:
Anti-CCK-4/CCK4 therapeutic antibody Drug
Conjugate |
Cofetuzumab Pelidotin |
PTK7 |
Whole mAb ADC |
 |
| GMP-Bios-INN-786 |
Pre-Made Coltuximab Ravtansine
Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody:
Anti-B4/CVID3 therapeutic antibody Drug
Conjugate |
Coltuximab Ravtansine |
CD19 |
Whole mAb ADC |
 |
| GMP-Bios-INN-787 |
Pre-Made Conbercept Biosimilar,
Fusion Protein targeting VEGFA fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting MVCD1/VEGF/VPF
|
Conbercept |
VEGFA |
Fusion Protein |
 |
| GMP-Bios-INN-788 |
Pre-Made Corifollitropin Alfa
Biosimilar, Fusion Protein targeting FSHR fused
with CTP (C-terminal peptide of hCG):
Recombinant therapeutic protein targeting
FSHRO/LGR1/ODG1 |
Corifollitropin Alfa |
FSHR |
Fusion Protein |
 |
| GMP-Bios-INN-789 |
Pre-Made Daclizumab Beta
Biosimilar, Whole Mab, Anti-Il2Ra Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody |
Daclizumab Beta |
IL2RA |
Whole mAb |
 |
| GMP-Bios-INN-790 |
Pre-Made Dafsolimab Setaritox
Biosimilar, Whole Mab Adc, Anti-Cd3E Antibody:
Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic
antibody Drug Conjugate |
Dafsolimab Setaritox |
CD3E |
Whole mAb ADC |
 |
| GMP-Bios-INN-791 |
Pre-Made Dalantercept
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting BMP10 fused with
human IGHG1 Fc (Fragment constant) |
Dalantercept |
BMP10 |
Fusion Protein |
 |
| GMP-Bios-INN-792 |
Pre-Made Dalcinonacog Alfa
Biosimilar, Recombinant Protein targeting F9:
Recombinant therapeutic protein targeting
FIX/P19/PTC/HEMB/THPH8 |
Dalcinonacog Alfa |
F9 |
Recombinant Protein |
 |
| GMP-Bios-INN-793 |
Pre-Made Dalutrafusp Alfa P
Alfaiosimilar, Bispecific,
Anti-NT5E/CD73;TGFB1;TGFB3 Antibody:
Anti-eN/NTE/eNT/CALJA;CED/DPD1/IBDIMDE/LAP/TGF-beta1/TGFbeta;ARVD/ARVD1/LDS5/RNHF
therapeutic antibody |
Dalutrafusp Alfa |
NT5E/CD73; TGFB1;TGFB3
|
Bispecific |
 |
| GMP-Bios-INN-795 |
Pre-Made Darbepoetin Alfa
biosimilar, Recombinant Protein: Recombinant
therapeutic protein targeting EPOR |
Darbepoetin Alfa |
EPOR |
Recombinant Protein |
 |
| GMP-Bios-INN-796 |
Pre-Made Datopotamab Deruxtecan
Biosimilar, Whole Mab Adc, Anti-Tacstd2
Antibody:
Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2
therapeutic antibody Drug Conjugate |
Datopotamab Deruxtecan |
TACSTD2 |
Whole mAb ADC |
 |
| GMP-Bios-INN-797 |
Pre-Made Davoceticept
Biosimilar, Fusion Protein targeting CD274/PD-L1
fused with human IGHG1 Fc (Fragment constant)
via a peptidyl linker: Recombinant therapeutic
protein targeting B7-H/B7H1/PDCD1L1/PDCD1LG1
|
Davoceticept |
CD274/PD-L1 |
Fusion Protein |
 |
| GMP-Bios-INN-798 |
Pre-Made Dazodalibep Biosimilar,
Fusion Protein targeting CD40LG fused with ALB
(albumin, human serum albumin, HSA): Recombinant
therapeutic protein targeting
CD154/CD40L/HIGM1/IGM/IMD3/T-BAM/TNFSF5/TRAP/gp39/hCD40L
|
Dazodalibep |
CD40LG |
Fusion Protein |
 |
| GMP-Bios-INN-799 |
Pre-Made Denileukin Diftitox
Biosimilar, Fusion Protein targeting IL1RL2
fused with human IL2 (interleukin 2, IL-2):
Recombinant therapeutic protein targeting
IL-1Rrp2/IL-36R/IL1R-rp2/IL1RRP2 |
Denileukin Diftitox |
IL1RL2 |
Fusion Protein |
 |
| GMP-Bios-INN-800 |
Pre-Made Denintuzumab Mafodotin
Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody:
Anti-B4/CVID3 therapeutic antibody Drug
Conjugate |
Denintuzumab Mafodotin |
CD19 |
Whole mAb ADC |
 |
| GMP-Bios-INN-801 |
Pre-Made Depatuxizumab Mafodotin
Biosimilar, Whole Mab Adc, Anti-Egfr Antibody:
Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA
therapeutic antibody Drug Conjugate |
Depatuxizumab Mafodotin |
EGFR |
Whole mAb ADC |
 |
| GMP-Bios-INN-802 |
Pre-Made Detumomab biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting human B-cell lymphoma |
Detumomab |
human B-cell lymphoma |
Recombinant Protein |
 |
| GMP-Bios-INN-803 |
Pre-Made Dinutuximab Beta
Biosimilar, Whole Mab: Anti-Ganglioside Gd2
therapeutic antibody |
Dinutuximab Beta |
ganglioside GD2 |
Whole mAb |
 |
| GMP-Bios-INN-804 |
Pre-Made Disitamab Vedotin
Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2
Antibody: Anti-CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic
antibody Drug Conjugate |
Disitamab Vedotin |
ERBB2/HER2 |
Whole mAb ADC |
 |
| GMP-Bios-INN-805 |
Pre-Made Dorlimomab Aritox
Biosimilar, Whole Mab Adc: Anti-40S Ribosomal
Protein S18 therapeutic antibody |
Dorlimomab Aritox |
40S ribosomal protein S18
|
ADC |
 |
| GMP-Bios-INN-806 |
Pre-Made Dulaglutide Biosimilar,
Peptide Protein Fusion targeting GLP1R: (Glp-12)
Peptide-Human Igg4 Fc Fusion Protein targeting
GLP-1/GLP-1-R/GLP-1R |
Dulaglutide |
GLP1R |
Peptide Protein fusion |
 |
| GMP-Bios-INN-807 |
Pre-Made Ecromeximab Biosimilar,
Whole Mab: Anti-Ganglioside Gd3 therapeutic
antibody |
Ecromeximab |
ganglioside GD3 |
Whole mAb |
 |
| GMP-Bios-INN-808 |
Pre-Made Edobacomab Biosimilar,
Whole Mab: Anti-Endotoxin (Lipid A, Domain Of
Lipopolyaccharide, Lps) [Gram Negative Bacteria]
therapeutic antibody |
Edobacomab |
endotoxin (lipid A,
domain of lipopolyaccharide, LPS) [gram
negative bacteria] |
Whole mAb |
 |
| GMP-Bios-INN-809 |
Pre-Made Efanesoctocog Alfa
Biosimilar, Fusion Protein targeting F8 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
AHF/F8B/F8C/HEMA/FVIII/DXS1253E |
Efanesoctocog Alfa |
F8 |
Fusion Protein |
 |
| GMP-Bios-INN-810 |
Pre-Made Efaprinermin Alfa
Biosimilar, Fusion Protein targeting TNFRSF18
fused with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
AITR/CD357/ENERGEN/GITR/GITR-D |
Efaprinermin Alfa |
TNFRSF18 |
Fusion Protein |
 |
| GMP-Bios-INN-811 |
Pre-Made Efavaleukin Alfa
Biosimilar, Fusion Protein targeting IL2 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
IL-2/TCGF/lymphokine |
Efavaleukin Alfa |
IL2 |
Fusion Protein |
 |
| GMP-Bios-INN-812 |
Pre-Made Efbemalenograstim Alfa
Biosimilar, Fusion Protein targeting
CSF3R/G-CSF-R fused with human IGHG2 Fc
(Fragment constant) via a peptidyl linker:
Recombinant therapeutic protein targeting
CD114/GCSFR/SCN7 |
Efbemalenograstim Alfa |
CSF3R/G-CSF-R |
Fusion Protein |
 |
| GMP-Bios-INN-813 |
Pre-Made Efdamrofusp Alfa P
Alfaiosimilar, Bispecific, Anti-C3/CO3;C4B;VEGFA
Antibody:
Anti-AHUS5/ARMD9/ASP/CPAMD1/HEL-S-62p;CH/C4F/CO4/C4BD/C4B12/CPAMD3;VPF/MVCD1
therapeutic antibody |
Efdamrofusp Alfa |
C3/CO3;C4B;VEGFA |
Bispecific |
 |
| GMP-Bios-INN-814 |
Pre-Made Efgartigimod Alfa
Biosimilar, Recombinant Protein targeting FCGRT:
Recombinant therapeutic protein targeting
FCRN/FcgammaRn/alpha-chain |
Efgartigimod Alfa |
FCGRT |
Recombinant Protein |
 |
| GMP-Bios-INN-815 |
Pre-Made Efgivanermin Alfa
Biosimilar, Fusion Protein targeting TNFRSF18
fused with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
AITR/CD357/ENERGEN/GITR/GITR-D |
Efgivanermin Alfa |
TNFRSF18 |
Fusion Protein |
 |
| GMP-Bios-INN-816 |
Pre-Made Efineptakin Alfa
Biosimilar, Fusion Protein targeting IL7R fused
with human IGHG4 Fc (Fragment constant):
Recombinant therapeutic protein targeting
CD127/CDW127 |
Efineptakin Alfa |
IL7R |
Fusion Protein |
 |
| GMP-Bios-INN-819 |
Pre-Made Eflepedocokin Alfa
Biosimilar, Fusion Protein targeting IL10RB
fused with human IGHG2 Fc (Fragment constant)
via a peptidyl linker: Recombinant therapeutic
protein targeting
CDW210B/CRF2-4/CRFB4/D21S58/D21S66/IL-10R2
|
Eflepedocokin Alfa |
IL10RB |
Fusion Protein |
 |
| GMP-Bios-INN-820 |
Pre-Made Eflimrufusp Alfa
Biosimilar, Fusion Protein targeting FGF2 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
BFGF/FGF-2/FGFB/HBGF-2 |
Eflimrufusp Alfa |
FGF2 |
Fusion Protein |
 |
| GMP-Bios-INN-821 |
Pre-Made Efmarodocokin Alfa
Biosimilar, Fusion Protein targeting
IL22RA1/IL22R1 fused with human IGHG4 Fc
(Fragment constant): Recombinant therapeutic
protein targeting CRF2-9 |
Efmarodocokin Alfa |
IL22RA1/IL22R1 |
Fusion Protein |
 |
| GMP-Bios-INN-822 |
Pre-Made Efmitermant Alfa
Biosimilar, Fusion Protein targeting MSTN/GDF-8
fused with human IGHG2 Fc (Fragment constant)
via a peptidyl linker: Recombinant therapeutic
protein targeting GDF8/MSLHP |
Efmitermant Alfa |
MSTN/GDF-8 |
Fusion Protein |
 |
| GMP-Bios-INN-823 |
Pre-Made Efmoroctocog Alfa
Biosimilar, Fusion Protein targeting F8 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
AHF/F8B/F8C/HEMA/FVIII/DXS1253E |
Efmoroctocog Alfa |
F8 |
Fusion Protein |
 |
| GMP-Bios-INN-826 |
Pre-Made Efruxifermin
Biosimilar, Fusion Protein targeting FGFR1 fused
with human IGHG1 Fc (Fragment constant) via a
peptidyl linker: Recombinant therapeutic protein
targeting
BFGFR/CD331/CEK/ECCL/FGFBR/FGFR-1/FLG/FLT-2/FLT2/HBGFR/HH2/HRTFDS/KAL2/N-SAM/OGD/bFGF-R-1
|
Efruxifermin |
FGFR1 |
Fusion Protein |
 |
| GMP-Bios-INN-827 |
Pre-Made Eftansomatropin Alfa
Biosimilar, Fusion Protein targeting GHR fused
with human IGHG4 Fc (Fragment constant):
Recombinant therapeutic protein targeting
GHBP/GHIP |
Eftansomatropin Alfa |
GHR |
Fusion Protein |
 |
| GMP-Bios-INN-828 |
Pre-Made Eftilagimod Alfa
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting MH2 fused with
human IGHG1 Fc (Fragment constant) |
Eftilagimod Alfa |
MH2 |
Fusion Protein |
 |
| GMP-Bios-INN-829 |
Pre-Made Eftozanermin Alfa
Biosimilar, Fusion Protein targeting
TNFRSF10B/TRAIL-R2 fused with human IGHG1 Fc
(Fragment constant): Recombinant therapeutic
protein targeting
CD262/DR5/KILLER/KILLER/DR5/TRICK2/TRICK2A/TRICK2B/TRICKB/ZTNFR9
|
Eftozanermin Alfa |
TNFRSF10B/TRAIL-R2 |
Fusion Protein |
 |
| GMP-Bios-INN-830 |
Pre-Made Eftrenonacog Alfa
Biosimilar, Fusion Protein targeting F9 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
FIX/P19/PTC/HEMB/THPH8 |
Eftrenonacog Alfa |
F9 |
Fusion Protein |
 |
| GMP-Bios-INN-831 |
Pre-Made Elsilimomab Biosimilar,
Whole Mab, Anti-Il6 Antibody:
Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
therapeutic antibody |
Elsilimomab |
IL6 |
Whole mAb |
 |
| GMP-Bios-INN-832 |
Pre-Made Enapotamab Vedotin
Biosimilar, Whole Mab Adc, Anti-Axl Antibody:
Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody
Drug Conjugate |
Enapotamab Vedotin |
AXL |
Whole mAb ADC |
 |
| GMP-Bios-INN-833 |
Pre-Made Enfortumab Vedotin
Biosimilar, Whole Mab Adc, Anti-PVRL4/NECTIN4
Antibody: Anti-EDSS1/LNIR/PRR4/nectin-4
therapeutic antibody Drug Conjugate |
Enfortumab Vedotin |
PVRL4/NECTIN4 |
Whole mAb ADC |
 |
| GMP-Bios-INN-834 |
Pre-Made Enlimomab Biosimilar,
Whole Mab, Anti-ICAM1 Antibody:
Anti-BB2/CD54/P3.58 therapeutic antibody
|
Enlimomab |
ICAM1 |
Whole mAb |
 |
| GMP-Bios-INN-836 |
Pre-Made Ensomafusp Alfa
Alfaiosimilar, Bispecific, Anti-Cd19; Tnfrsf9
Antibody: Anti-B4/CVID3;ILA/4-1BB/CDw137
therapeutic antibody |
Ensomafusp Alfa |
CD19;TNFRSF9 |
Bispecific |
 |
| GMP-Bios-INN-837 |
Pre-Made Ensovibep biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting Severe acute respiratory
syndrome coronavirus 2 RBD |
Ensovibep |
Severe acute respiratory
syndrome coronavirus 2 RBD |
Recombinant Protein |
 |
| GMP-Bios-INN-838 |
Pre-Made Epitumomab Biosimilar,
Whole Mab, Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Epitumomab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-INN-839 |
Pre-Made Epitumomab Cituxetan
Biosimilar, Radiolabelled Antibody, Anti-Muc1
Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Epitumomab Cituxetan |
MUC1 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-840 |
Pre-Made Epoetin Alfa
biosimilar, Recombinant Protein: Recombinant
EPO(erythropoietin) therapeutic protein
targeting EPOR |
Epoetin Alfa |
EPOR |
Recombinant Protein |
 |
| GMP-Bios-INN-842 |
Pre-Made Eptacog Alfa (Actived
Biosimilar, Recombinant Protein targeting F7:
Recombinant therapeutic protein targeting
SPCA |
Eptacog Alfa (Actived) |
F7 |
Recombinant Protein |
 |
| GMP-Bios-INN-843 |
Pre-Made Eramkafusp Alfa
Biosimilar, Fusion Protein targeting MS4A1/CD20
fused with human IFNA2 (interferon alpha 2) via
a peptidyl linker: Recombinant therapeutic
protein targeting
B1/Bp35/CVID5/FMC7/LEU-16/S7 |
Eramkafusp Alfa |
MS4A1/CD20 |
Fusion Protein |
 |
| GMP-Bios-INN-844 |
Pre-Made Erlizumab Biosimilar,
Whole Mab, Anti-Itgb2 Antibody:
Anti-CD18/LAD/LCAMB/LFA-1/MAC-1/MF17/MFI7
therapeutic antibody |
Erlizumab |
ITGB2 |
Whole mAb |
 |
| GMP-Bios-INN-845 |
Pre-Made Ertumaxomab Biosimilar,
Bispecific, Anti-Cd3E;Erbb2 Antibody:
Anti-T3E/TCRE/IMD18/CD3epsilon;CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2 therapeutic antibody
|
Ertumaxomab |
CD3E;ERBB2 |
Bispecific |
 |
| GMP-Bios-INN-846 |
Pre-Made Etanercept Biosimilar,
Fusion Protein targeting TNF fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
DIF/TNFSF2/TNLG1F |
Etanercept |
TNF |
Fusion Protein |
 |
| GMP-Bios-INN-848 |
Pre-Made Exbivirumab Biosimilar,
Whole Mab: Anti-Hbv (Hepatitis B Virus) Surface
Antigen (Hbsag) [Hepatitis B Virus] therapeutic
antibody |
Exbivirumab |
HBV (hepatitis B virus)
surface antigen (HBsAg) [Hepatitis B virus] |
Whole mAb |
 |
| GMP-Bios-INN-849 |
Pre-Made Faralimomab Biosimilar,
Whole Mab, Anti-Ifna1 Antibody:
Anti-IFL/IFN/IFN-ALPHA/IFN-alphaD/IFNA13/leIF D
therapeutic antibody |
Faralimomab |
IFNA1 |
Whole mAb |
 |
| GMP-Bios-INN-850 |
Pre-Made Farletuzumab
Ecteribulin Biosimilar, Whole Mab Adc,
Anti-Folr1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD
therapeutic antibody Drug Conjugate |
Farletuzumab Ecteribulin
|
FOLR1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-851 |
Pre-Made Felvizumab Biosimilar,
Whole Mab: Anti-Rsv (Respiratory Syncytial
Virus) Glycoprotein F [Respiratory Syncytial
Virus] therapeutic antibody |
Felvizumab |
RSV (respiratory syncytial
virus) glycoprotein F [Respiratory syncytial virus] |
Whole mAb |
 |
| GMP-Bios-INN-852 |
Pre-Made Filgrastim Biosimilar,
Recombinant Protein targeting CSF3R: Recombinant
therapeutic protein targeting
CD114/GCSFR/SCN7 |
Filgrastim |
CSF3R/G-CSF-R |
Recombinant Protein |
 |
| GMP-Bios-INN-853 |
Pre-Made Gavilimomab Biosimilar,
Whole Mab, Anti-Bsg Antibody:
Anti-5F7/CD147/EMMPRIN/EMPRIN/HAb18G/OK/TCSF
therapeutic antibody |
Gavilimomab |
BSG |
Whole mAb |
 |
| GMP-Bios-INN-855 |
Pre-Made Gemtuzumab Ozogamicin
Biosimilar, Whole Mab Adc, Anti-Cd33 Antibody:
Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody
Drug Conjugate |
Gemtuzumab Ozogamicin |
CD33 |
Whole mAb ADC |
 |
| GMP-Bios-INN-856 |
Pre-Made Glembatumumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Gpnmb Antibody:
Anti-HGFIN/NMB/PLCA3 therapeutic antibody Drug
Conjugate |
Glembatumumab Vedotin |
GPNMB |
Whole mAb ADC |
 |
| GMP-Bios-INN-857 |
Pre-Made Glucagon Biosimilar,
Recombinant Protein targeting GCGR: Recombinant
therapeutic protein targeting GGR/GL-R/MVAH
|
Glucagon |
GCGR |
Recombinant Protein |
 |
| GMP-Bios-INN-858 |
Pre-Made Grisnilimab Setaritox
Biosimilar, Whole Mab Adc, Anti-Cd7 Antibody:
Anti-GP40/LEU-9/TP41/Tp40 therapeutic antibody
Drug Conjugate |
Grisnilimab Setaritox |
CD7 |
Whole mAb ADC |
 |
| GMP-Bios-INN-859 |
Pre-Made Ibritumomab Tiuxetan
Biosimilar, Radiolabelled Antibody,
Anti-MS4A1/CD20 Antibody:
Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic
antibody |
Ibritumomab Tiuxetan |
MS4A1/CD20 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-861 |
Pre-Made Igovomab Biosimilar,
Radiolabelled Antibody, Anti-Muc16 Antibody:
Anti-CA125 therapeutic antibody |
Igovomab |
MUC16 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-862 |
Pre-Made Iladatuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Cd79B Antibody:
Anti-AGM6/B29/IGB therapeutic antibody Drug
Conjugate |
Iladatuzumab Vedotin |
CD79B |
Whole mAb ADC |
 |
| GMP-Bios-INN-863 |
Pre-Made Imciromab Biosimilar,
Radiolabelled Antibody: Anti-Myosin therapeutic
antibody |
Imciromab |
myosin |
Radiolabelled antibody |
 |
| GMP-Bios-INN-864 |
Pre-Made Inbakicept biosimilar,
Fusion Protein: Recombinant therapeutic protein
targeting IL15 fused with human IGHG1 Fc
(Fragment constant) |
Inbakicept |
IL15 |
Fusion Protein |
 |
| GMP-Bios-INN-865 |
Pre-Made Indatuximab Ravtansine
Biosimilar, Whole Mab Adc, Anti-Sdc1 Antibody:
Anti-CD138/SDC/SYND1/syndecan therapeutic
antibody Drug Conjugate |
Indatuximab Ravtansine |
SDC1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-866 |
Pre-Made Indusatumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Gucy2C Antibody:
Anti-DIAR6/GC-C/GUC2C/MECILIL/STAR therapeutic
antibody Drug Conjugate |
Indusatumab Vedotin |
GUCY2C |
Whole mAb ADC |
 |
| GMP-Bios-INN-867 |
Pre-Made Inolimomab Biosimilar,
Whole Mab, Anti-Il2Ra Antibody:
Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55
therapeutic antibody |
Inolimomab |
IL2RA |
Whole mAb |
 |
| GMP-Bios-INN-868 |
Pre-Made Inotuzumab Ozogamicin
Biosimilar, Whole Mab Adc, Anti-Cd22 Antibody:
Anti-SIGLEC-2/SIGLEC2 therapeutic antibody Drug
Conjugate |
Inotuzumab Ozogamicin |
CD22 |
Whole mAb ADC |
 |
| GMP-Bios-INN-869 |
Pre-Made Insulin Biosimilar,
Recombinant Protein targeting INSR: Recombinant
therapeutic protein targeting CD220/HHF5
|
Insulin |
INSR |
Recombinant Protein |
 |
| GMP-Bios-INN-870 |
Pre-Made Insulin Efsitora Alfa
Biosimilar, Fusion Protein targeting INSR fused
with human IGHG2 Fc (Fragment constant):
Recombinant therapeutic protein targeting
CD220/HHF5 |
Insulin Efsitora Alfa |
INSR |
Fusion Protein |
 |
| GMP-Bios-INN-871 |
Pre-Made Interferon Alfa
Biosimilar, Recombinant Protein targeting
IFNAR1: Recombinant therapeutic protein
targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC
|
Interferon Alfa |
IFNAR1 |
Recombinant Protein |
 |
| GMP-Bios-INN-872 |
Pre-Made Interferon Alfacon-1
Biosimilar, Recombinant Protein targeting
IFNAR1: Recombinant therapeutic protein
targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC
|
Interferon Alfacon-1 |
IFNAR1 |
Recombinant Protein |
 |
| GMP-Bios-INN-873 |
Pre-Made Interferon Beta
Biosimilar, Recombinant Protein targeting
IFNAR1: Recombinant therapeutic protein
targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC
|
Interferon Beta |
IFNAR1 |
Recombinant Protein |
 |
| GMP-Bios-INN-874 |
Pre-Made Interferon Gamma
Biosimilar, Recombinant Protein targeting
IFNGR1: Recombinant therapeutic protein
targeting CD119/IFNGR/IMD27A/IMD27B |
Interferon Gamma |
IFNGR1 |
Recombinant Protein |
 |
| GMP-Bios-INN-875 |
Pre-Made Iodine (131I)
Apamistamab Biosimilar, Radiolabelled Antibody,
Anti-Ptprc Antibody:
Anti-B220/CD45/CD45R/GP180/L-CA/LCA/LY5/T200
therapeutic antibody |
Iodine (131I) Apamistamab
|
PTPRC |
Radiolabelled antibody |
 |
| GMP-Bios-INN-876 |
Pre-Made Iodine (131I)
Derlotuximab Biotin Biosimilar, Radiolabelled
Antibody: Anti-Dna/Histone (H1) Complex
therapeutic antibody |
Iodine (131I) Derlotuximab
Biotin |
DNA;histone (H1) complex
|
Radiolabelled antibody |
 |
| GMP-Bios-INN-877 |
Pre-Made Iodo (124I)
Girentuximab Biosimilar, Radiolabelled Antibody,
Anti-CA9/CA-IX Antibody: Anti-CAIX/MN
therapeutic antibody |
Iodo (124I) Girentuximab
|
CA9/CA-IX |
Radiolabelled antibody |
 |
| GMP-Bios-INN-878 |
Pre-Made Ipafricept biosimilar,
Fusion Protein: Recombinant therapeutic protein
targeting Wnt fused with human IGHG1 Fc
(Fragment constant) |
Ipafricept |
Wnt |
Fusion Protein |
 |
| GMP-Bios-INN-881 |
Pre-Made Keliximab Biosimilar,
Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D
therapeutic antibody |
Keliximab |
CD4 |
Whole mAb |
 |
| GMP-Bios-INN-882 |
Pre-Made Labetuzumab Govitecan
Biosimilar, Whole Mab Adc, Anti-CEACAM5/CD66e
Antibody: Anti-CEA therapeutic antibody Drug
Conjugate |
Labetuzumab Govitecan |
CEACAM5/CD66e |
Whole mAb ADC |
 |
| GMP-Bios-INN-883 |
Pre-Made Ladiratuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Slc39A6
Antibody: Anti-LIV-1/LIV1/ZIP6 therapeutic
antibody Drug Conjugate |
Ladiratuzumab Vedotin |
SLC39A6 |
Whole mAb ADC |
 |
| GMP-Bios-INN-884 |
Pre-Made Laprituximab Emtansine
Biosimilar, Whole Mab Adc, Anti-Egfr Antibody:
Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA
therapeutic antibody Drug Conjugate |
Laprituximab Emtansine |
EGFR |
Whole mAb ADC |
 |
| GMP-Bios-INN-885 |
Pre-Made Ledelabricin Alfa
biosimilar, Recombinant Protein: Recombinant
therapeutic protein targeting PRG4(PROTEOGLYCAN
4) |
Ledelabricin Alfa |
PRG4 (PROTEOGLYCAN 4)
|
Recombinant Protein |
 |
| GMP-Bios-INN-886 |
Pre-Made Lemalesomab Biosimilar,
Whole Mab: Anti-Nca-90 (Nonspecific Cross-
Reacting Antigens 90Kda Glycoproteins,
Granulocyte Cell Antigen) [human] therapeutic
antibody |
Lemalesomab |
NCA-90 (nonspecific cross-
reacting antigens 90kDa glycoproteins, granulocyte cell
antigen) [human] |
Whole mAb |
 |
| GMP-Bios-INN-887 |
Pre-Made Lenercept Biosimilar,
Fusion Protein targeting TNF fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
DIF/TNFSF2/TNLG1F |
Lenercept |
TNF |
Fusion Protein |
 |
| GMP-Bios-INN-888 |
Pre-Made Lepunafusp Alfa
Biosimilar, Fusion Protein targeting TFRC fused
with human IDUA (iduronidase, alpha-L-) isoform
1 via a peptidyl linker: Recombinant therapeutic
protein targeting
CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 |
Lepunafusp Alfa |
TFRC |
Fusion Protein |
 |
| GMP-Bios-INN-889 |
Pre-Made Lerdelimumab
Biosimilar, Whole Mab, Anti-Tgfb2 Antibody:
Anti-G-TSF/LDS4/TGF-beta2 therapeutic
antibody |
Lerdelimumab |
TGFB2 |
Whole mAb |
 |
| GMP-Bios-INN-890 |
Pre-Made Lerodalcibep
Biosimilar, Fusion Protein targeting PCSK9 fused
with ALB (albumin, human serum albumin, HSA):
Recombinant therapeutic protein targeting
FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9
|
Lerodalcibep |
PCSK9 |
Fusion Protein |
 |
| GMP-Bios-INN-892 |
Pre-Made Libivirumab Biosimilar,
Whole Mab: Anti-Hbv (Hepatitis B Virus) Surface
Antigen (Hbsag) [Hepatitis B Virus] therapeutic
antibody |
Libivirumab |
HBV (hepatitis B virus)
surface antigen (HBsAg) [Hepatitis B virus] |
Whole mAb |
 |
| GMP-Bios-INN-893 |
Pre-Made Lifastuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Slc34A2
Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM
therapeutic antibody Drug Conjugate |
Lifastuzumab Vedotin |
SLC34A2 |
Whole mAb ADC |
 |
| GMP-Bios-INN-896 |
Pre-Made Loncastuximab Tesirine
Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody:
Anti-B4/CVID3 therapeutic antibody Drug
Conjugate |
Loncastuximab Tesirine |
CD19 |
Whole mAb ADC |
 |
| GMP-Bios-INN-897 |
Pre-Made Lonigutamab Ugodotin
Biosimilar, Whole Mab Adc, Anti-Igf1R Antibody:
Anti-CD221/IGFIR/IGFR/JTK13 therapeutic antibody
Drug Conjugate |
Lonigutamab Ugodotin |
IGF1R |
Whole mAb ADC |
 |
| GMP-Bios-INN-898 |
Pre-Made Lorukafusp Alfa
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting ganglioside GD2
fused with human IL2 (interleukin 2, IL-2)
|
Lorukafusp Alfa |
ganglioside GD2 |
Fusion Protein |
 |
| GMP-Bios-INN-899 |
Pre-Made Lorvotuzumab Mertansine
Biosimilar, Whole Mab Adc, Anti-Ncam1 Antibody:
Anti-CD56/MSK39/NCAM therapeutic antibody Drug
Conjugate |
Lorvotuzumab Mertansine |
NCAM1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-900 |
Pre-Made Losatuxizumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Egfr Antibody:
Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA
therapeutic antibody Drug Conjugate |
Losatuxizumab Vedotin |
EGFR |
Whole mAb ADC |
 |
| GMP-Bios-INN-902 |
Pre-Made Lupartumab Amadotin
Biosimilar, Whole Mab Adc, Anti-Lypd3 Antibody:
Anti-C4.4A therapeutic antibody Drug
Conjugate |
Lupartumab Amadotin |
LYPD3 |
Whole mAb ADC |
 |
| GMP-Bios-INN-903 |
Pre-Made Luspatercept
Biosimilar, Fusion Protein targeting GDF11 fused
with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
BMP-11/BMP11/VHO |
Luspatercept |
GDF11 |
Fusion Protein |
 |
| GMP-Bios-INN-904 |
Pre-Made Lutetium (177Lu)
Lilotomab Satetraxetan Biosimilar, Radiolabelled
Antibody, Anti-Cd37 Antibody:
Anti-GP52-40/TSPAN26 therapeutic antibody
|
Lutetium (177Lu) Lilotomab
Satetraxetan |
CD37 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-905 |
Pre-Made Mapatumumab Biosimilar,
Whole Mab, Anti-TNFRSF10A/TRAIL-R1 Antibody:
Anti-APO2/CD261/DR4/TRAILR-1/TRAILR1 therapeutic
antibody |
Mapatumumab |
TNFRSF10A/TRAIL-R1 |
Whole mAb |
 |
| GMP-Bios-INN-906 |
Pre-Made Maslimomab Biosimilar,
Whole Mab: Anti-T Cell Receptor (Tr, Tr
Alpha_Beta) [human] therapeutic antibody
|
Maslimomab |
T cell receptor (TR, TR
alpha_beta) [human] |
Whole mAb |
 |
| GMP-Bios-INN-907 |
Pre-Made Melredableukin Alfa
Biosimilar, Fusion Protein targeting IL2RA fused
with human IL2 (interleukin 2, IL-2) via a
peptidyl linker: Recombinant therapeutic protein
targeting CD25/IDDM10/IL2R/IMD41/TCGFR/p55
|
Melredableukin Alfa |
IL2RA |
Fusion Protein |
 |
| GMP-Bios-INN-908 |
Pre-Made Metelimumab Biosimilar,
Whole Mab, Anti-Tgfb1 Antibody:
Anti-CED/DPD1/IBDIMDE/LAP therapeutic
antibody |
Metelimumab |
TGFB1 |
Whole mAb |
 |
| GMP-Bios-INN-909 |
Pre-Made Minretumomab
Biosimilar, Whole Mab: Anti-Tag-72 therapeutic
antibody |
Minretumomab |
TAG-72 |
Whole mAb |
 |
| GMP-Bios-INN-910 |
Pre-Made Mipasetamab Uzoptirine
Biosimilar, Whole Mab Adc, Anti-Axl Antibody:
Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody
Drug Conjugate |
Mipasetamab Uzoptirine |
AXL |
Whole mAb ADC |
 |
| GMP-Bios-INN-913 |
Pre-Made Mirococept biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting C3b/C4b |
Mirococept |
C3b/CO3;C4b |
Recombinant Protein |
 |
| GMP-Bios-INN-914 |
Pre-Made Mirvetuximab
Soravtansine Biosimilar, Whole Mab Adc,
Anti-Folr1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD
therapeutic antibody Drug Conjugate |
Mirvetuximab Soravtansine
|
FOLR1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-915 |
Pre-Made Mirzotamab Clezutoclax
Biosimilar, Whole Mab Adc, Anti-Cd276 Antibody:
Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic
antibody Drug Conjugate |
Mirzotamab Clezutoclax |
CD276 |
Whole mAb ADC |
 |
| GMP-Bios-INN-916 |
Pre-Made Mitumomab Biosimilar,
Whole Mab: Anti-Ganglioside Gd3 therapeutic
antibody |
Mitumomab |
ganglioside GD3 |
Whole mAb |
 |
| GMP-Bios-INN-917 |
Pre-Made Modakafusp Alfa
Biosimilar, Fusion Protein targeting CD38 fused
with human IFNA2 (interferon alpha 2) *b
(R46,H57) 24-188: Recombinant therapeutic
protein targeting ADPRC 1/ADPRC1 |
Modakafusp Alfa |
CD38 |
Fusion Protein |
 |
| GMP-Bios-INN-918 |
Pre-Made Morolimumab Biosimilar,
Whole Mab, Anti-Rhd Antibody:
Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI
therapeutic antibody |
Morolimumab |
RHD |
Whole mAb |
 |
| GMP-Bios-INN-920 |
Pre-Made Moxetumomab Pasudotox
biosimilar, Fusion Protein,
Moxetumomab-Anti-CD22 Antibody:
Anti-SIGLEC-2/SIGLEC2 therapeutic antibody fused
with Pseudomonas aeruginosa exotoxin A |
Moxetumomab Pasudotox |
CD22 |
Fusion Protein |
 |
| GMP-Bios-INN-921 |
Pre-Made Muromonab-Cd3
3Iosimilar, Whole Mab, Anti-Cd3E Antibody:
Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic
antibody |
Muromonab-Cd3 |
CD3E |
Whole mAb |
 |
| GMP-Bios-INN-922 |
Pre-Made Nacolomab Tafenatox
biosimilar, Fusion Protein, Nacolomab-Anti-MUC1
Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody fused with Staphylococcus
aureus enterotoxin A |
Nacolomab Tafenatox |
MUC1 |
Fusion Protein |
 |
| GMP-Bios-INN-923 |
Pre-Made Naptumomab Estafenatox
biosimilar, Fusion Protein, Naptumomab-Anti-TPBG
Antibody: Anti-5T4/5T4AG/M6P1/WAIF1 therapeutic
antibody fused with Staphylococcus aureus
enterotoxin E SEA/E120 superantigen
(synthetic) |
Naptumomab Estafenatox |
TPBG |
Fusion Protein |
 |
| GMP-Bios-INN-924 |
Pre-Made Naratuximab Emtansine
Biosimilar, Whole Mab Adc, Anti-Cd37 Antibody:
Anti-GP52-40/TSPAN26 therapeutic antibody Drug
Conjugate |
Naratuximab Emtansine |
CD37 |
Whole mAb ADC |
 |
| GMP-Bios-INN-925 |
Pre-Made Nebacumab Biosimilar,
Whole Mab: Anti-Endotoxin (Lipid A, Domain Of
Lipopolyaccharide, Lps) [Gram Negative Bacteria]
therapeutic antibody |
Nebacumab |
endotoxin (lipid A, domain
of lipopolyaccharide, LPS) [gram negative bacteria] |
Whole mAb |
 |
| GMP-Bios-INN-926 |
Pre-Made Nemvaleukin Alfa
Biosimilar, Fusion Protein targeting IL2RA fused
with human IL2RA (interleukin 2 receptor alpha
subunit, IL-2RA, TAC, p55, CD25) 139-303
(1-165): Recombinant therapeutic protein
targeting CD25/IDDM10/IL2R/IMD41/TCGFR/p55
|
Nemvaleukin Alfa |
IL2RA |
Fusion Protein |
 |
| GMP-Bios-INN-927 |
Pre-Made Nerelimomab Biosimilar,
Whole Mab, Anti-Tnf Antibody:
Anti-DIF/TNFSF2/TNLG1F therapeutic antibody
|
Nerelimomab |
TNF |
Whole mAb |
 |
| GMP-Bios-INN-928 |
Pre-Made Nogapendekin Alfa
Biosimilar, Recombinant Protein targeting
IL15RA: Recombinant therapeutic protein
targeting CD215 |
Nogapendekin Alfa |
IL15RA |
Recombinant Protein |
 |
| GMP-Bios-INN-929 |
Pre-Made Nonacog Gamma
Biosimilar, Recombinant Protein targeting F9:
Recombinant therapeutic protein targeting
FIX/P19/PTC/HEMB/THPH8 |
Nonacog Gamma |
F9 |
Recombinant Protein |
 |
| GMP-Bios-INN-931 |
Pre-Made Odulimomab Biosimilar,
Fab Fusion, Anti-Itgal Antibody:
Anti-CD11A/LFA-1/LFA1A therapeutic antibody
|
Odulimomab |
ITGAL |
Fab Fusion |
 |
| GMP-Bios-INN-932 |
Pre-Made Olamkicept Biosimilar,
Fusion Protein targeting IL6 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6
|
Olamkicept |
IL6 |
Fusion Protein |
 |
| GMP-Bios-INN-934 |
Pre-Made Omfiloctocog Alfa
Biosimilar, Recombinant Protein targeting F8:
Recombinant therapeutic protein targeting
AHF/F8B/F8C/HEMA/FVIII/DXS1253E |
Omfiloctocog Alfa |
F8 |
Recombinant Protein |
 |
| GMP-Bios-INN-935 |
Pre-Made Onercept Biosimilar,
Recombinant Protein targeting TNF: Recombinant
therapeutic protein targeting
DIF/TNFSF2/TNLG1F |
Onercept |
TNF |
Recombinant Protein |
 |
| GMP-Bios-INN-936 |
Pre-Made Onfekafusp Alfa
Biosimilar, Fusion Protein targeting FN/FN1
fused with human TNF (tumor necrosis factor
(TNF) superfamily member 2, TNFSF2, TNF-alpha,
TNFA) - trimer: Recombinant therapeutic protein
targeting
CIG/ED-B/FINCZ/GFND/GFND2/LETS/MSF/SMDCF
|
Onfekafusp Alfa |
FN/FN1 |
Fusion Protein |
 |
| GMP-Bios-INN-937 |
Pre-Made Ontorpacept Biosimilar,
Fusion Protein targeting CD47 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting IAP/MER6/OA3
|
Ontorpacept |
CD47 |
Fusion Protein |
 |
| GMP-Bios-INN-938 |
Pre-Made Opinercept Biosimilar,
Fusion Protein targeting TNF fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
DIF/TNFSF2/TNLG1F |
Opinercept |
TNF |
Fusion Protein |
 |
| GMP-Bios-INN-939 |
Pre-Made Oportuzumab Monatox
biosimilar, Fusion Protein,
Oportuzumab-Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody fused with Pseudomonas
aeruginosa exotoxin A |
Oportuzumab Monatox |
EPCAM |
Fusion Protein |
 |
| GMP-Bios-INN-940 |
Pre-Made Oregovomab Biosimilar,
Whole Mab, Anti-Muc16 Antibody: Anti-CA125
therapeutic antibody |
Oregovomab |
MUC16 |
Whole mAb |
 |
| GMP-Bios-INN-941 |
Pre-Made Oreptacog Alfa
Biosimilar, Recombinant Protein targeting F7:
Recombinant therapeutic protein targeting
SPCA |
Oreptacog Alfa |
F7 |
Recombinant Protein |
 |
| GMP-Bios-INN-943 |
Pre-Made Pabinafusp Alfa
Biosimilar, Fusion Protein targeting TFRC fused
with iduronate-2-sulfatase: Recombinant
therapeutic protein targeting
CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 |
Pabinafusp Alfa |
TFRC |
Fusion Protein |
 |
| GMP-Bios-INN-944 |
Pre-Made Pagibaximab Biosimilar,
Whole Mab: Anti-Staphylococcus Epidermidis
Lipoteichoic Acid therapeutic antibody |
Pagibaximab |
Staphylococcus epidermidis
lipoteichoic acid |
Whole mAb |
 |
| GMP-Bios-INN-945 |
Pre-Made Pascolizumab
Biosimilar, Whole Mab, Anti-Il4 Antibody:
Anti-BCGF-1/BCGF1/BSF-1/BSF1/IL-4 therapeutic
antibody |
Pascolizumab |
IL4 |
Whole mAb |
 |
| GMP-Bios-INN-946 |
Pre-Made Patritumab Deruxtecan
Biosimilar, Whole Mab Adc, Anti-ERBB3/Erbb-3
Antibody:
Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3
therapeutic antibody Drug Conjugate |
Patritumab Deruxtecan |
ERBB3/Erbb-3 |
Whole mAb ADC |
 |
| GMP-Bios-INN-958 |
Pre-Made Pelgifatamab Corixetan
Biosimilar, Whole Mab Adc, Anti-FOLH1/GCPII
Antibody:
Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP
therapeutic antibody Drug Conjugate |
Pelgifatamab Corixetan |
FOLH1/GCPII |
Whole mAb ADC |
 |
| GMP-Bios-INN-959 |
Pre-Made Pexelizumab Biosimilar,
Scfv, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB
therapeutic antibody |
Pexelizumab |
C5/CO5 |
scFv |
 |
| GMP-Bios-INN-960 |
Pre-Made Pinatuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Cd22 Antibody:
Anti-SIGLEC-2/SIGLEC2 therapeutic antibody Drug
Conjugate |
Pinatuzumab Vedotin |
CD22 |
Whole mAb ADC |
 |
| GMP-Bios-INN-961 |
Pre-Made Pivekimab Sunirine
Biosimilar, Whole Mab Adc, Anti-Il3Ra Antibody:
Anti-CD123/IL3R/IL3RX/IL3RY/hIL-3Ra therapeutic
antibody Drug Conjugate |
Pivekimab Sunirine |
IL3RA |
Whole mAb ADC |
 |
| GMP-Bios-INN-962 |
Pre-Made Polatuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Cd79B Antibody:
Anti-AGM6/B29/IGB therapeutic antibody Drug
Conjugate |
Polatuzumab Vedotin |
CD79B |
Whole mAb ADC |
 |
| GMP-Bios-INN-963 |
Pre-Made Pozelimab Biosimilar,
Whole Mab, Anti-C5/CO5 Antibody:
Anti-CPAMD4/ECLZB therapeutic antibody |
Pozelimab |
C5/CO5 |
Whole mAb |
 |
| GMP-Bios-INN-964 |
Pre-Made Praluzatamab Ravtansine
Biosimilar, Whole Mab Adc, Anti-Alcam Antibody:
Anti-CD166/MEMD therapeutic antibody Drug
Conjugate |
Praluzatamab Ravtansine |
ALCAM |
Whole mAb ADC |
 |
| GMP-Bios-INN-965 |
Pre-Made Priliximab Biosimilar,
Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D
therapeutic antibody |
Priliximab |
CD4 |
Whole mAb |
 |
| GMP-Bios-INN-966 |
Pre-Made Pritumumab Biosimilar,
Whole Mab: Anti-Vim/Vimentin therapeutic
antibody |
Pritumumab |
VIM/Vimentin
|
Whole mAb |
 |
| GMP-Bios-INN-967 |
Pre-Made Ramatercept Biosimilar,
Fusion Protein targeting MSTN/GDF-8 fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting GDF8/MSLHP
|
Ramatercept |
MSTN/GDF-8 |
Fusion Protein |
 |
| GMP-Bios-INN-968 |
Pre-Made Raxibacumab Biosimilar,
Whole Mab: Anti-Anthrax Protective Antigen (Pa)
[Bacillus Anthracis] therapeutic antibody
|
Raxibacumab |
anthrax protective antigen
(PA) [Bacillus anthracis] |
Whole mAb |
 |
| GMP-Bios-INN-969 |
Pre-Made Recifercept biosimilar,
Recombinant Protein: Recombinant therapeutic
protein targeting FGF |
Recifercept |
FGF |
Recombinant Protein |
 |
| GMP-Bios-INN-970 |
Pre-Made Regavirumab Biosimilar,
Whole Mab: Anti-Hcmv (Human Cytomegalovirus)
Envelope Glycoprotein B (Gb) [Human
Betaherpesvirus 5] therapeutic antibody |
Regavirumab |
HCMV (human cytomegalovirus)
envelope glycoprotein B (gB) [Human betaherpesvirus 5]
|
Whole mAb |
 |
| GMP-Bios-INN-972 |
Pre-Made Retlirafusp Alfa
Biosimilar, Fusion Protein targeting CD274/PD-L1
fused with human TGFBR2 (transforming growth
factor beta receptor 2) extracellular fragment
(20-136) via a peptidyl linker: Recombinant
therapeutic protein targeting
B7-H/B7H1/PDCD1L1/PDCD1LG1 |
Retlirafusp Alfa |
CD274/PD-L1 |
Fusion Protein |
 |
| GMP-Bios-INN-973 |
Pre-Made Rilonacept Biosimilar,
Fusion Protein targeting IL1B fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
IL-1/IL1-BETA/IL1F2/IL1beta |
Rilonacept |
IL1B |
Fusion Protein |
 |
| GMP-Bios-INN-974 |
Pre-Made Ripafollitropin Alfa
(Bovine) biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting Bostau FSHR fused
with CTP (C-terminal peptide of hCG) |
Ripafollitropin Alfa
(Bovine) |
Bostau FSHR |
Fusion Protein |
 |
| GMP-Bios-INN-976 |
Pre-Made Rolinsatamab Talirine
Biosimilar, Whole Mab Adc, Anti-Prlr Antibody:
Anti-HPRL/MFAB/RI-PRLR/hPRLrI therapeutic
antibody Drug Conjugate |
Rolinsatamab Talirine |
PRLR |
Whole mAb ADC |
 |
| GMP-Bios-INN-977 |
Pre-Made Romiplostim Biosimilar,
Fusion Protein targeting MPL fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
C-MPL/CD110/MPLV/THCYT2/THPOR/TPOR |
Romiplostim |
MPL |
Fusion Protein |
 |
| GMP-Bios-INN-979 |
Pre-Made Rosopatamab Tetraxetan
Biosimilar, Whole Mab Adc, Anti-FOLH1/GCPII
Antibody:
Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP
therapeutic antibody Drug Conjugate |
Rosopatamab Tetraxetan |
FOLH1/GCPII |
Whole mAb ADC |
 |
| GMP-Bios-INN-980 |
Pre-Made Rovalpituzumab Tesirine
Biosimilar, Whole Mab Adc, Anti-Dll3 Antibody:
Anti-SCDO1 therapeutic antibody Drug
Conjugate |
Rovalpituzumab Tesirine |
DLL3 |
Whole mAb ADC |
 |
| GMP-Bios-INN-981 |
Pre-Made Rovelizumab Biosimilar,
Bispecific, Anti-Itgal;Itgb2 Antibody:
Anti-CD11A/LFA-1/LFA1A;CD18/LAD/LCAMB/LFA-1/MAC-1/MF17/MFI7
therapeutic antibody |
Rovelizumab |
ITGAL;ITGB2 |
Bispecific |
 |
| GMP-Bios-INN-982 |
Pre-Made Rozibafusp Alfa
Biosimilar, Fusion Protein targeting ICOS fused
with human TNFSF13B (tumor necrosis factor (TNF)
superfamily member 13B, BAFF, THANK, TALL1,
TALL-1, BLYS, BLyS, B cell activating factor, B
lymphocyte activator, CD257): Recombinant
therapeutic protein targeting
AILIM/CD278/CVID1 |
Rozibafusp Alfa |
ICOS |
Fusion Protein |
 |
| GMP-Bios-INN-983 |
Pre-Made Sacituzumab Govitecan
Biosimilar, Whole Mab Adc, Anti-Tacstd2
Antibody:
Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2
therapeutic antibody Drug Conjugate |
Sacituzumab Govitecan |
TACSTD2 |
Whole mAb ADC |
 |
| GMP-Bios-INN-985 |
Pre-Made Samrotamab Vedotin
Biosimilar, Whole Mab Adc, Anti-Lrrc15 Antibody:
Anti-LIB therapeutic antibody Drug Conjugate
|
Samrotamab Vedotin |
LRRC15 |
Whole mAb ADC |
 |
| GMP-Bios-INN-986 |
Pre-Made Sargramostim
Biosimilar, Recombinant Protein targeting
CSF2RA: Recombinant therapeutic protein
targeting
CD116/CDw116/CSF2R/CSF2RAX/CSF2RAY/CSF2RX/CSF2RY/GM-CSF-R-alpha/GMCSFR/GMCSFR-alpha/GMR/GMR-alpha/SMDP4/alphaGMR
|
Sargramostim |
CSF2RA |
Recombinant Protein |
 |
| GMP-Bios-INN-987 |
Pre-Made Satumomab Biosimilar,
Radiolabelled Antibody: Anti-Tag-72 therapeutic
antibody |
Satumomab |
TAG-72 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-988 |
Pre-Made Serclutamab Talirine
Biosimilar, Whole Mab Adc, Anti-Egfr Antibody:
Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA
therapeutic antibody Drug Conjugate |
Serclutamab Talirine |
EGFR |
Whole mAb ADC |
 |
| GMP-Bios-INN-989 |
Pre-Made Sevirumab Biosimilar,
Whole Mab: Anti-Hcmv (Human Cytomegalovirus)
Envelope Glycoprotein H (Gh) [Human
Betaherpesvirus 5] therapeutic antibody |
Sevirumab |
HCMV (human cytomegalovirus)
envelope glycoprotein H (gH) [Human betaherpesvirus 5]
|
Whole mAb |
 |
| GMP-Bios-INN-990 |
Pre-Made Sibrotuzumab
Biosimilar, Whole Mab, Anti-Fap Antibody:
Anti-DPPIV/FAPA/FAPalpha/SIMP therapeutic
antibody |
Sibrotuzumab |
FAP |
Whole mAb |
 |
| GMP-Bios-INN-991 |
Pre-Made Simlukafusp Alfa
Biosimilar, Fusion Protein targeting FAP fused
with human IL2 (interleukin 2, IL-2):
Recombinant therapeutic protein targeting
DPPIV/FAPA/FAPalpha/SIMP |
Simlukafusp Alfa |
FAP |
Fusion Protein |
 |
| GMP-Bios-INN-992 |
Pre-Made Siplizumab Biosimilar,
Whole Mab, Anti-Cd2 Antibody:
Anti-LFA-2/SRBC/T11 therapeutic antibody
|
Siplizumab |
CD2 |
Whole mAb |
 |
| GMP-Bios-INN-993 |
Pre-Made Sirtratumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Slitrk6
Antibody: Anti-DFNMYP therapeutic antibody Drug
Conjugate |
Sirtratumab Vedotin |
SLITRK6 |
Whole mAb ADC |
 |
| GMP-Bios-INN-994 |
Pre-Made Sofituzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Muc16 Antibody:
Anti-CA125 therapeutic antibody Drug
Conjugate |
Sofituzumab Vedotin |
MUC16 |
Whole mAb ADC |
 |
| GMP-Bios-INN-995 |
Pre-Made Somatropin Biosimilar,
Recombinant Protein targeting GHR: Recombinant
therapeutic protein targeting GHBP/GHIP |
Somatropin |
GHR |
Recombinant Protein |
 |
| GMP-Bios-INN-996 |
Pre-Made Sonelokimab Biosimilar,
Bispecific, Anti-ALB;IL17A/IL17;IL17F Antibody:
Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;CTLA-8/CTLA8/IL-17A/ILA17;CANDF6/ML-1/ML1
therapeutic antibody |
Sonelokimab |
ALB;IL17A/IL17;IL17F |
Bispecific |
 |
| GMP-Bios-INN-997 |
Pre-Made Sontuzumab Biosimilar,
Whole Mab, Anti-Muc1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Sontuzumab |
MUC1 |
Whole mAb |
 |
| GMP-Bios-INN-998 |
Pre-Made Sotatercept Biosimilar,
Fusion Protein targeting INHBA/ACT fused with
human IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting EDF/FRP |
Sotatercept |
INHBA/ACT |
Fusion Protein |
 |
| GMP-Bios-INN-999 |
Pre-Made Stamulumab Biosimilar,
Whole Mab, Anti-MSTN/GDF-8 Antibody:
Anti-GDF8/MSLHP therapeutic antibody |
Stamulumab |
MSTN/GDF-8 |
Whole mAb |
 |
| GMP-Bios-INN-1000 |
Pre-Made Sulesomab Biosimilar,
Radiolabelled Antibody: Anti-Nca-90 (Nonspecific
Cross- Reacting Antigens 90Kda Glycoproteins,
Granulocyte Cell Antigen) therapeutic
antibody |
Sulesomab |
NCA-90 (nonspecific cross-
reacting antigens 90kDa glycoproteins, granulocyte cell
antigen) |
Radiolabelled antibody |
 |
| GMP-Bios-INN-1001 |
Pre-Made Tabituximab Barzuxetan
Biosimilar, Whole Mab Adc, Anti-Fzd10 Antibody:
Anti-CD350/FZ-10/Fz10/FzE7/hFz10 therapeutic
antibody Drug Conjugate |
Tabituximab Barzuxetan |
FZD10 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1003 |
Pre-Made Tagraxofusp biosimilar,
Protein drug conjugate: Recombinant therapeutic
protein drug conjugate |
Tagraxofusp |
IL3 |
Protein drug conjugate |
 |
| GMP-Bios-INN-1004 |
Pre-Made Taldefgrobep Alfa
Biosimilar, Fusion Protein targeting MSTN/GDF-8
fused with human IGHG1 Fc (Fragment constant)
via a peptidyl linker: Recombinant therapeutic
protein targeting GDF8/MSLHP |
Taldefgrobep Alfa |
MSTN/GDF-8 |
Fusion Protein |
 |
| GMP-Bios-INN-1005 |
Pre-Made Talizumab Biosimilar,
Whole Mab: Anti-Ighe/IgE therapeutic
antibody |
Talizumab |
Ighe/IgE
|
Whole mAb |
 |
| GMP-Bios-INN-1006 |
Pre-Made Tamrintamab Pamozirine
Biosimilar, Whole Mab Adc, Anti-Dpep3 Antibody:
Anti-MBD3 therapeutic antibody Drug
Conjugate |
Tamrintamab Pamozirine |
DPEP3 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1007 |
Pre-Made Tanfanercept
biosimilar, Recombinant Protein: Recombinant
therapeutic protein targeting TNF-α receptor
|
Tanfanercept |
TNF-α receptor |
Recombinant Protein |
 |
| GMP-Bios-INN-1008 |
Pre-Made Taplitumomab Paptox
biosimilar, Fusion Protein,
Taplitumomab-Anti-CD19 Antibody: Anti-B4/CVID3
therapeutic antibody s |
Taplitumomab Paptox |
CD19 |
Fusion Protein |
 |
| GMP-Bios-INN-1009 |
Pre-Made Tarcocimab Biosimilar,
Whole Mab, Anti-Vegfa Antibody:
Anti-MVCD1/VEGF/VPF therapeutic antibody
|
Tarcocimab |
VEGFA |
Whole mAb |
 |
| GMP-Bios-INN-1011 |
Pre-Made Technetium (99Mtc)
Fanolesomab Biosimilar, Radiolabelled Antibody,
Anti-Cd15 Antibody:
Anti-ELFT/FCT3A/FUC-TIV/FUTIV/LeX/SSEA-1
therapeutic antibody |
Technetium (99Mtc)
Fanolesomab |
CD15 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-1012 |
Pre-Made Technetium (99Mtc)
Nofetumomab Merpentan Biosimilar, Radiolabelled
Antibody: Anti-MS4A1/CD20 therapeutic
antibody |
Technetium (99Mtc)
Nofetumomab Merpentan |
MS4A1/CD20 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-1013 |
Pre-Made Technetium (99Mtc)
Pintumomab Biosimilar, Radiolabelled Antibody:
Anti-Human Adenocarcinoma Antigen therapeutic
antibody |
Technetium (99Mtc)
Pintumomab |
human adenocarcinoma antigen
|
Radiolabelled antibody |
 |
| GMP-Bios-INN-1015 |
Pre-Made Tefibazumab Biosimilar,
Whole Mab: Anti-Staphylococcus Aureus
Fibrin-Binding Surface Epitope Clumping Factor A
(Clfa) therapeutic antibody |
Tefibazumab |
Staphylococcus aureus
fibrin-binding surface epitope clumping factor A (ClfA)
|
Whole mAb |
 |
| GMP-Bios-INN-1016 |
Pre-Made Telimomab Aritox
Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody:
Anti-LEU1/T1 therapeutic antibody |
Telimomab Aritox |
CD5 |
ADC |
 |
| GMP-Bios-INN-1017 |
Pre-Made Telisotuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Met Antibody:
Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic
antibody Drug Conjugate |
Telisotuzumab Vedotin |
MET |
Whole mAb ADC |
 |
| GMP-Bios-INN-1018 |
Pre-Made Telitacicept
Biosimilar, Fusion Protein targeting TNFSF13B
fused with human IGHG1 Fc (Fragment constant):
Recombinant therapeutic protein targeting
BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4
|
Telitacicept |
TNFSF13B |
Fusion Protein |
 |
| GMP-Bios-INN-1019 |
Pre-Made Teneliximab Biosimilar,
Whole Mab, Anti-Cd40 Antibody:
Anti-Bp50/CDW40/TNFRSF5/p50 therapeutic
antibody |
Teneliximab |
CD40 |
Whole mAb |
 |
| GMP-Bios-INN-1020 |
Pre-Made Tengonermin Biosimilar,
Fusion Protein targeting ANPEP fused with human
TNF (tumor necrosis factor (TNF) superfamily
member 2, TNFSF2, TNF-alpha, TNFA): Recombinant
therapeutic protein targeting
APN/CD13/GP150/LAP1/P150/PEPN |
Tengonermin |
ANPEP |
Fusion Protein |
 |
| GMP-Bios-INN-1024 |
Pre-Made Tisotumab Vedotin
Biosimilar, Whole Mab Adc, Anti-F3 Antibody:
Anti-CD142/TF/TFA therapeutic antibody Drug
Conjugate |
Tisotumab Vedotin |
F3 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1025 |
Pre-Made Topsalysin biosimilar,
Fusion Protein: Recombinant therapeutic protein
targeting proaerolysin fused with
hexahistidine |
Topsalysin |
proaerolysin |
Fusion Protein |
 |
| GMP-Bios-INN-1026 |
Pre-Made Toralizumab Biosimilar,
Whole Mab, Anti-Cd40Lg Antibody:
Anti-CD154/CD40L/HIGM1/IGM/IMD3/T-BAM/TNFSF5/TRAP/gp39/hCD40L
therapeutic antibody |
Toralizumab |
CD40LG |
Whole mAb |
 |
| GMP-Bios-INN-1027 |
Pre-Made Torapsel Biosimilar,
Fusion Protein targeting SELP fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL
|
Torapsel |
SELP |
Fusion Protein |
 |
| GMP-Bios-INN-1028 |
Pre-Made Tositumomab Biosimilar,
Radiolabelled Antibody, Anti-MS4A1/CD20
Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7
therapeutic antibody |
Tositumomab |
MS4A1/CD20 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-1029 |
Pre-Made Transferrin Aldifitox
Biosimilar, Protein Drug Conjugate: Recombinant
Therapeutic Protein Drug Conjugate |
Transferrin Aldifitox |
transferrin |
Protein drug conjugate |
 |
| GMP-Bios-INN-1030 |
Pre-Made Trastuzumab Beta
Biosimilar, Whole Mab, Anti-ERBB2/HER2 Antibody:
Anti-CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic
antibody |
Trastuzumab Beta |
ERBB2/HER2 |
Whole mAb |
 |
| GMP-Bios-INN-1031 |
Pre-Made Trastuzumab Deruxtecan
Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2
Antibody: Anti-CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic
antibody Drug Conjugate |
Trastuzumab Deruxtecan |
ERBB2/HER2 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1032 |
Pre-Made Trastuzumab
Duocarmazine Biosimilar, Whole Mab Adc,
Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic
antibody Drug Conjugate |
Trastuzumab Duocarmazine
|
ERBB2/HER2 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1033 |
Pre-Made Trastuzumab Emtansine
Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2
Antibody: Anti-CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic
antibody Drug Conjugate |
Trastuzumab Emtansine |
ERBB2/HER2 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1034 |
Pre-Made Trebananib Biosimilar,
Fusion Protein targeting ANGPT2 fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
AGPT2/ANG2/LMPHM10 |
Trebananib |
ANGPT2 |
Fusion Protein |
 |
| GMP-Bios-INN-1035 |
Pre-Made Tucotuzumab Celmoleukin
biosimilar, Fusion Protein,
Tucotuzumab-Anti-EPCAM Antibody:
Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1
therapeutic antibody fused with human IL2
(interleukin 2, IL-2) Pr21-153 |
Tucotuzumab Celmoleukin |
EPCAM |
Fusion Protein |
 |
| GMP-Bios-INN-1036 |
Pre-Made Tulinercept Biosimilar,
Fusion Protein targeting TNF fused with human
IGHG1 Fc (Fragment constant): Recombinant
therapeutic protein targeting
DIF/TNFSF2/TNLG1F |
Tulinercept |
TNF |
Fusion Protein |
 |
| GMP-Bios-INN-1037 |
Pre-Made Tusamitamab Ravtansine
Biosimilar, Whole Mab Adc, Anti-CEACAM5/CD66e
Antibody: Anti-CEA therapeutic antibody Drug
Conjugate |
Tusamitamab Ravtansine |
CEACAM5/CD66e |
Whole mAb ADC |
 |
| GMP-Bios-INN-1038 |
Pre-Made Tuvirumab Biosimilar,
Whole Mab: Anti-Hbv (Hepatitis B Virus)
[Hepatitis B Virus] therapeutic antibody
|
Tuvirumab |
HBV (hepatitis B virus)
[Hepatitis B virus] |
Whole mAb |
 |
| GMP-Bios-INN-1039 |
Pre-Made Upifitamab Rilsodotin
Biosimilar, Whole Mab Adc, Anti-Slc34A2
Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM
therapeutic antibody Drug Conjugate |
Upifitamab Rilsodotin |
SLC34A2 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1040 |
Pre-Made Urtoxazumab Biosimilar,
Whole Mab: Anti-E.Coli Shiga-Like Toxin 2 B
Subunit therapeutic antibody |
Urtoxazumab |
E.coli Shiga-like toxin 2 B
subunit |
Whole mAb |
 |
| GMP-Bios-INN-1042 |
Pre-Made Vadastuximab Talirine
Biosimilar, Whole Mab Adc, Anti-Cd33 Antibody:
Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody
Drug Conjugate |
Vadastuximab Talirine |
CD33 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1043 |
Pre-Made Valanafusp Alfa
Biosimilar, Fusion Protein targeting INSR fused
with human IDUA (iduronidase, alpha-L-) (1:2):
Recombinant therapeutic protein targeting
CD220/HHF5 |
Valanafusp Alfa |
INSR |
Fusion Protein |
 |
| GMP-Bios-INN-1044 |
Pre-Made Vandortuzumab Vedotin
Biosimilar, Whole Mab Adc, Anti-Steap1 Antibody:
Anti-PRSS24/STEAP therapeutic antibody Drug
Conjugate |
Vandortuzumab Vedotin |
STEAP1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1046 |
Pre-Made Vapaliximab Biosimilar,
Whole Mab, Anti-Aoc3 Antibody:
Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic
antibody |
Vapaliximab |
AOC3 |
Whole mAb |
 |
| GMP-Bios-INN-1047 |
Pre-Made Vepalimomab Biosimilar,
Whole Mab, Anti-Aoc3 Antibody:
Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic
antibody |
Vepalimomab |
AOC3 |
Whole mAb |
 |
| GMP-Bios-INN-1048 |
Pre-Made Verpasep Caltespen
biosimilar, Fusion Protein: Recombinant
therapeutic protein targeting
HspE7(Mycobacterium bovis HSP65-HBV E7) fused
with chaperonin 2 (HSP65 from Mycobacterium
bovis) |
Verpasep Caltespen |
HspE7(Mycobacterium
bovis HSP65-HBV E7) |
Fusion Protein |
 |
| GMP-Bios-INN-1049 |
Pre-Made Volociximab Biosimilar,
Whole Mab, Anti-Itga5 Antibody:
Anti-CD49eRA/VLA-5/VLA5A therapeutic
antibody |
Volociximab |
ITGA5 |
Whole mAb |
 |
| GMP-Bios-INN-1050 |
Pre-Made Vorsetuzumab Mafodotin
Biosimilar, Whole Mab Adc, Anti-CD70/CD27-L
Antibody: Anti-CD27LG/LPFS3/TNFSF7/TNLG8A
therapeutic antibody Drug Conjugate |
Vorsetuzumab Mafodotin |
CD70/CD27-L |
Whole mAb ADC |
 |
| GMP-Bios-INN-1051 |
Pre-Made Votumumab Biosimilar,
Radiolabelled Antibody: Anti-Human Carcinoma
Associated Antigen Ctaa16 therapeutic
antibody |
Votumumab |
human carcinoma associated
antigen CTAA16 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-1052 |
Pre-Made Yttrium (90Y)
Clivatuzumab Tetraxetan Biosimilar,
Radiolabelled Antibody, Anti-Muc1 Antibody:
Anti-ADMCKD/ADMCKD1/ADTKD2/CA
15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM
therapeutic antibody |
Yttrium (90Y) Clivatuzumab
Tetraxetan |
MUC1 |
Radiolabelled antibody |
 |
| GMP-Bios-INN-1053 |
Pre-Made Yttrium (90Y)
Tacatuzumab Tetraxetan Biosimilar, Radiolabelled
Antibody, Anti-Afp Antibody:
Anti-AFPD/FETA/HPAFP therapeutic antibody
|
Yttrium (90Y) Tacatuzumab
Tetraxetan |
AFP |
Radiolabelled antibody |
 |
| GMP-Bios-INN-1055 |
Pre-Made Zanidatamab Zovodotin B
Zovodotiniosimilar, Bispecific/Biparatopic,
Anti-ERBB2/HER2;ERBB2/HER2
Therapeutic/Biparatopic Antibody Antibody:
Anti-CD340/MLN
19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN
19/NEU/NGL/TKR1/VSCN2 |
Zanidatamab Zovodotin |
ERBB2/HER2; ERBB2/HER2
|
Bispecific /biparatopic
|
 |
| GMP-Bios-INN-1057 |
Pre-Made Zilovertamab Vedotin
Biosimilar, Whole Mab Adc, Anti-Ror1 Antibody:
Anti-NTRKR1/dJ537F10.1 therapeutic antibody Drug
Conjugate |
Zilovertamab Vedotin |
ROR1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1058 |
Pre-Made Zimbirelimab
Biosimilar, Whole Mab, Anti-PDCD1/PD-1 Antibody:
Anti-CD279/PD1/SLEB2/hSLE1 therapeutic
antibody |
Zimbirelimab |
PDCD1/PD-1 |
Whole mAb |
 |
| GMP-Bios-INN-1059 |
Pre-Made Ziralimumab Biosimilar,
Whole Mab, Anti-Bsg Antibody:
Anti-5F7/CD147/EMMPRIN/EMPRIN/HAb18G/OK/TCSF
therapeutic antibody |
Ziralimumab |
BSG |
Whole mAb |
 |
| GMP-Bios-INN-1060 |
Pre-Made Zolimomab Aritox
Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody:
Anti-LEU1/T1 therapeutic antibody |
Zolimomab Aritox |
CD5 |
ADC |
 |
| GMP-Bios-INN-1061 |
Pre-Made Abazistobart biosimilar, Whole mAb, Anti-PDCD1/CD279/PD1 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Abazistobart |
PDCD1/CD279/PD1 |
Whole mAb |
 |
| GMP-Bios-INN-1062 |
Pre-Made Abiprubart biosimilar, Whole mAb, Anti-TNFRSF5/CD40 Antibody: Anti-CD40/Tumor necrosis factor receptor superfamily member 5/B-cell surface antigen CD40/Bp50 therapeutic antibody |
Abiprubart |
TNFRSF5/CD40 |
Whole mAb |
 |
| GMP-Bios-INN-1063 |
Pre-Made Acimtamig biosimilar, Bispecific (VH-VK-VH'-VL Homodimer), Anti-FCGR3A/CD16/CD16A;TNFRSF8/CD30 Antibody: Anti-CD16/CD16a/FCGR3A/Low affinity immunoglobulin gamma Fc region receptor III-A therapeutic antibody |
Acimtamig |
FCGR3A/CD16/CD16A;TNFRSF8/CD30 |
Bispecific (VH-VK-VH'-VL Homodimer) |
 |
| GMP-Bios-INN-1064 |
Pre-Made Acrixolimab biosimilar, Whole mAb, Anti-PDCD1/CD279/PD1 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Acrixolimab |
PDCD1/CD279/PD1 |
Whole mAb |
 |
| GMP-Bios-INN-1065 |
Pre-Made Adakitug biosimilar, Whole mAb, Anti-CXCL8 Antibody: Anti-CXCL8/IL-8/IL8/Interleukin-8 therapeutic antibody |
Adakitug |
CXCL8 |
Whole mAb |
 |
| GMP-Bios-INN-1066 |
Pre-Made Adezkibart biosimilar, Whole mAb, Anti-FLT3LG Antibody: Anti-FLT3 Ligand/NeutraControl FLT3 Ligand/NeutraKine FLT3 Ligand/FLT3LG therapeutic antibody |
Adezkibart |
FLT3LG |
Whole mAb |
 |
| GMP-Bios-INN-1067 |
Pre-Made Adimanebart biosimilar, Whole mAb, Anti-MUSK Antibody: Anti-MUSK/Muscle/skeletal receptor tyrosine-protein kinase/Muscle-specific tyrosine-protein kinase receptor (MuSK therapeutic antibody |
Adimanebart |
MUSK |
Whole mAb |
 |
| GMP-Bios-INN-1068 |
Pre-Made Afimkibart biosimilar, Whole mAb, Anti-TNFSF15/TL1A/VEGI Antibody: Anti-TNFSF15/Tumor necrosis factor ligand superfamily member 15/TNF ligand-related molecule 1/Vascular endothelial cell growth inhibitor therapeutic antibody |
Afimkibart |
TNFSF15/TL1A/VEGI |
Whole mAb |
 |
| GMP-Bios-INN-1069 |
Pre-Made Alcestobart biosimilar, Whole mAb: Anti-LAG3/CD223 therapeutic antibody |
Alcestobart |
LAG3/CD223 |
Whole mAb |
 |
| GMP-Bios-INN-1070 |
Pre-Made Aldastotug biosimilar, Whole mAb, Anti-SIGLEC15/CD33L3 Antibody: Anti-Siglec-15/SIGLEC15/Sialic acid-binding Ig-like lectin 15/CD33 antigen-like 3 therapeutic antibody |
Aldastotug |
SIGLEC15/CD33L3 |
Whole mAb |
 |
| GMP-Bios-INN-1071 |
Pre-Made Aletekitug biosimilar, Whole mAb, Anti-IL18 Antibody: Anti-IL-18/IL18/Interleukin-18/Iboctadekin therapeutic antibody |
Aletekitug |
IL18 |
Whole mAb |
 |
| GMP-Bios-INN-1072 |
Pre-Made Alextatug biosimilar, Whole mAb, Anti-RNP complex containing PABPC1 Antibody: Anti-PABP/PABPC1/Polyadenylate-binding protein 1/PABP-1 therapeutic antibody |
Alextatug |
RNP complex containing PABPC1 |
Whole mAb |
 |
| GMP-Bios-INN-1073 |
Pre-Made Alpitatug biosimilar, Whole mAb, Anti-KLK2/KLK2A2/hGK-1/hK2 Antibody: Anti-Kallikrein 2/KLK2/Kallikrein-2/Glandular kallikrein-1 (hGK-1) therapeutic antibody |
Alpitatug |
KLK2/KLK2A2/hGK-1/hK2 |
Whole mAb |
 |
| GMP-Bios-INN-1074 |
Pre-Made Amdokitug biosimilar, Whole mAb, Anti-IL17A Antibody: Anti-IL-17A/IL17A/IL17/Interleukin-17A therapeutic antibody |
Amdokitug |
IL17A |
Whole mAb |
 |
| GMP-Bios-INN-1075 |
Pre-Made Amtabafusp biosimilar, Whole mAb Fusion, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Amtabafusp |
CD3E |
Whole mAb Fusion |
 |
| GMP-Bios-INN-1076 |
Pre-Made Amlenetug biosimilar, Whole mAb, Anti-SNCA/PARK1/PARK4 Antibody: Anti-Alpha Synuclein/SNCA/Alpha-synuclein/Non-A beta component of AD amyloid therapeutic antibody |
Amlenetug |
SNCA/PARK1/PARK4 |
Whole mAb |
 |
| GMP-Bios-INN-1077 |
Pre-Made Amostomig biosimilar, Bispecific mAb, Anti-IAP/CD47/MER6/OA3;PDL1/CD274 Antibody: Anti-CD47/Leukocyte surface antigen CD47/Antigenic surface determinant protein OA3/Integrin-associated protein (IAP) therapeutic antibody |
Amostomig |
IAP/CD47/MER6/OA3;PDL1/CD274 |
Bispecific mAb |
 |
| GMP-Bios-INN-1078 |
Pre-Made Amrecibart biosimilar, Whole mAb, Anti-F11 Antibody: Anti-F11/Coagulation factor XI/FXI/Plasma thromboplastin antecedent (PTA) therapeutic antibody |
Amrecibart |
F11 |
Whole mAb |
 |
| GMP-Bios-INN-1079 |
Pre-Made Amulirafusp biosimilar, Whole mAb Fusion, Anti-MS4A1/CD20 Antibody: Anti-CD20/MS4A1/B-lymphocyte antigen CD20/B-lymphocyte surface antigen B1 therapeutic antibody |
Amulirafusp |
MS4A1/CD20 |
Whole mAb Fusion |
 |
| GMP-Bios-INN-1080 |
Pre-Made Anivovetmab biosimilar, Canine Whole mAb: Anti-Minor Capsid VP2 (Canine) therapeutic antibody |
Anivovetmab |
Minor Capsid VP2 (Canine) |
Canine Whole mAb |
 |
| GMP-Bios-INN-1081 |
Pre-Made Ansipastobart biosimilar, Whole mAb, Anti-NT5E/CALJA/CD73 Antibody: Anti-CD73/NT5E/5'-nucleotidase/5'-NT therapeutic antibody |
Ansipastobart |
NT5E/CALJA/CD73 |
Whole mAb |
 |
| GMP-Bios-INN-1082 |
Pre-Made Anvatabart biosimilar, Whole mAb ADC, Anti-ERBB2/CD340/HER2 Antibody: Anti-HER2/ERBB2/CD340/Receptor tyrosine-protein kinase erbB-2 therapeutic antibody |
Anvatabart |
ERBB2/CD340/HER2 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1083 |
Pre-Made Anzurstobart biosimilar, Whole mAb, Anti-SIRPA Antibody: Anti-SIRP Alpha/CD172a/SIRPA/Tyrosine-protein phosphatase non-receptor type substrate 1 therapeutic antibody |
Anzurstobart |
SIRPA |
Whole mAb |
 |
| GMP-Bios-INN-1084 |
Pre-Made Aplitabart biosimilar, Whole IgM+J Chain (Cyclic Pentamer), Anti-TNFRSF10B/CD262/DR5/TRAILR2 Antibody: Anti-DR5/TNFRSF10B/CD262/TRAIL-R2 therapeutic antibody |
Aplitabart |
TNFRSF10B/CD262/DR5/TRAILR2 |
Whole IgM+J Chain (Cyclic Pentamer) |
 |
| GMP-Bios-INN-1085 |
Pre-Made Armocibart biosimilar, Whole mAb, Anti-TFPI Antibody: Anti-TFPI/Tissue factor pathway inhibitor/Extrinsic pathway inhibitor (EPI)/Lipoprotein-associated coagulation inhibitor (LACI) therapeutic antibody |
Armocibart |
TFPI |
Whole mAb |
 |
| GMP-Bios-INN-1086 |
Pre-Made Arumakimig biosimilar, Bispecific mAb, Anti-IL18;IL1B Antibody: Anti-IL-18/IL18/Interleukin-18/Iboctadekin therapeutic antibody |
Arumakimig |
IL18;IL1B |
Bispecific mAb |
 |
| GMP-Bios-INN-1087 |
Pre-Made Atenastobart biosimilar, Whole mAb, Anti-TNFRSF9/CD137/4-1BB Antibody: Anti-TNFRSF9/CD137/Tumor necrosis factor receptor superfamily member 9/4-1BB ligand receptor therapeutic antibody |
Atenastobart |
TNFRSF9/CD137/4-1BB |
Whole mAb |
 |
| GMP-Bios-INN-1088 |
Pre-Made Atigotatug biosimilar, Whole mAb: Anti-Fucosyl-GM1 therapeutic antibody |
Atigotatug |
Fucosyl-GM1 |
Whole mAb |
 |
| GMP-Bios-INN-1089 |
Pre-Made Atisnolerbart biosimilar, Whole mAb: Anti-Bet v 1 therapeutic antibody |
Atisnolerbart |
Bet v 1 |
Whole mAb |
 |
| GMP-Bios-INN-1090 |
Pre-Made Avitotamig biosimilar, Whole mAb, Anti-SIGLEC3/CD33/p67 Antibody: Anti-CD33/Myeloid cell surface antigen CD33/Sialic acid-binding Ig-like lectin 3 (Siglec-3)/gp67 therapeutic antibody |
Avitotamig |
SIGLEC3/CD33/p67 |
Whole mAb |
 |
| GMP-Bios-INN-1091 |
Pre-Made Azerutamig biosimilar, Bispecific Mixed mAb and scFv-CH2-CH3, Anti-KLRK1/NKG2D/CD314;ERBB2/CD340/HER2 Antibody: Anti-CD314/NKG2D/KLRK1/NKG2-D type II integral membrane protein therapeutic antibody |
Azerutamig |
KLRK1/NKG2D/CD314;ERBB2/CD340/HER2 |
Bispecific Mixed mAb and scFv-CH2-CH3 |
 |
| GMP-Bios-INN-1092 |
Pre-Made Azirkitug biosimilar, Whole mAb, Anti-CCR8/CKR-L1/CDw198 Antibody: Anti-CCR8/CDw198/C-C chemokine receptor type 8/C-C CKR-8 therapeutic antibody |
Azirkitug |
CCR8/CKR-L1/CDw198 |
Whole mAb |
 |
| GMP-Bios-INN-1093 |
Pre-Made Balertatug biosimilar, Whole mAb, Anti-CD70 Antibody: Anti-CD70/CD27-L/CD70 antigen/CD27 ligand (CD27-L) therapeutic antibody |
Balertatug |
CD70 |
Whole mAb |
 |
| GMP-Bios-INN-1094 |
Pre-Made Balonkibart biosimilar, Whole mAb, Anti-NPR1/ANPRA/ANPa/GUC2A/GUCY2A/NPRA Antibody: Anti-NPR1/Atrial natriuretic peptide receptor 1/Atrial natriuretic peptide receptor type A (ANP-A/ANPR-A therapeutic antibody |
Balonkibart |
NPR1/ANPRA/ANPa/GUC2A/GUCY2A/NPRA |
Whole mAb |
 |
| GMP-Bios-INN-1095 |
Pre-Made Bebtelovimab biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Bebtelovimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1096 |
Pre-Made Becotatug biosimilar, Whole mAb, Anti-EGFR/ERBB1/HER1 Antibody: Anti-EGFR/Epidermal growth factor receptor/Proto-oncogene c-ErbB-1/Receptor tyrosine-protein kinase erbB-1 therapeutic antibody |
Becotatug |
EGFR/ERBB1/HER1 |
Whole mAb |
 |
| GMP-Bios-INN-1097 |
Pre-Made Belrestotug biosimilar, Whole mAb, Anti-TIGIT/WUCAM/VSTM3 Antibody: Anti-TIGIT/T-cell immunoreceptor with Ig and ITIM domains/V-set and immunoglobulin domain-containing protein 9/V-set and transmembrane domain-containing protein 3 therapeutic antibody |
Belrestotug |
TIGIT/WUCAM/VSTM3 |
Whole mAb |
 |
| GMP-Bios-INN-1098 |
Pre-Made Bempikibart biosimilar, Whole mAb, Anti-IL7R/CD127 Antibody: Anti-IL-7Ra/CD127/IL7R/Interleukin-7 receptor subunit alpha therapeutic antibody |
Bempikibart |
IL7R/CD127 |
Whole mAb |
 |
| GMP-Bios-INN-1099 |
Pre-Made Benmelstobart biosimilar, Whole mAb, Anti-PDL1/CD274 Antibody: Anti-PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 therapeutic antibody |
Benmelstobart |
PDL1/CD274 |
Whole mAb |
 |
| GMP-Bios-INN-1100 |
Pre-Made Besufetamig biosimilar, Bispecific mAb, Anti-PDCD1/CD279/PD1;CD3E Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Besufetamig |
PDCD1/CD279/PD1;CD3E |
Bispecific mAb |
 |
| GMP-Bios-INN-1101 |
Pre-Made Betinukibart biosimilar, Whole mAb, Anti-IL17A Antibody: Anti-IL-17A/IL17A/IL17/Interleukin-17A therapeutic antibody |
Betinukibart |
IL17A |
Whole mAb |
 |
| GMP-Bios-INN-1102 |
Pre-Made Betifisolimab biosimilar, Whole mAb, Anti-PDL1/CD274 Antibody: Anti-PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 therapeutic antibody |
Betifisolimab |
PDL1/CD274 |
Whole mAb |
 |
| GMP-Bios-INN-1103 |
Pre-Made Bexatamig biosimilar, Bispecific (H-gamma1-VH-G1CH1h_L-kappa)_L-kappa-G1hCH2CH3, Anti-IL3RA/CD123;NCR1/NKP46/NKp46/LY94/CD335 Antibody: Anti-CD123/IL3RA/Interleukin-3 receptor subunit alpha/IL-3 receptor subunit alpha therapeutic antibody |
Bexatamig |
IL3RA/CD123;NCR1/NKP46/NKp46/LY94/CD335 |
Bispecific (H-gamma1-VH-G1CH1h_L-kappa)_L-kappa-G1hCH2CH3 |
 |
| GMP-Bios-INN-1104 |
Pre-Made Bezetabart biosimilar, Whole mAb ADC, Anti-CD74/HLA class II histocompatibility antigen gamma chain Antibody: Anti-CD74/HLA class II histocompatibility antigen gamma chain/HLA-DR antigens-associated invariant chain/Ia antigen-associated invariant chain (Ii) therapeutic antibody |
Bezetabart |
CD74/HLA class II histocompatibility antigen gamma chain |
Whole mAb ADC |
 |
| GMP-Bios-INN-1105 |
Pre-Made Birinkibart biosimilar, Whole mAb, Anti-CSF2RB/CD131/IL3RB/IL5RB Antibody: Anti-IL-3RB/CD131/CSF2RB/Cytokine receptor common subunit beta therapeutic antibody |
Birinkibart |
CSF2RB/CD131/IL3RB/IL5RB |
Whole mAb |
 |
| GMP-Bios-INN-1106 |
Pre-Made Bocunebart biosimilar, Whole mAb, Anti-ADCYAP1/PACAP Antibody: Anti-ADCYAP1/PACAP-38/Pituitary adenylate cyclase-activating polypeptide/PACAP therapeutic antibody |
Bocunebart |
ADCYAP1/PACAP |
Whole mAb |
 |
| GMP-Bios-INN-1107 |
Pre-Made Bosakitug biosimilar, Whole mAb, Anti-TSLP Antibody: Anti-TSLP/Thymic stromal lymphopoietin therapeutic antibody |
Bosakitug |
TSLP |
Whole mAb |
 |
| GMP-Bios-INN-1108 |
Pre-Made Boserolimab biosimilar, Whole mAb, Anti-TNFRSF7/CD27 Antibody: Anti-CD27/CD27 antigen/CD27L receptor/T-cell activation antigen CD27 therapeutic antibody |
Boserolimab |
TNFRSF7/CD27 |
Whole mAb |
 |
| GMP-Bios-INN-1109 |
Pre-Made Bremzalerbart biosimilar, Whole mAb: Anti-Bet v 1 therapeutic antibody |
Bremzalerbart |
Bet v 1 |
Whole mAb |
 |
| GMP-Bios-INN-1110 |
Pre-Made Brenetafusp biosimilar, Fusion Protein (scFv fused to TCR Fab) targeting CD3: Recombinant therapeutic protein targeting CD3/CD3E/CD3e/T-cell surface glycoprotein CD3 epsilon chain |
Brenetafusp |
CD3 |
Fusion Protein (scFv fused to TCR Fab) |
 |
| GMP-Bios-INN-1111 |
Pre-Made Briquilimab biosimilar, Whole mAb, Anti-KIT/CD117 Antibody: Anti-CD117/c-Kit/KIT/Mast therapeutic antibody |
Briquilimab |
KIT/CD117 |
Whole mAb |
 |
| GMP-Bios-INN-1112 |
Pre-Made Brivekimig biosimilar, Trispecific Single Domains (VH-VH-VH'-VH''-VH'), Anti-TNFSF4/CD134/CD252/OX40L;TNF/TNFA;ALB Antibody: Anti-OX40L/TNFSF4/CD252/OX40 therapeutic antibody |
Brivekimig |
TNFSF4/CD134/CD252/OX40L;TNF/TNFA;ALB |
Trispecific Single Domains (VH-VH-VH'-VH''-VH'); Bispecific entry |
 |
| GMP-Bios-INN-1114 |
Pre-Made Brivestobart biosimilar, Whole mAb: Anti-LAG3/CD223 therapeutic antibody |
Brivestobart |
LAG3/CD223 |
Whole mAb |
 |
| GMP-Bios-INN-1115 |
Pre-Made Budoprutug biosimilar, Whole mAb, Anti-CD19 Antibody: Anti-CD19/B-lymphocyte antigen CD19/B-lymphocyte surface antigen B4/Differentiation antigen CD19 therapeutic antibody |
Budoprutug |
CD19 |
Whole mAb |
 |
| GMP-Bios-INN-1116 |
Pre-Made Bulumtatug biosimilar, Whole mAb: Anti-LAG3/CD223 therapeutic antibody |
Bulumtatug |
LAG3/CD223 |
Whole mAb |
 |
| GMP-Bios-INN-1117 |
Pre-Made Burfiralimab biosimilar, Whole mAb, Anti-VIM Antibody: Anti-VIM/Vimentin therapeutic antibody |
Burfiralimab |
VIM |
Whole mAb |
 |
| GMP-Bios-INN-1118 |
Pre-Made Cabotamig biosimilar, Bispecific (VH-G1CH1h-G4CH2CH3-scFv), Anti-CDH17;CD3E Antibody: Anti-Cadherin-17/CDH17/Intestinal peptide-associated transporter HPT-1/Liver-intestine cadherin (LI-cadherin) therapeutic antibody |
Cabotamig |
CDH17;CD3E |
Bispecific (VH-G1CH1h-G4CH2CH3-scFv) |
 |
| GMP-Bios-INN-1119 |
Pre-Made Cafelkibart biosimilar, Whole mAb, Anti-CCR8/CKR-L1/CDw198 Antibody: Anti-CCR8/CDw198/C-C chemokine receptor type 8/C-C CKR-8 therapeutic antibody |
Cafelkibart |
CCR8/CKR-L1/CDw198 |
Whole mAb |
 |
| GMP-Bios-INN-1120 |
Pre-Made Calpurbatug biosimilar, Whole mAb: Anti-Bacteria Proteins HU and IHF therapeutic antibody |
Calpurbatug |
Bacteria Proteins HU and IHF |
Whole mAb |
 |
| GMP-Bios-INN-1121 |
Pre-Made Calotatug biosimilar, Whole mAb, Anti-ERBB2/CD340/HER2 Antibody: Anti-HER2/ERBB2/CD340/Receptor tyrosine-protein kinase erbB-2 therapeutic antibody |
Calotatug |
ERBB2/CD340/HER2 |
Whole mAb |
 |
| GMP-Bios-INN-1122 |
Pre-Made Camoteskimab biosimilar, Whole mAb, Anti-IL18 Antibody: Anti-IL-18/IL18/Interleukin-18/Iboctadekin therapeutic antibody |
Camoteskimab |
IL18 |
Whole mAb |
 |
| GMP-Bios-INN-1123 |
Pre-Made Canrivitug biosimilar, Whole mAb: Anti-SARS-CoV-2 RBD therapeutic antibody |
Canrivitug |
SARS-CoV-2 RBD |
Whole mAb |
 |
| GMP-Bios-INN-1124 |
Pre-Made Casdozokitug biosimilar, Whole mAb, Anti-IL27 Antibody: Anti-IL-17D/IL17D/IL27/Interleukin-17D therapeutic antibody |
Casdozokitug |
IL27 |
Whole mAb |
 |
| GMP-Bios-INN-1125 |
Pre-Made Caxmotabart biosimilar, Whole mAb, Anti-ERBB2/CD340/HER2 Antibody: Anti-HER2/ERBB2/CD340/Receptor tyrosine-protein kinase erbB-2 therapeutic antibody |
Caxmotabart |
ERBB2/CD340/HER2 |
Whole mAb |
 |
| GMP-Bios-INN-1126 |
Pre-Made Cemavafusp biosimilar, Fusion Protein (Toxin fused to an scFv) targeting PDL1/CD274: Recombinant therapeutic protein targeting PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 |
Cemavafusp |
PDL1/CD274 |
Fusion Protein (Toxin fused to an scFv) |
 |
| GMP-Bios-INN-1127 |
Pre-Made Cenvacibart biosimilar, Whole mAb, Anti-F11 Antibody: Anti-F11/Coagulation factor XI/FXI/Plasma thromboplastin antecedent (PTA) therapeutic antibody |
Cenvacibart |
F11 |
Whole mAb |
 |
| GMP-Bios-INN-1128 |
Pre-Made Cenzestotug biosimilar, Whole mAb, Anti-TNFRSF4/CD134/OX40 Antibody: Anti-CD134/OX40/TNFRSF4/Tumor necrosis factor receptor superfamily member 4 therapeutic antibody |
Cenzestotug |
TNFRSF4/CD134/OX40 |
Whole mAb |
 |
| GMP-Bios-INN-1129 |
Pre-Made Cepeprubart biosimilar, Whole mAb, Anti-SELPLG/CD162/PSGL1 Antibody: Anti-SELPLG/CD162/P-selectin glycoprotein ligand 1/PSGL-1 therapeutic antibody |
Cepeprubart |
SELPLG/CD162/PSGL1 |
Whole mAb |
 |
| GMP-Bios-INN-1130 |
Pre-Made Ciduvectamig biosimilar, Bispecific mAb, Anti-TMEFF2;CD3E Antibody: Anti-TMEFF2/Tomoregulin-2/TR-2/Hyperplastic polyposis protein 1 therapeutic antibody |
Ciduvectamig |
TMEFF2;CD3E |
Bispecific mAb |
 |
| GMP-Bios-INN-1131 |
Pre-Made Cifurtilimab biosimilar, Whole mAb, Anti-TNFRSF5/CD40 Antibody: Anti-CD40/Tumor necrosis factor receptor superfamily member 5/B-cell surface antigen CD40/Bp50 therapeutic antibody |
Cifurtilimab |
TNFRSF5/CD40 |
Whole mAb |
 |
| GMP-Bios-INN-1132 |
Pre-Made Ciletatug biosimilar, Whole mAb, Anti-CLDN18 Antibody: Anti-SFTA5/SFTPJ therapeutic antibody |
Ciletatug |
CLDN18 |
Whole mAb |
 |
| GMP-Bios-INN-1133 |
Pre-Made Ciltistotug biosimilar, Whole mAb, Anti-TNFRSF5/CD40 Antibody: Anti-CD40/Tumor necrosis factor receptor superfamily member 5/B-cell surface antigen CD40/Bp50 therapeutic antibody |
Ciltistotug |
TNFRSF5/CD40 |
Whole mAb |
 |
| GMP-Bios-INN-1134 |
Pre-Made Cinrebafusp biosimilar, Fusion Protein targeting ERBB2/CD340/HER2: Recombinant therapeutic protein targeting HER2/ERBB2/CD340/Receptor tyrosine-protein kinase erbB-2 |
Cinrebafusp |
ERBB2/CD340/HER2 |
Fusion Protein |
 |
| GMP-Bios-INN-1135 |
Pre-Made Cirevetmab biosimilar, Canine Whole mAb, Anti-TGFB1 (Canine) Antibody: Anti-CED/DPD1/IBDIMDE/LAP therapeutic antibody |
Cirevetmab |
TGFB1 (Canine) |
Canine Whole mAb |
 |
| GMP-Bios-INN-1136 |
Pre-Made Cizutamig biosimilar, Bispecific Mixed Domains (L-kappa-H-gamma1_[VH-G1(CH1-h)]_L-kappa), Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E Antibody: Anti-TNFRSF17/BCMA/CD269/Tumor necrosis factor receptor superfamily member 17 therapeutic antibody |
Cizutamig |
TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E |
Bispecific Mixed Domains (L-kappa-H-gamma1_[VH-G1(CH1-h)]_L-kappa) |
 |
| GMP-Bios-INN-1137 |
Pre-Made Claseprubart biosimilar, Whole mAb, Anti-C1S Antibody: Anti-C1S/Complement C1s subcomponent/C1 esterase/Complement component 1 subcomponent s therapeutic antibody |
Claseprubart |
C1S |
Whole mAb |
 |
| GMP-Bios-INN-1138 |
Pre-Made Clesitamig biosimilar, Bispecific Mixed Domains ((V-kappa-G4CH1-G1h-H-gamma1_L-kappa)_L-kappa)]_(H-gamma1_L-kappa)); Trispecific through dual targetting Fv2, Anti-DLL3;CD3&TNFRSF9/CD137/4-1BB Antibody: Anti-DLL3/Delta-like protein 3/Drosophila Delta homolog 3 (Delta3)/SCDO1 therapeutic antibody |
Clesitamig |
DLL3;CD3&TNFRSF9/CD137/4-1BB |
Bispecific Mixed Domains ((V-kappa-G4CH1-G1h-H-gamma1_L-kappa)_L-kappa)]_(H-gamma1_L-kappa)); Trispecific through dual targetting Fv2 |
 |
| GMP-Bios-INN-1139 |
Pre-Made Clesrovimab biosimilar, Whole mAb: Anti-RSV gpF therapeutic antibody |
Clesrovimab |
RSV gpF |
Whole mAb |
 |
| GMP-Bios-INN-1140 |
Pre-Made Cliramitug biosimilar, Whole mAb, Anti-Misfolded TTR Antibody: Anti-Prealbumin/transthyretin/TTR/Transthyretin therapeutic antibody |
Cliramitug |
Misfolded TTR |
Whole mAb |
 |
| GMP-Bios-INN-1141 |
Pre-Made Comekibart biosimilar, Whole mAb, Anti-IL4R/CD124 Antibody: Anti-IL-4RA/CD124/IL4R/Interleukin-4 receptor subunit alpha therapeutic antibody |
Comekibart |
IL4R/CD124 |
Whole mAb |
 |
| GMP-Bios-INN-1142 |
Pre-Made Coramitug biosimilar, Whole mAb, Anti-Misfolded TTR Antibody: Anti-Prealbumin/transthyretin/TTR/Transthyretin therapeutic antibody |
Coramitug |
Misfolded TTR |
Whole mAb |
 |
| GMP-Bios-INN-1143 |
Pre-Made Crebankitug biosimilar, Whole mAb, Anti-IL7R/CD127 Antibody: Anti-IL-7Ra/CD127/IL7R/Interleukin-7 receptor subunit alpha therapeutic antibody |
Crebankitug |
IL7R/CD127 |
Whole mAb |
 |
| GMP-Bios-INN-1144 |
Pre-Made Crefmirlimab biosimilar, scFv Engineered Dimer, Anti-CD8A Antibody: Anti-CD8/CD8A/CD8a/T-cell surface glycoprotein CD8 alpha chain therapeutic antibody |
Crefmirlimab |
CD8A |
scFv Engineered Dimer |
 |
| GMP-Bios-INN-1145 |
Pre-Made Crexavibart biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Crexavibart |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1146 |
Pre-Made Crusekitug biosimilar, Whole mAb, Anti-IL17A Antibody: Anti-IL-17A/IL17A/IL17/Interleukin-17A therapeutic antibody |
Crusekitug |
IL17A |
Whole mAb |
 |
| GMP-Bios-INN-1147 |
Pre-Made Cugrastomig biosimilar, Bispecific Mixed mAb and scFv, Anti-LAG3/CD223;PDCD1/CD279/PD1 Antibody: Anti-CD223/PD-1/CD279/PDCD1 therapeutic antibody |
Cugrastomig |
LAG3/CD223;PDCD1/CD279/PD1 |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1148 |
Pre-Made Dalidnetug biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP therapeutic antibody |
Dalidnetug |
APP |
Whole mAb |
 |
| GMP-Bios-INN-1149 |
Pre-Made Dalnicastobart biosimilar, Whole mAb, Anti-TNFRSF5/CD40 Antibody: Anti-CD40/Tumor necrosis factor receptor superfamily member 5/B-cell surface antigen CD40/Bp50 therapeutic antibody |
Dalnicastobart |
TNFRSF5/CD40 |
Whole mAb |
 |
| GMP-Bios-INN-1150 |
Pre-Made Danburstotug biosimilar, Whole mAb Fusion, Anti-PDL1/CD274 Antibody: Anti-PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 therapeutic antibody |
Danburstotug |
PDL1/CD274 |
Whole mAb Fusion |
 |
| GMP-Bios-INN-1151 |
Pre-Made Danvilostomig biosimilar, Bispecific Mixed mAb and scFv, Anti-CTLA4/CD152;PDCD1/CD279/PD1 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Danvilostomig |
CTLA4/CD152;PDCD1/CD279/PD1 |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1152 |
Pre-Made Daretabart biosimilar, Whole mAb: Anti-Ganglioside GD2 therapeutic antibody |
Daretabart |
Ganglioside GD2 |
Whole mAb |
 |
| GMP-Bios-INN-1153 |
Pre-Made Dargistotug biosimilar, Whole mAb, Anti-TIGIT/WUCAM/VSTM3 Antibody: Anti-TIGIT/T-cell immunoreceptor with Ig and ITIM domains/V-set and immunoglobulin domain-containing protein 9/V-set and transmembrane domain-containing protein 3 therapeutic antibody |
Dargistotug |
TIGIT/WUCAM/VSTM3 |
Whole mAb |
 |
| GMP-Bios-INN-1154 |
Pre-Made Davutamig biosimilar, Bispecific mAb, Anti-MET/HGFR;MET/HGFR Antibody: Anti-c-Met/MET/Hepatocyte growth factor receptor/HGF receptor therapeutic antibody |
Davutamig |
MET/HGFR;MET/HGFR |
Bispecific mAb |
 |
| GMP-Bios-INN-1155 |
Pre-Made Dazukibart biosimilar, Whole mAb, Anti-IFNB1 Antibody: Anti-IFN beta/IFN beta1/IFNB1/Interferon beta therapeutic antibody |
Dazukibart |
IFNB1 |
Whole mAb |
 |
| GMP-Bios-INN-1156 |
Pre-Made Delpacibart biosimilar, Whole mAb, Anti-TFRC/CD71 Antibody: Anti-CD71/TFRC/Transferrin receptor protein 1/TR therapeutic antibody |
Delpacibart |
TFRC/CD71 |
Whole mAb |
 |
| GMP-Bios-INN-1157 |
Pre-Made Denecimig biosimilar, Bispecific mAb, Anti-F9;F10 Antibody: Anti-FIX/P19/PTC/HEMB therapeutic antibody |
Denecimig |
F9;F10 |
Bispecific mAb |
 |
| GMP-Bios-INN-1158 |
Pre-Made Denikitug biosimilar, Whole mAb, Anti-CCR8/CKR-L1/CDw198 Antibody: Anti-CCR8/CDw198/C-C chemokine receptor type 8/C-C CKR-8 therapeutic antibody |
Denikitug |
CCR8/CKR-L1/CDw198 |
Whole mAb |
 |
| GMP-Bios-INN-1159 |
Pre-Made Denrakibart biosimilar, Whole mAb, Anti-CCL17/ABCD-2/SCYA17/TARC Antibody: Anti-CCL17/C-C motif chemokine 17/CC chemokine TARC/Small-inducible cytokine A17 therapeutic antibody |
Denrakibart |
CCL17/ABCD-2/SCYA17/TARC |
Whole mAb |
 |
| GMP-Bios-INN-1160 |
Pre-Made Devextinetug biosimilar, Whole mAb: Anti-Metamphetamine therapeutic antibody |
Devextinetug |
Metamphetamine |
Whole mAb |
 |
| GMP-Bios-INN-1161 |
Pre-Made Dibotatug biosimilar, Whole mAb, Anti-KLRD1/CD94 Antibody: Anti-CD94/KLRD1/Natural killer cells antigen CD94/KP43 therapeutic antibody |
Dibotatug |
KLRD1/CD94 |
Whole mAb |
 |
| GMP-Bios-INN-1162 |
Pre-Made Donitabart biosimilar, Whole mAb: Anti-Ganglioside GD2 therapeutic antibody |
Donitabart |
Ganglioside GD2 |
Whole mAb |
 |
| GMP-Bios-INN-1163 |
Pre-Made Donzakimig biosimilar, Trispecific (G1(VH-CH1-h)-scFv_L-kappa-scFv), Anti-IL22;ALB;IL13 Antibody: Anti-IL-21/IL-22/IL-D110/IL-TIF therapeutic antibody |
Donzakimig |
IL22;ALB;IL13 |
Trispecific (G1(VH-CH1-h)-scFv_L-kappa-scFv); Bispecific entry |
 |
| GMP-Bios-INN-1165 |
Pre-Made Drotokibart biosimilar, Whole mAb, Anti-IL4R/CD124 Antibody: Anti-IL-4RA/CD124/IL4R/Interleukin-4 receptor subunit alpha therapeutic antibody |
Drotokibart |
IL4R/CD124 |
Whole mAb |
 |
| GMP-Bios-INN-1166 |
Pre-Made Duvakitug biosimilar, Whole mAb, Anti-TNFSF15/TL1A/VEGI Antibody: Anti-TNFSF15/Tumor necrosis factor ligand superfamily member 15/TNF ligand-related molecule 1/Vascular endothelial cell growth inhibitor therapeutic antibody |
Duvakitug |
TNFSF15/TL1A/VEGI |
Whole mAb |
 |
| GMP-Bios-INN-1167 |
Pre-Made Ebrasodebart biosimilar, Whole mAb, Anti-TMEM219/IGFBP-3R Antibody: Anti-TMEM219/Insulin-like growth factor-binding protein 3 receptor/IGFBP-3R/Transmembrane protein 219 therapeutic antibody |
Ebrasodebart |
TMEM219/IGFBP-3R |
Whole mAb |
 |
| GMP-Bios-INN-1168 |
Pre-Made Ebribafusp biosimilar, Fusion Protein targeting C3d: Recombinant therapeutic protein targeting C3/C3b/C3c/CO3 |
Ebribafusp |
C3d |
Fusion Protein |
 |
| GMP-Bios-INN-1169 |
Pre-Made Eciskafusp biosimilar, Fusion Protein targeting PDCD1/CD279/PD1: Recombinant therapeutic protein targeting PD-1/CD279/PDCD1/Programmed cell death protein 1 |
Eciskafusp |
PDCD1/CD279/PD1 |
Fusion Protein |
 |
| GMP-Bios-INN-1170 |
Pre-Made Eclutatug biosimilar, Whole mAb, Anti-CLDN1 Antibody: Anti-Claudin 1/CLDN1/Claudin-1/Senescence-associated epithelial membrane protein therapeutic antibody |
Eclutatug |
CLDN1 |
Whole mAb |
 |
| GMP-Bios-INN-1171 |
Pre-Made Eglatoprutug biosimilar, Whole mAb, Anti-KIT/CD117 Antibody: Anti-CD117/c-Kit/KIT/Mast therapeutic antibody |
Eglatoprutug |
KIT/CD117 |
Whole mAb |
 |
| GMP-Bios-INN-1172 |
Pre-Made Elegrobart biosimilar, Whole mAb: Anti-TBC therapeutic antibody |
Elegrobart |
TBC |
Whole mAb |
 |
| GMP-Bios-INN-1173 |
Pre-Made Eltivutabart biosimilar, Whole mAb, Anti-ENTPD1/CD39 Antibody: Anti-ENTPD1/CD39/Ectonucleoside triphosphate diphosphohydrolase 1/ATP diphosphohydrolase (ATP-DPH therapeutic antibody |
Eltivutabart |
ENTPD1/CD39 |
Whole mAb |
 |
| GMP-Bios-INN-1174 |
Pre-Made Eltrekibart biosimilar, Whole mAb, Anti-CXCL1/CXCL2/CXCL3/CXCL5/CXCL6/CXCL7/CXCL8 Antibody: Anti-CXCL1/Growth-regulated alpha protein/C-X-C motif chemokine 1/GRO-alpha(1-73) therapeutic antibody |
Eltrekibart |
CXCL1/CXCL2/CXCL3/CXCL5/CXCL6/CXCL7/CXCL8 |
Whole mAb |
 |
| GMP-Bios-INN-1175 |
Pre-Made Emfizatamab biosimilar, Tetraspecific (scFv-IgG-scFv-scFv; Bispecific entry 1), Anti-CD3E;CD19;PDL1/CD274;TNFRSF9/CD137/4-1BB Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Emfizatamab |
CD3E;CD19;PDL1/CD274;TNFRSF9/CD137/4-1BB |
Tetraspecific (scFv-IgG-scFv-scFv; Bispecific entry 1) |
 |
| GMP-Bios-INN-1177 |
Pre-Made Emiltatug biosimilar, Whole mAb, Anti-VTCN1/B7H4 Antibody: Anti-B7‑H4/B7-H4/VTCN1/V-set domain-containing T-cell activation inhibitor 1 therapeutic antibody |
Emiltatug |
VTCN1/B7H4 |
Whole mAb |
 |
| GMP-Bios-INN-1178 |
Pre-Made Emirodatamab biosimilar, Bispecific scFv-scFv-scFc, Anti-FLT3/CD135/FLK2;CD3E Antibody: Anti-FLT3/CD135/FLT-3/Receptor-type tyrosine-protein kinase FLT3 therapeutic antibody |
Emirodatamab |
FLT3/CD135/FLK2;CD3E |
Bispecific scFv-scFv-scFc |
 |
| GMP-Bios-INN-1179 |
Pre-Made Empasiprubart biosimilar, Whole mAb, Anti-C2 Antibody: Anti-C2/Complement C2/C3/C5 convertase therapeutic antibody |
Empasiprubart |
C2 |
Whole mAb |
 |
| GMP-Bios-INN-1180 |
Pre-Made Emugrobart biosimilar, Whole mAb, Anti-ENTPD1/CD39 Antibody: Anti-ENTPD1/CD39/Ectonucleoside triphosphate diphosphohydrolase 1/ATP diphosphohydrolase (ATP-DPH therapeutic antibody |
Emugrobart |
ENTPD1/CD39 |
Whole mAb |
 |
| GMP-Bios-INN-1181 |
Pre-Made Emunkitug biosimilar, Whole mAb, Anti-TNFRSF1B/TNFR2/CD120b/TNFR80/p75 Antibody: Anti-TNFR2/TNFRSF1B/CD120b/TNF-R2 therapeutic antibody |
Emunkitug |
TNFRSF1B/TNFR2/CD120b/TNFR80/p75 |
Whole mAb |
 |
| GMP-Bios-INN-1182 |
Pre-Made Englumafusp biosimilar, Fusion Protein targeting CD19: Recombinant therapeutic protein targeting CD19/B-lymphocyte antigen CD19/B-lymphocyte surface antigen B4/Differentiation antigen CD19 |
Englumafusp |
CD19 |
Fusion Protein |
 |
| GMP-Bios-INN-1183 |
Pre-Made Enlonstobart biosimilar, Whole mAb, Anti-PDCD1/CD279/PD1 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Enlonstobart |
PDCD1/CD279/PD1 |
Whole mAb |
 |
| GMP-Bios-INN-1184 |
Pre-Made Enristomig biosimilar, Bispecific Single Domains (VH-VH'-G1(h-CH2-CH3) Dimer), Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB Antibody: Anti-PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 therapeutic antibody |
Enristomig |
PDL1/CD274;TNFRSF9/CD137/4-1BB |
Bispecific Single Domains (VH-VH'-G1(h-CH2-CH3) Dimer) |
 |
| GMP-Bios-INN-1185 |
Pre-Made Enzelkitug biosimilar, Whole mAb, Anti-CCR8/CKR-L1/CDw198 Antibody: Anti-CCR8/CDw198/C-C chemokine receptor type 8/C-C CKR-8 therapeutic antibody |
Enzelkitug |
CCR8/CKR-L1/CDw198 |
Whole mAb |
 |
| GMP-Bios-INN-1186 |
Pre-Made Epacmarstobart biosimilar, Whole mAb, Anti-SIRPA Antibody: Anti-SIRP Alpha/CD172a/SIRPA/Tyrosine-protein phosphatase non-receptor type substrate 1 therapeutic antibody |
Epacmarstobart |
SIRPA |
Whole mAb |
 |
| GMP-Bios-INN-1187 |
Pre-Made Etuptamig biosimilar, Bispecific mAb, Anti-NCR3LG1/B7-H6;CD3E Antibody: Anti-B7-H6/NCR3LG1/Natural cytotoxicity triggering receptor 3 ligand 1/B7 homolog 6 (B7-H6) therapeutic antibody |
Etuptamig |
NCR3LG1/B7-H6;CD3E |
Bispecific mAb |
 |
| GMP-Bios-INN-1188 |
Pre-Made Ersodetug biosimilar, Whole mAb, Anti-INSR/CD220 Antibody: Anti-INSR/CD220/Insulin receptor/IR therapeutic antibody |
Ersodetug |
INSR/CD220 |
Whole mAb |
 |
| GMP-Bios-INN-1189 |
Pre-Made Erzotabart biosimilar, Whole mAb, Anti-ADPRC1/CD38 Antibody: Anti-CD38/ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1/2'-phospho-ADP-ribosyl cyclase therapeutic antibody |
Erzotabart |
ADPRC1/CD38 |
Whole mAb |
 |
| GMP-Bios-INN-1190 |
Pre-Made Etakafusp biosimilar, Fusion Protein targeting CD8: Recombinant therapeutic protein targeting CD8/CD8A/CD8a/T-cell surface glycoprotein CD8 alpha chain |
Etakafusp |
CD8 |
Fusion Protein |
 |
| GMP-Bios-INN-1191 |
Pre-Made Etalanetug biosimilar, Whole mAb, Anti-MAPT Antibody: Anti-DDPAC/FTDP-17/MAPTL/MSTD therapeutic antibody |
Etalanetug |
MAPT |
Whole mAb |
 |
| GMP-Bios-INN-1192 |
Pre-Made Etentamig biosimilar, Bispecific mAb, Anti-CD3E;TNFRSF17/CD269/BCMA/TNFRSF13A Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Etentamig |
CD3E;TNFRSF17/CD269/BCMA/TNFRSF13A |
Bispecific mAb |
 |
| GMP-Bios-INN-1193 |
Pre-Made Eurestobart biosimilar, Whole mAb, Anti-ENTPD1/CD39 Antibody: Anti-ENTPD1/CD39/Ectonucleoside triphosphate diphosphohydrolase 1/ATP diphosphohydrolase (ATP-DPH therapeutic antibody |
Eurestobart |
ENTPD1/CD39 |
Whole mAb |
 |
| GMP-Bios-INN-1194 |
Pre-Made Evalstotug biosimilar, Whole mAb, Anti-CTLA4/CD152 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Evalstotug |
CTLA4/CD152 |
Whole mAb |
 |
| GMP-Bios-INN-1195 |
Pre-Made Evunzekibart biosimilar, Whole mAb, Anti-TNFRSF9/CD137/4-1BB Antibody: Anti-TNFRSF9/CD137/Tumor necrosis factor receptor superfamily member 9/4-1BB ligand receptor therapeutic antibody |
Evunzekibart |
TNFRSF9/CD137/4-1BB |
Whole mAb |
 |
| GMP-Bios-INN-1196 |
Pre-Made Exerenibart biosimilar, Whole mAb, Anti-TMPRSS6/MT2 Antibody: Anti-TMPRSS6/Transmembrane protease serine 6/Matriptase-2/MT2 therapeutic antibody |
Exerenibart |
TMPRSS6/MT2 |
Whole mAb |
 |
| GMP-Bios-INN-1197 |
Pre-Made Exlinkibart biosimilar, Whole mAb, Anti-TNFRSF9/CD137/4-1BB Antibody: Anti-TNFRSF9/CD137/Tumor necrosis factor receptor superfamily member 9/4-1BB ligand receptor therapeutic antibody |
Exlinkibart |
TNFRSF9/CD137/4-1BB |
Whole mAb |
 |
| GMP-Bios-INN-1198 |
Pre-Made Falbikitug biosimilar, Whole mAb, Anti-LIF Antibody: Anti-LIF/Leukemia inhibitory factor/Differentiation-stimulating factor (D factor)/Melanoma-derived LPL inhibitor (MLPLI) therapeutic antibody |
Falbikitug |
LIF |
Whole mAb |
 |
| GMP-Bios-INN-1199 |
Pre-Made Fanastomig biosimilar, Bispecific (L-kappa-H-gamma1_G1(VH-CH1-h)_L-kappa), Anti-LAG3/CD223;PDCD1/CD279/PD1 Antibody: Anti-CD223/PD-1/CD279/PDCD1 therapeutic antibody |
Fanastomig |
LAG3/CD223;PDCD1/CD279/PD1 |
Bispecific (L-kappa-H-gamma1_G1(VH-CH1-h)_L-kappa) |
 |
| GMP-Bios-INN-1200 |
Pre-Made Fazpilodemab biosimilar, Bispecific mAb, Anti-KLB;FGFR1/CD331/BFGFR Antibody: Anti-KLB/Beta-klotho/BKL/BetaKlotho therapeutic antibody |
Fazpilodemab |
KLB;FGFR1/CD331/BFGFR |
Bispecific mAb |
 |
| GMP-Bios-INN-1201 |
Pre-Made Felmetatug biosimilar, Whole mAb, Anti-VTCN1/B7H4 Antibody: Anti-B7‑H4/B7-H4/VTCN1/V-set domain-containing T-cell activation inhibitor 1 therapeutic antibody |
Felmetatug |
VTCN1/B7H4 |
Whole mAb |
 |
| GMP-Bios-INN-1202 |
Pre-Made Fepixnebart biosimilar, Whole mAb, Anti-EREG Antibody: Anti-EREG/Epiregulin/Proepiregulin/ER therapeutic antibody |
Fepixnebart |
EREG |
Whole mAb |
 |
| GMP-Bios-INN-1203 |
Pre-Made Ficerafusp biosimilar, Fusion Protein targeting EGFR/ERBB1/HER1: Recombinant therapeutic protein targeting EGFR/Epidermal growth factor receptor/Proto-oncogene c-ErbB-1/Receptor tyrosine-protein kinase erbB-1 |
Ficerafusp |
EGFR/ERBB1/HER1 |
Fusion Protein |
 |
| GMP-Bios-INN-1204 |
Pre-Made Firastotug biosimilar, Whole mAb, Anti-CTLA4/CD152 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Firastotug |
CTLA4/CD152 |
Whole mAb |
 |
| GMP-Bios-INN-1205 |
Pre-Made Firsekibart biosimilar, Whole mAb, Anti-IL1B Antibody: Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody |
Firsekibart |
IL1B |
Whole mAb |
 |
| GMP-Bios-INN-1206 |
Pre-Made Fiztasovimab biosimilar, Whole mAb: Anti-Human Herpesvirus Glycoprotein B AD-1 therapeutic antibody |
Fiztasovimab |
Human Herpesvirus Glycoprotein B AD-1 |
Whole mAb |
 |
| GMP-Bios-INN-1207 |
Pre-Made Forimtamig biosimilar, Bispecific mAb with Domain Crossover, Anti-GPRC5D;CD3E Antibody: Anti-GPRC5D/G-protein coupled receptor family C group 5 member D/T3E/TCRE therapeutic antibody |
Forimtamig |
GPRC5D;CD3E |
Bispecific mAb with Domain Crossover |
 |
| GMP-Bios-INN-1208 |
Pre-Made Freneslerbart biosimilar, Whole mAb: Anti-Fel d 1 therapeutic antibody |
Freneslerbart |
Fel d 1 |
Whole mAb |
 |
| GMP-Bios-INN-1209 |
Pre-Made Frexalimab biosimilar, Whole mAb, Anti-CD40LG/CD154 Antibody: Anti-CD40LG/CD154/CD40 ligand/CD40-L therapeutic antibody |
Frexalimab |
CD40LG/CD154 |
Whole mAb |
 |
| GMP-Bios-INN-1210 |
Pre-Made Futermestotug biosimilar, Whole mAb, Anti-CTLA4/CD152 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Futermestotug |
CTLA4/CD152 |
Whole mAb |
 |
| GMP-Bios-INN-1211 |
Pre-Made Gacovetug biosimilar, Dimerised heavy domain (VH-h-CH2-CH3-CHS dimer): Anti-F4+ ETEC (Veterinary Application) therapeutic antibody |
Gacovetug |
F4+ ETEC (Veterinary Application) |
Dimerised heavy domain (VH-h-CH2-CH3-CHS dimer) |
 |
| GMP-Bios-INN-1212 |
Pre-Made Galvokimig biosimilar, Trispecific (G1(VH-CH1-h)-scFv_L-kappa-scFv), Anti-IL17A and IL17F;ALB;IL13 Antibody: Anti-Albumin/ALB/HSA/FDAHT therapeutic antibody |
Galvokimig |
IL17A and IL17F;ALB;IL13 |
Trispecific (G1(VH-CH1-h)-scFv_L-kappa-scFv); Bispecific entry |
 |
| GMP-Bios-INN-1214 |
Pre-Made Garetatug biosimilar, Whole mAb ADC, Anti-CLDN18 Antibody: Anti-SFTA5/SFTPJ therapeutic antibody |
Garetatug |
CLDN18 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1215 |
Pre-Made Gefurulimab biosimilar, Bispecific Single Domains (VH-VH'), Anti-C5;ALB Antibody: Anti-C5/CO5/Complement C5/C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4 therapeutic antibody |
Gefurulimab |
C5;ALB |
Bispecific Single Domains (VH-VH') |
 |
| GMP-Bios-INN-1216 |
Pre-Made Gimistotug biosimilar, Whole mAb, Anti-TNFRSF4/CD134/OX40 Antibody: Anti-CD134/OX40/TNFRSF4/Tumor necrosis factor receptor superfamily member 4 therapeutic antibody |
Gimistotug |
TNFRSF4/CD134/OX40 |
Whole mAb |
 |
| GMP-Bios-INN-1217 |
Pre-Made Givastomig biosimilar, Bispecific (G1-scFv_L-kappa), Anti-CLDN18;TNFRSF9/CD137/4-1BB Antibody: Anti-SFTA5/SFTPJ/TNFRSF9/CD137 therapeutic antibody |
Givastomig |
CLDN18;TNFRSF9/CD137/4-1BB |
Bispecific (G1-scFv_L-kappa) |
 |
| GMP-Bios-INN-1218 |
Pre-Made Gocatamig biosimilar, Trispecific Mixed scFv and Single Domains (scFvhl-VH-VH'), Anti-CD3E;ALB;DLL3 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Gocatamig |
CD3E;ALB;DLL3 |
Trispecific Mixed scFv and Single Domains (scFvhl-VH-VH'); Bispecific entry |
 |
| GMP-Bios-INN-1220 |
Pre-Made Golocdacimab biosimilar, Whole mAb, Anti-OLR1/LOX1 Antibody: Anti-OLR1/LOX1/Oxidized low-density lipoprotein receptor 1/Ox-LDL receptor 1 therapeutic antibody |
Golocdacimab |
OLR1/LOX1 |
Whole mAb |
 |
| GMP-Bios-INN-1221 |
Pre-Made Gorivitug biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Gorivitug |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1222 |
Pre-Made Gotistobart biosimilar, Whole mAb, Anti-CTLA4/CD152 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Gotistobart |
CTLA4/CD152 |
Whole mAb |
 |
| GMP-Bios-INN-1223 |
Pre-Made Greziprubart biosimilar, Whole mAb, Anti-C5 Antibody: Anti-C5/CO5/Complement C5/C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4 therapeutic antibody |
Greziprubart |
C5 |
Whole mAb |
 |
| GMP-Bios-INN-1224 |
Pre-Made Gruticibart biosimilar, Whole mAb, Anti-F11 Antibody: Anti-F11/Coagulation factor XI/FXI/Plasma thromboplastin antecedent (PTA) therapeutic antibody |
Gruticibart |
F11 |
Whole mAb |
 |
| GMP-Bios-INN-1225 |
Pre-Made Gulgafafusp biosimilar, Fusion Protein (whole mAb with protein) targeting GLP1R: Recombinant therapeutic protein targeting GLP1R/Glucagon-like peptide 1 receptor/GLP-1 receptor/GLP-1-R |
Gulgafafusp |
GLP1R |
Fusion Protein (whole mAb with protein) |
 |
| GMP-Bios-INN-1226 |
Pre-Made Ibramvibart biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Ibramvibart |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1227 |
Pre-Made Ibentatug biosimilar, Whole mAb, Anti-CSP1 Antibody: Anti-Calcipressin 1/RCAN1/Calcipressin-1/Adapt78 therapeutic antibody |
Ibentatug |
CSP1 |
Whole mAb |
 |
| GMP-Bios-INN-1228 |
Pre-Made Ibritumomab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-CD20/MS4A1/B-lymphocyte antigen CD20/B-lymphocyte surface antigen B1 therapeutic antibody |
Ibritumomab |
MS4A1/CD20 |
Whole mAb |
 |
| GMP-Bios-INN-1229 |
Pre-Made Ifinatamab biosimilar, Whole mAb, Anti-B7H3/CD276 Antibody: Anti-B7-H3/CD276/CD276 antigen/4Ig-B7-H3 therapeutic antibody |
Ifinatamab |
B7H3/CD276 |
Whole mAb |
 |
| GMP-Bios-INN-1230 |
Pre-Made Iluzanebart biosimilar, Whole mAb, Anti-TREM2 Antibody: Anti-TREM2/Triggering receptor expressed on myeloid cells 2/TREM-2/Triggering receptor expressed on monocytes 2 therapeutic antibody |
Iluzanebart |
TREM2 |
Whole mAb |
 |
| GMP-Bios-INN-1231 |
Pre-Made Imeroprubart biosimilar, Whole mAb, Anti-FCGRT/FcRn Antibody: Anti-FcRn/FCGRT/IgG receptor FcRn large subunit p51/IgG Fc fragment receptor transporter alpha chain therapeutic antibody |
Imeroprubart |
FCGRT/FcRn |
Whole mAb |
 |
| GMP-Bios-INN-1232 |
Pre-Made Imneskibart biosimilar, Whole mAb, Anti-IL2RA/CD25 Antibody: Anti-CD25/IL-2RA/IL2RA/Interleukin-2 receptor subunit alpha therapeutic antibody |
Imneskibart |
IL2RA/CD25 |
Whole mAb |
 |
| GMP-Bios-INN-1233 |
Pre-Made Imvotamab biosimilar, Pentameric IgM with Fused scFv (Bispecific), Anti-CD3E;MS4A1/CD20 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Imvotamab |
CD3E;MS4A1/CD20 |
Pentameric IgM with Fused scFv (Bispecific) |
 |
| GMP-Bios-INN-1234 |
Pre-Made Imzokitug biosimilar, Whole mAb, Anti-CCR8/CKR-L1/CDw198 Antibody: Anti-CCR8/CDw198/C-C chemokine receptor type 8/C-C CKR-8 therapeutic antibody |
Imzokitug |
CCR8/CKR-L1/CDw198 |
Whole mAb |
 |
| GMP-Bios-INN-1235 |
Pre-Made Indematug biosimilar, Whole mAb, Anti-IFNG Antibody: Anti-IFG/IFI/IMD69 therapeutic antibody |
Indematug |
IFNG |
Whole mAb |
 |
| GMP-Bios-INN-1236 |
Pre-Made Indenebart biosimilar, Whole mAb, Anti-SNCA/PARK1/PARK4 Antibody: Anti-Alpha Synuclein/SNCA/Alpha-synuclein/Non-A beta component of AD amyloid therapeutic antibody |
Indenebart |
SNCA/PARK1/PARK4 |
Whole mAb |
 |
| GMP-Bios-INN-1237 |
Pre-Made Inezetamab biosimilar, Bispecific Mixed mAb and scFv, Anti-CD40;MSLN Antibody: Anti-CD40/Tumor necrosis factor receptor superfamily member 5/B-cell surface antigen CD40/Bp50 therapeutic antibody |
Inezetamab |
CD40;MSLN |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1238 |
Pre-Made Ingitamig biosimilar, Bispecific Mixed mAb and tandem mAb/scFv, Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;KLRK1/NKG2D/CD314 Antibody: Anti-TNFRSF17/BCMA/CD269/Tumor necrosis factor receptor superfamily member 17 therapeutic antibody |
Ingitamig |
TNFRSF17/CD269/BCMA/TNFRSF13A;KLRK1/NKG2D/CD314 |
Bispecific Mixed mAb and tandem mAb/scFv |
 |
| GMP-Bios-INN-1239 |
Pre-Made Inlecitug biosimilar, Whole mAb, Anti-KDR/CD309/VEGFR2 Antibody: Anti-VEGFR2/KDR/CD309/Vascular endothelial growth factor receptor 2 therapeutic antibody |
Inlecitug |
KDR/CD309/VEGFR2 |
Whole mAb |
 |
| GMP-Bios-INN-1240 |
Pre-Made Invikafusp biosimilar, Fusion Protein: Recombinant therapeutic protein targeting TRBV6&TRBV10 |
Invikafusp |
TRBV6&TRBV10 |
Fusion Protein |
 |
| GMP-Bios-INN-1241 |
Pre-Made Ispectamab biosimilar, Whole mAb, Anti-TNFRSF17/CD269/BCMA/TNFRSF13A Antibody: Anti-TNFRSF17/BCMA/CD269/Tumor necrosis factor receptor superfamily member 17 therapeutic antibody |
Ispectamab |
TNFRSF17/CD269/BCMA/TNFRSF13A |
Whole mAb |
 |
| GMP-Bios-INN-1242 |
Pre-Made Isuventatug biosimilar, Whole mAb, Anti-MICA&MICB Antibody: Anti-MICA/MICB/MHC class I polypeptide-related sequence A/MIC-A therapeutic antibody |
Isuventatug |
MICA&MICB |
Whole mAb |
 |
| GMP-Bios-INN-1243 |
Pre-Made Itanistomig biosimilar, Bispecific Mixed Domains (VH-G1CH1-h)-H-gamma1_L-kappa-L-kappa), Anti-PDL1/CD274;IAP/CD47 Antibody: Anti-PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 therapeutic antibody |
Itanistomig |
PDL1/CD274;IAP/CD47 |
Bispecific Mixed Domains (VH-G1CH1-h)-H-gamma1_L-kappa-L-kappa) |
 |
| GMP-Bios-INN-1244 |
Pre-Made Ixotatug biosimilar, Whole mAb ADC, Anti-CLDN6 Antibody: Anti-CLDN6/Claudin-6/Skullin therapeutic antibody |
Ixotatug |
CLDN6 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1245 |
Pre-Made Izalontamab biosimilar, Bispecific Mixed mAb and scFv, Anti-EGFR/ERBB1/HER1;ERBB3/HER3 Antibody: Anti-EGFR/Epidermal growth factor receptor/Proto-oncogene c-ErbB-1/Receptor tyrosine-protein kinase erbB-1 therapeutic antibody |
Izalontamab |
EGFR/ERBB1/HER1;ERBB3/HER3 |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1246 |
Pre-Made Izastobart biosimilar, Whole mAb, Anti-C5AR1/CD88 Antibody: Anti-C5aR/C5AR1/CD88/C5a anaphylatoxin chemotactic receptor 1 therapeutic antibody |
Izastobart |
C5AR1/CD88 |
Whole mAb |
 |
| GMP-Bios-INN-1247 |
Pre-Made Izeltabart biosimilar, Whole mAb, Anti-ADAM9 Antibody: Anti-ADAM9/Disintegrin and metalloproteinase domain-containing protein 9/ADAM 9/Cellular disintegrin-related protein therapeutic antibody |
Izeltabart |
ADAM9 |
Whole mAb |
 |
| GMP-Bios-INN-1248 |
Pre-Made Izenivetmab biosimilar, Canine Whole mAb, Anti-NGFB (Canine) Antibody: Anti-STSP1/NGFB/STS-Y/STSP therapeutic antibody |
Izenivetmab |
NGFB (Canine) |
Canine Whole mAb |
 |
| GMP-Bios-INN-1249 |
Pre-Made Lancastotug biosimilar, Whole mAb, Anti-TIGIT/WUCAM/VSTM3 Antibody: Anti-TIGIT/T-cell immunoreceptor with Ig and ITIM domains/V-set and immunoglobulin domain-containing protein 9/V-set and transmembrane domain-containing protein 3 therapeutic antibody |
Lancastotug |
TIGIT/WUCAM/VSTM3 |
Whole mAb |
 |
| GMP-Bios-INN-1250 |
Pre-Made Lanerkitug biosimilar, Whole mAb, Anti-CCR8/CKR-L1/CDw198 Antibody: Anti-CCR8/CDw198/C-C chemokine receptor type 8/C-C CKR-8 therapeutic antibody |
Lanerkitug |
CCR8/CKR-L1/CDw198 |
Whole mAb |
 |
| GMP-Bios-INN-1251 |
Pre-Made Lasrekibart biosimilar, Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF therapeutic antibody |
Lasrekibart |
IL5 |
Whole mAb |
 |
| GMP-Bios-INN-1252 |
Pre-Made Latikafusp biosimilar, Whole mAb Fusion, Anti-PDCD1/CD279/PD1 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Latikafusp |
PDCD1/CD279/PD1 |
Whole mAb Fusion |
 |
| GMP-Bios-INN-1253 |
Pre-Made Laventatug biosimilar, Whole mAb ADC, Anti-SLC39A6/ZIP6 Antibody: Anti-LIV-1/ZIP6/SLC39A6/Zinc transporter ZIP6 therapeutic antibody |
Laventatug |
SLC39A6/ZIP6 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1254 |
Pre-Made Lecankitug biosimilar, Whole mAb, Anti-IL17A&IL17F Antibody: Anti-IL-17A/IL17A/IL17/Interleukin-17A therapeutic antibody |
Lecankitug |
IL17A&IL17F |
Whole mAb |
 |
| GMP-Bios-INN-1255 |
Pre-Made Ledostomig biosimilar, Bispecific Mixed mAb and scFv, Anti-NT5E/CALJA/CD73;PDCD1/CD279/PD1 Antibody: Anti-CD73/NT5E/5'-nucleotidase/5'-NT therapeutic antibody |
Ledostomig |
NT5E/CALJA/CD73;PDCD1/CD279/PD1 |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1256 |
Pre-Made Lesabelimab biosimilar, Whole mAb, Anti-PDL1/CD274 Antibody: Anti-PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 therapeutic antibody |
Lesabelimab |
PDL1/CD274 |
Whole mAb |
 |
| GMP-Bios-INN-1257 |
Pre-Made Libevitug biosimilar, Whole mAb: Anti-Hepatitis B Virus Surface Antigen therapeutic antibody |
Libevitug |
Hepatitis B Virus Surface Antigen |
Whole mAb |
 |
| GMP-Bios-INN-1258 |
Pre-Made Linavonkibart biosimilar, Whole mAb, Anti-TGFB1 Antibody: Anti-CED/DPD1/IBDIMDE/LAP therapeutic antibody |
Linavonkibart |
TGFB1 |
Whole mAb |
 |
| GMP-Bios-INN-1259 |
Pre-Made Linclatamig biosimilar, Bispecific mAb, Anti-LY6G6D/G6D/NG25/LY6-D/MEGT1/C6orf23;CD3E Antibody: Anti-LY6G6D/Lymphocyte antigen 6 complex locus protein G6d/Protein Ly6-D/Megakaryocyte-enhanced gene transcript 1 protein therapeutic antibody |
Linclatamig |
LY6G6D/G6D/NG25/LY6-D/MEGT1/C6orf23;CD3E |
Bispecific mAb |
 |
| GMP-Bios-INN-1260 |
Pre-Made Linvoseltamab biosimilar, Bispecific mAb, Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E Antibody: Anti-TNFRSF17/BCMA/CD269/Tumor necrosis factor receptor superfamily member 17 therapeutic antibody |
Linvoseltamab |
TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E |
Bispecific mAb |
 |
| GMP-Bios-INN-1261 |
Pre-Made Lipustobart biosimilar, Whole mAb, Anti-PDCD1/CD279/PD1 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Lipustobart |
PDCD1/CD279/PD1 |
Whole mAb |
 |
| GMP-Bios-INN-1262 |
Pre-Made Litifilimab biosimilar, Whole mAb, Anti-CLEC4C Antibody: Anti-CLEC4C/CD303/C-type lectin domain family 4 member C/Blood dendritic cell antigen 2 (BDCA-2) therapeutic antibody |
Litifilimab |
CLEC4C |
Whole mAb |
 |
| GMP-Bios-INN-1263 |
Pre-Made Lixudebart biosimilar, Whole mAb, Anti-CLDN1 Antibody: Anti-Claudin 1/CLDN1/Claudin-1/Senescence-associated epithelial membrane protein therapeutic antibody |
Lixudebart |
CLDN1 |
Whole mAb |
 |
| GMP-Bios-INN-1264 |
Pre-Made Lofacimig biosimilar, Bispecific Tandem VH Domains fused to G1 Constant Domain, Anti-F11;F11 Antibody: Anti-F11/Coagulation factor XI/FXI/Plasma thromboplastin antecedent (PTA) therapeutic antibody |
Lofacimig |
F11;F11 |
Bispecific Tandem VH Domains fused to G1 Constant Domain |
 |
| GMP-Bios-INN-1265 |
Pre-Made Lomvastomig biosimilar, Bispecific mAb with Domain Crossover, Anti-PDCD1/CD279/PD1;HAVCR2/TIM3 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Lomvastomig |
PDCD1/CD279/PD1;HAVCR2/TIM3 |
Bispecific mAb with Domain Crossover |
 |
| GMP-Bios-INN-1266 |
Pre-Made Lotivibart biosimilar, Whole mAb: Anti-HIV-1 gp120 therapeutic antibody |
Lotivibart |
HIV-1 gp120 |
Whole mAb |
 |
| GMP-Bios-INN-1267 |
Pre-Made Lucorafusp biosimilar, Whole mAb, Anti-TIGIT/WUCAM/VSTM3 Antibody: Anti-TIGIT/T-cell immunoreceptor with Ig and ITIM domains/V-set and immunoglobulin domain-containing protein 9/V-set and transmembrane domain-containing protein 3 therapeutic antibody |
Lucorafusp |
TIGIT/WUCAM/VSTM3 |
Whole mAb |
 |
| GMP-Bios-INN-1268 |
Pre-Made Lumistobart biosimilar, Whole mAb, Anti-SIRPA Antibody: Anti-SIRP Alpha/CD172a/SIRPA/Tyrosine-protein phosphatase non-receptor type substrate 1 therapeutic antibody |
Lumistobart |
SIRPA |
Whole mAb |
 |
| GMP-Bios-INN-1269 |
Pre-Made Lumrotatug biosimilar, Whole mAb, Anti-ADPRC1/CD38 Antibody: Anti-CD38/ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1/2'-phospho-ADP-ribosyl cyclase therapeutic antibody |
Lumrotatug |
ADPRC1/CD38 |
Whole mAb |
 |
| GMP-Bios-INN-1270 |
Pre-Made Lunaxafusp biosimilar, Fusion Protein targeting ERBB2/CD340/HER2: Recombinant therapeutic protein targeting HER2/ERBB2/CD340/Receptor tyrosine-protein kinase erbB-2 |
Lunaxafusp |
ERBB2/CD340/HER2 |
Fusion Protein |
 |
| GMP-Bios-INN-1271 |
Pre-Made Lunlekitug biosimilar, Whole mAb, Anti-IL1A Antibody: Anti-IL1/IL-1A/IL1F1/IL1-ALPHA therapeutic antibody |
Lunlekitug |
IL1A |
Whole mAb |
 |
| GMP-Bios-INN-1272 |
Pre-Made Lunsekimig biosimilar, Trispecific and Pentavalent (sc-5-VH), Anti-IL13;IL13;TSLP;ALB Antibody: Anti-IL-13/P600 therapeutic antibody |
Lunsekimig |
IL13;IL13;TSLP;ALB |
Trispecific and Pentavalent (sc-5-VH); Bispecific entry |
 |
| GMP-Bios-INN-1275 |
Pre-Made Luvagrobart biosimilar, Whole mAb, Anti-NGF Antibody: Anti-NGF/beta NGF/Beta-nerve growth factor/Beta-NGF therapeutic antibody |
Luvagrobart |
NGF |
Whole mAb |
 |
| GMP-Bios-INN-1276 |
Pre-Made Luveltamab biosimilar, Whole mAb ADC, Anti-FOLR1 Antibody: Anti-FOLR1/Folate receptor alpha/FR-alpha/Adult folate-binding protein (FBP) therapeutic antibody |
Luveltamab |
FOLR1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1277 |
Pre-Made Maridebart biosimilar, Whole mAb, Anti-GIPR Antibody: Anti-GIPR/Gastric inhibitory polypeptide receptor/GIP-R/Glucose-dependent insulinotropic polypeptide receptor therapeutic antibody |
Maridebart |
GIPR |
Whole mAb |
 |
| GMP-Bios-INN-1278 |
Pre-Made Marlotamig biosimilar, Bispecific mAb, Anti-EGFR/ERBB1/HER1;CD28 Antibody: Anti-EGFR/Epidermal growth factor receptor/Proto-oncogene c-ErbB-1/Receptor tyrosine-protein kinase erbB-1 therapeutic antibody |
Marlotamig |
EGFR/ERBB1/HER1;CD28 |
Bispecific mAb |
 |
| GMP-Bios-INN-1279 |
Pre-Made Masavibart biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Masavibart |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1280 |
Pre-Made Mavrostobart biosimilar, Whole mAb, Anti-NT5E/CALJA/CD73 Antibody: Anti-CD73/NT5E/5'-nucleotidase/5'-NT therapeutic antibody |
Mavrostobart |
NT5E/CALJA/CD73 |
Whole mAb |
 |
| GMP-Bios-INN-1281 |
Pre-Made Mecbotamab biosimilar, Whole mAb, Anti-AXL/UFO Antibody: Anti-AXL/Tyrosine-protein kinase receptor UFO/AXL oncogene/ARK therapeutic antibody |
Mecbotamab |
AXL/UFO |
Whole mAb |
 |
| GMP-Bios-INN-1282 |
Pre-Made Mevonlerbart biosimilar, Whole mAb: Anti-Fel d 1 therapeutic antibody |
Mevonlerbart |
Fel d 1 |
Whole mAb |
 |
| GMP-Bios-INN-1283 |
Pre-Made Micvotabart biosimilar, Whole mAb, Anti-FN extracellular domain B Antibody: Anti-Fibronectin/FN1/FN/Cold-insoluble globulin (CIG) therapeutic antibody |
Micvotabart |
FN extracellular domain B |
Whole mAb |
 |
| GMP-Bios-INN-1284 |
Pre-Made Mipletamig biosimilar, Bispecific Mixed scFv (scFv-CH2-CH3-scFv), Anti-IL3RA/CD123;CD3E Antibody: Anti-CD123/IL3RA/Interleukin-3 receptor subunit alpha/IL-3 receptor subunit alpha therapeutic antibody |
Mipletamig |
IL3RA/CD123;CD3E |
Bispecific Mixed scFv (scFv-CH2-CH3-scFv) |
 |
| GMP-Bios-INN-1285 |
Pre-Made Misitatug biosimilar, Whole mAb, Anti-MSLN Antibody: Anti-MPF/SMRP therapeutic antibody |
Misitatug |
MSLN |
Whole mAb |
 |
| GMP-Bios-INN-1286 |
Pre-Made Moflerafusp biosimilar, Fusion Protein targeting SIRPA: Recombinant therapeutic protein targeting SIRP Alpha/CD172a/SIRPA/Tyrosine-protein phosphatase non-receptor type substrate 1 |
Moflerafusp |
SIRPA |
Fusion Protein |
 |
| GMP-Bios-INN-1287 |
Pre-Made Mozistobart biosimilar, Whole mAb, Anti-SIGLEC2/CD22 Antibody: Anti-CD22/B-cell receptor CD22/B-lymphocyte cell adhesion molecule (BL-CAM)/Sialic acid-binding Ig-like lectin 2 (Siglec-2) therapeutic antibody |
Mozistobart |
SIGLEC2/CD22 |
Whole mAb |
 |
| GMP-Bios-INN-1288 |
Pre-Made Muzastotug biosimilar, Whole mAb, Anti-CTLA4/CD152 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Muzastotug |
CTLA4/CD152 |
Whole mAb |
 |
| GMP-Bios-INN-1289 |
Pre-Made Narlumosbart biosimilar, Whole mAb, Anti-TNFSF11/CD254/RANKL/TRANCE/OPGL/ODF Antibody: Anti-TNFSF11/RANKL/CD254/ODF therapeutic antibody |
Narlumosbart |
TNFSF11/CD254/RANKL/TRANCE/OPGL/ODF |
Whole mAb |
 |
| GMP-Bios-INN-1290 |
Pre-Made Navenibart biosimilar, Whole mAb, Anti-KLKB1 Antibody: Anti-KLKB1/Plasma kallikrein/Fletcher factor/Kininogenin therapeutic antibody |
Navenibart |
KLKB1 |
Whole mAb |
 |
| GMP-Bios-INN-1291 |
Pre-Made Nebokitug biosimilar, Whole mAb, Anti-CCL24/SCYA24/Ckb-6/MPIF-2/eotaxin-2 Antibody: Anti-CCL24/Eotaxin 2/C-C motif chemokine 24/CK-beta-6 therapeutic antibody |
Nebokitug |
CCL24/SCYA24/Ckb-6/MPIF-2/eotaxin-2 |
Whole mAb |
 |
| GMP-Bios-INN-1292 |
Pre-Made Nebratamig biosimilar, Tetraspecific scFv-IgG-scFv-scFv (Bispecific entry 1), Anti-TNFRSF9/CD137/4-1BB;PDL1/CD274;ROR1;CD3D and CD3E Antibody: Anti-TNFRSF9/CD137/Tumor necrosis factor receptor superfamily member 9/4-1BB ligand receptor therapeutic antibody |
Nebratamig |
TNFRSF9/CD137/4-1BB;PDL1/CD274;ROR1;CD3D and CD3E |
Tetraspecific scFv-IgG-scFv-scFv (Bispecific entry 1) |
 |
| GMP-Bios-INN-1294 |
Pre-Made Negalstobart biosimilar, Whole mAb: Anti-LAG3/CD223 therapeutic antibody |
Negalstobart |
LAG3/CD223 |
Whole mAb |
 |
| GMP-Bios-INN-1295 |
Pre-Made Nelmastobart biosimilar, Whole mAb, Anti-BTN1A1 Antibody: Anti-BTN1A1/Butyrophilin subfamily 1 member A1/BT/BTN therapeutic antibody |
Nelmastobart |
BTN1A1 |
Whole mAb |
 |
| GMP-Bios-INN-1296 |
Pre-Made Nelistotug biosimilar, Whole mAb, Anti-TACTILE/CD96 Antibody: Anti-CD96/T-cell surface protein tactile/Cell surface antigen CD96/T cell-activated increased late expression protein therapeutic antibody |
Nelistotug |
TACTILE/CD96 |
Whole mAb |
 |
| GMP-Bios-INN-1297 |
Pre-Made Nepuvibart biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Nepuvibart |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1298 |
Pre-Made Nesfrotamig biosimilar, Bispecific Mixed mAb and scFv, Anti-ERBB2/CD340/HER2;TNFRSF9/CD137/4-1BB Antibody: Anti-HER2/ERBB2/CD340/Receptor tyrosine-protein kinase erbB-2 therapeutic antibody |
Nesfrotamig |
ERBB2/CD340/HER2;TNFRSF9/CD137/4-1BB |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1299 |
Pre-Made Nezastomig biosimilar, Bispecific mAb, Anti-FOLH1/GCPII/PSMA;CD28 Antibody: Anti-PSMA/GCPII/FOLH1/Glutamate carboxypeptidase 2 therapeutic antibody |
Nezastomig |
FOLH1/GCPII/PSMA;CD28 |
Bispecific mAb |
 |
| GMP-Bios-INN-1300 |
Pre-Made Nezutatug biosimilar, Whole mAb, Anti-ERBB3/HER3 Antibody: Anti-ERBB3/ErbB3/HER3/Erbb-3 therapeutic antibody |
Nezutatug |
ERBB3/HER3 |
Whole mAb |
 |
| GMP-Bios-INN-1301 |
Pre-Made Nisevokitug biosimilar, Whole mAb, Anti-TGFB1/TGFB2 Antibody: Anti-TGF Beta 1/TGFB1/Transforming growth factor beta-1 proprotein/CED therapeutic antibody |
Nisevokitug |
TGFB1/TGFB2 |
Whole mAb |
 |
| GMP-Bios-INN-1302 |
Pre-Made Nivisnebart biosimilar, Whole mAb, Anti-SORT1/Gp95/NT3 Antibody: Anti-Sortilin/SORT1/100 kDa NT receptor/Glycoprotein 95 (Gp95) therapeutic antibody |
Nivisnebart |
SORT1/Gp95/NT3 |
Whole mAb |
 |
| GMP-Bios-INN-1303 |
Pre-Made Nolavetbart biosimilar, Whole mAb (Canine), Anti-IL31RA (Canine) Antibody: Anti-IL31RA/IL31R/Interleukin-31 receptor subunit alpha/IL-31 receptor subunit alpha therapeutic antibody |
Nolavetbart |
IL31RA (Canine) |
Whole mAb (Canine) |
 |
| GMP-Bios-INN-1304 |
Pre-Made Nuvustotug biosimilar, Whole mAb, Anti-TNFRSF4/CD134/OX40 Antibody: Anti-CD134/OX40/TNFRSF4/Tumor necrosis factor receptor superfamily member 4 therapeutic antibody |
Nuvustotug |
TNFRSF4/CD134/OX40 |
Whole mAb |
 |
| GMP-Bios-INN-1305 |
Pre-Made Oberotatug biosimilar, Whole mAb, Anti-LY75/CD205/DEC205 Antibody: Anti-LY75/CD205/Lymphocyte antigen 75/Ly-75 therapeutic antibody |
Oberotatug |
LY75/CD205/DEC205 |
Whole mAb |
 |
| GMP-Bios-INN-1306 |
Pre-Made Obertamig biosimilar, Bispecific Mixed mAb and scFv, Anti-CD3E;HLA-G Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Obertamig |
CD3E;HLA-G |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1307 |
Pre-Made Obrixtamig biosimilar, Bispecific mAb (L-kappa-H-gamma1_L-lambda-H-gamma1), Anti-DLL3;CD3E Antibody: Anti-DLL3/Delta-like protein 3/Drosophila Delta homolog 3 (Delta3)/SCDO1 therapeutic antibody |
Obrixtamig |
DLL3;CD3E |
Bispecific mAb (L-kappa-H-gamma1_L-lambda-H-gamma1) |
 |
| GMP-Bios-INN-1308 |
Pre-Made Ocankitug biosimilar, Whole mAb, Anti-TSLP Antibody: Anti-TSLP/Thymic stromal lymphopoietin therapeutic antibody |
Ocankitug |
TSLP |
Whole mAb |
 |
| GMP-Bios-INN-1309 |
Pre-Made Ogalvibart biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Ogalvibart |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1310 |
Pre-Made Olintatug biosimilar, Whole mAb, Anti-KAAG1/RU2AS Antibody: Anti-KAAG1/Kidney-associated antigen 1/RU2 antisense gene protein/RU2AS therapeutic antibody |
Olintatug |
KAAG1/RU2AS |
Whole mAb |
 |
| GMP-Bios-INN-1311 |
Pre-Made Oloctinebart biosimilar, Whole mAb, Anti-LGALS3/GAL3 Antibody: Anti-Galectin-3/Galectin 3/LGALS3/Gal-3 therapeutic antibody |
Oloctinebart |
LGALS3/GAL3 |
Whole mAb |
 |
| GMP-Bios-INN-1312 |
Pre-Made Omectatug biosimilar, Whole mAb, Anti-CLDN18 Antibody: Anti-SFTA5/SFTPJ therapeutic antibody |
Omectatug |
CLDN18 |
Whole mAb |
 |
| GMP-Bios-INN-1313 |
Pre-Made Omoprubart biosimilar, Whole mAb, Anti-C5 Antibody: Anti-C5/CO5/Complement C5/C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4 therapeutic antibody |
Omoprubart |
C5 |
Whole mAb |
 |
| GMP-Bios-INN-1314 |
Pre-Made Ompekimig biosimilar, Trispecific Mixed mAb and scFv, Anti-IL13;IL4;IL33 Antibody: Anti-IL-13/P600/BCGF-1/BCGF1 therapeutic antibody |
Ompekimig |
IL13;IL4;IL33 |
Trispecific Mixed mAb and scFv; Bispecific entry |
 |
| GMP-Bios-INN-1316 |
Pre-Made Opamistomig biosimilar, Bispecific Mixed mAb and scFv, Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB Antibody: Anti-PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 therapeutic antibody |
Opamistomig |
PDL1/CD274;TNFRSF9/CD137/4-1BB |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1317 |
Pre-Made Opelkibart biosimilar, Whole mAb ADC, Anti-KIT/CD117 Antibody: Anti-CD117/c-Kit/KIT/Mast therapeutic antibody |
Opelkibart |
KIT/CD117 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1318 |
Pre-Made Opugotamig biosimilar, Bispecific Mixed mAb and scFv ((G1_L-kappa)_scFvkh-G1(h-CH2-CH3)), Anti-FOLR1;FOLR1 Antibody: Anti-FOLR1/Folate receptor alpha/FR-alpha/Adult folate-binding protein (FBP) therapeutic antibody |
Opugotamig |
FOLR1;FOLR1 |
Bispecific Mixed mAb and scFv ((G1_L-kappa)_scFvkh-G1(h-CH2-CH3)) |
 |
| GMP-Bios-INN-1319 |
Pre-Made Osemitamab biosimilar, Whole mAb, Anti-CLDN18 Antibody: Anti-SFTA5/SFTPJ therapeutic antibody |
Osemitamab |
CLDN18 |
Whole mAb |
 |
| GMP-Bios-INN-1320 |
Pre-Made Oturkibart biosimilar, Whole mAb, Anti-IL4R/CD124 Antibody: Anti-IL-4RA/CD124/IL4R/Interleukin-4 receptor subunit alpha therapeutic antibody |
Oturkibart |
IL4R/CD124 |
Whole mAb |
 |
| GMP-Bios-INN-1321 |
Pre-Made Ozekibart biosimilar, VH-IgG, Anti-TNFRSF10B/CD262/DR5/TRAILR2 Antibody: Anti-DR5/TNFRSF10B/CD262/TRAIL-R2 therapeutic antibody |
Ozekibart |
TNFRSF10B/CD262/DR5/TRAILR2 |
VH-IgG |
 |
| GMP-Bios-INN-1322 |
Pre-Made Ozureprubart biosimilar, Whole mAb, Anti-IGHE Antibody: Anti-IGHE/Immunoglobulin heavy constant epsilon/Ig epsilon chain C region/Ig epsilon chain C region ND therapeutic antibody |
Ozureprubart |
IGHE |
Whole mAb |
 |
| GMP-Bios-INN-1323 |
Pre-Made Ozuriftamab biosimilar, Whole mAb, Anti-ROR2 Antibody: Anti-ROR2/Tyrosine-protein kinase transmembrane receptor ROR2/Neurotrophic tyrosine kinase/receptor-related 2 therapeutic antibody |
Ozuriftamab |
ROR2 |
Whole mAb |
 |
| GMP-Bios-INN-1324 |
Pre-Made Pacibekitug biosimilar, Whole mAb, Anti-IL6 Antibody: Anti-BSF-2/BSF2/CDF/HGF therapeutic antibody |
Pacibekitug |
IL6 |
Whole mAb |
 |
| GMP-Bios-INN-1325 |
Pre-Made Palverafusp biosimilar, Fusion Protein targeting VEGF: Recombinant therapeutic protein targeting VEGFA/Vascular endothelial growth factor A/long form/L-VEGF |
Palverafusp |
VEGF |
Fusion Protein |
 |
| GMP-Bios-INN-1326 |
Pre-Made Pamlectabart biosimilar, Whole mAb, Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E Antibody: Anti-TNFRSF17/BCMA/CD269/Tumor necrosis factor receptor superfamily member 17 therapeutic antibody |
Pamlectabart |
TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E |
Whole mAb |
 |
| GMP-Bios-INN-1327 |
Pre-Made Pamvatamig biosimilar, Bispecific mAb, Anti-MET/HGFR;EGFR/ERBB1/HER1 Antibody: Anti-c-Met/MET/Hepatocyte growth factor receptor/HGF receptor therapeutic antibody |
Pamvatamig |
MET/HGFR;EGFR/ERBB1/HER1 |
Bispecific mAb |
 |
| GMP-Bios-INN-1328 |
Pre-Made Paridiprubart biosimilar, Whole mAb, Anti-TLR4/CD284 Antibody: Anti-TLR4/CD284/Toll-like receptor 4/hToll therapeutic antibody |
Paridiprubart |
TLR4/CD284 |
Whole mAb |
 |
| GMP-Bios-INN-1329 |
Pre-Made Pasritamig biosimilar, Bispecific Mixed Domains ((H-gamma1_L-kappa)_scFvkh-G1(h-CH2-CH3)), Anti-KLK2/KLK2A2/hGK-1/hK2;CD3E Antibody: Anti-Kallikrein 2/KLK2/Kallikrein-2/Glandular kallikrein-1 (hGK-1) therapeutic antibody |
Pasritamig |
KLK2/KLK2A2/hGK-1/hK2;CD3E |
Bispecific Mixed Domains ((H-gamma1_L-kappa)_scFvkh-G1(h-CH2-CH3)) |
 |
| GMP-Bios-INN-1330 |
Pre-Made Patecibart biosimilar, Whole mAb, Anti-EDNRA Antibody: Anti-EDNRA/Endothelin-1 receptor/Endothelin receptor type A (ET-A/ETA-R therapeutic antibody |
Patecibart |
EDNRA |
Whole mAb |
 |
| GMP-Bios-INN-1331 |
Pre-Made Pegrizeprument biosimilar, Fab (VH-G1CH1h_L-kappa), Anti-CD28 Antibody: Anti-CD28/T-cell-specific surface glycoprotein CD28/TP44/Tp44 therapeutic antibody |
Pegrizeprument |
CD28 |
Fab (VH-G1CH1h_L-kappa) |
 |
| GMP-Bios-INN-1332 |
Pre-Made Peluntamig biosimilar, Bispecific Whole mAb, Anti-IAP/CD47;DLL3 Antibody: Anti-CD47/Leukocyte surface antigen CD47/Antigenic surface determinant protein OA3/Integrin-associated protein (IAP) therapeutic antibody |
Peluntamig |
IAP/CD47;DLL3 |
Bispecific Whole mAb |
 |
| GMP-Bios-INN-1333 |
Pre-Made Pemivibart biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Pemivibart |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1334 |
Pre-Made Perenostobart biosimilar, Whole mAb, Anti-ENTPD1/CD39 Antibody: Anti-ENTPD1/CD39/Ectonucleoside triphosphate diphosphohydrolase 1/ATP diphosphohydrolase (ATP-DPH therapeutic antibody |
Perenostobart |
ENTPD1/CD39 |
Whole mAb |
 |
| GMP-Bios-INN-1335 |
Pre-Made Peresolimab biosimilar, Whole mAb, Anti-PDCD1/CD279/PD1 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Peresolimab |
PDCD1/CD279/PD1 |
Whole mAb |
 |
| GMP-Bios-INN-1336 |
Pre-Made Picankibart biosimilar, Whole mAb, Anti-IL23A Antibody: Anti-IL-23 p19/NeutraControl IL-23 p19/IL23A/IL23 therapeutic antibody |
Picankibart |
IL23A |
Whole mAb |
 |
| GMP-Bios-INN-1337 |
Pre-Made Podentamig biosimilar, Trispecific Mixed scFv and Single Domains (VH-VH'-scFvhl), Anti-TNFRSF17/BCM/BCMA/CD269/TNFRSF13A;ALB;CD3E Antibody: Anti-TNFRSF17/BCMA/CD269/Tumor necrosis factor receptor superfamily member 17 therapeutic antibody |
Podentamig |
TNFRSF17/BCM/BCMA/CD269/TNFRSF13A;ALB;CD3E |
Trispecific Mixed scFv and Single Domains (VH-VH'-scFvhl); Bispecific entry |
 |
| GMP-Bios-INN-1339 |
Pre-Made Polzastobart biosimilar, Whole mAb, Anti-LILRB2 Antibody: Anti-ATAD1/LILRB2/CD85d/Leukocyte immunoglobulin-like receptor subfamily B member 2 therapeutic antibody |
Polzastobart |
LILRB2 |
Whole mAb |
 |
| GMP-Bios-INN-1340 |
Pre-Made Porustobart biosimilar, VH-CH2-CH3, Anti-CTLA4/CD152 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Porustobart |
CTLA4/CD152 |
VH-CH2-CH3 |
 |
| GMP-Bios-INN-1341 |
Pre-Made Posnafusp biosimilar, Fab Fusion Protein targeting TFRC/CD71: Recombinant therapeutic protein targeting CD71/TFRC/Transferrin receptor protein 1/TR |
Posnafusp |
TFRC/CD71 |
Fab Fusion Protein |
 |
| GMP-Bios-INN-1342 |
Pre-Made Posdinemab biosimilar, Whole mAb, Anti-MAPT Antibody: Anti-DDPAC/FTDP-17/MAPTL/MSTD therapeutic antibody |
Posdinemab |
MAPT |
Whole mAb |
 |
| GMP-Bios-INN-1343 |
Pre-Made Potravitug biosimilar, Whole mAb: Anti-BK polyomavirus VP1 therapeutic antibody |
Potravitug |
BK polyomavirus VP1 |
Whole mAb |
 |
| GMP-Bios-INN-1344 |
Pre-Made Plutavimab biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Plutavimab |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1345 |
Pre-Made Pradusinstobart biosimilar, Whole mAb, Anti-PDCD1/CD279/PD1 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Pradusinstobart |
PDCD1/CD279/PD1 |
Whole mAb |
 |
| GMP-Bios-INN-1346 |
Pre-Made Prafnosbart biosimilar, Whole mAb, Anti-ACVR1 Antibody: Anti-ACVR1/ALK-2/Activin receptor type-1/Activin receptor type I (ACTR-I) therapeutic antibody |
Prafnosbart |
ACVR1 |
Whole mAb |
 |
| GMP-Bios-INN-1347 |
Pre-Made Precemtabart biosimilar, Whole mAb, Anti-CEACAM5/CD66e Antibody: Anti-CD66e/CEA therapeutic antibody |
Precemtabart |
CEACAM5/CD66e |
Whole mAb |
 |
| GMP-Bios-INN-1348 |
Pre-Made Produvofusp biosimilar, Nanobody Fusion Protein: Recombinant therapeutic protein targeting TBC |
Produvofusp |
TBC |
Nanobody Fusion Protein |
 |
| GMP-Bios-INN-1349 |
Pre-Made Pumitamig biosimilar, Bispec Mixed Domains (Fv entry), Anti-VEGFA;PDL1/CD274 Antibody: Anti-VEGFA/Vascular endothelial growth factor A/long form/L-VEGF therapeutic antibody |
Pumitamig |
VEGFA;PDL1/CD274 |
Bispec Mixed Domains (Fv entry) |
 |
| GMP-Bios-INN-1351 |
Pre-Made Puxitatug biosimilar, Whole mAb, Anti-VTCN1/B7H4 Antibody: Anti-B7‑H4/B7-H4/VTCN1/V-set domain-containing T-cell activation inhibitor 1 therapeutic antibody |
Puxitatug |
VTCN1/B7H4 |
Whole mAb |
 |
| GMP-Bios-INN-1352 |
Pre-Made Rademikibart biosimilar, Whole mAb, Anti-IL4R/CD124 Antibody: Anti-IL-4RA/CD124/IL4R/Interleukin-4 receptor subunit alpha therapeutic antibody |
Rademikibart |
IL4R/CD124 |
Whole mAb |
 |
| GMP-Bios-INN-1353 |
Pre-Made Ragistomig biosimilar, Bispecific (G1-scFv_L-kappa), Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB Antibody: Anti-PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 therapeutic antibody |
Ragistomig |
PDL1/CD274;TNFRSF9/CD137/4-1BB |
Bispecific (G1-scFv_L-kappa) |
 |
| GMP-Bios-INN-1354 |
Pre-Made Raludotatug biosimilar, Whole mAb, Anti-CDH6 Antibody: Anti-Cadherin-6/CDH6/Kidney cadherin (K-cadherin)/CAD6 therapeutic antibody |
Raludotatug |
CDH6 |
Whole mAb |
 |
| GMP-Bios-INN-1355 |
Pre-Made Ralzapastotug biosimilar, Whole mAb, Anti-TIGIT/WUCAM/VSTM3 Antibody: Anti-TIGIT/T-cell immunoreceptor with Ig and ITIM domains/V-set and immunoglobulin domain-containing protein 9/V-set and transmembrane domain-containing protein 3 therapeutic antibody |
Ralzapastotug |
TIGIT/WUCAM/VSTM3 |
Whole mAb |
 |
| GMP-Bios-INN-1356 |
Pre-Made Ramantamig biosimilar, Trispecific Mixed mAb and scFv, Anti-CD3E;GPRC5D;TNFRSF17/CD269/BCMA/TNFRSF13A Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Ramantamig |
CD3E;GPRC5D;TNFRSF17/CD269/BCMA/TNFRSF13A |
Trispecific Mixed mAb and scFv; Bispecific entry |
 |
| GMP-Bios-INN-1358 |
Pre-Made Rapaprutug biosimilar, Whole mAb, Anti-KARS1 Antibody: Anti-KARS/KARS1/Lysine--tRNA ligase/Lysyl-tRNA synthetase (LysRS) therapeutic antibody |
Rapaprutug |
KARS1 |
Whole mAb |
 |
| GMP-Bios-INN-1359 |
Pre-Made Recibokibart biosimilar, Whole mAb, Anti-IL1RL2/IL1Rrp2/IL1RRP2/IL-36R/IL36R Antibody: Anti-IL-36R/IL1RRP2/IL-1Rrp2/IL1R-rp2 therapeutic antibody |
Recibokibart |
IL1RL2/IL1Rrp2/IL1RRP2/IL-36R/IL36R |
Whole mAb |
 |
| GMP-Bios-INN-1360 |
Pre-Made Reflocibart biosimilar, Whole mAb, Anti-VEGFB Antibody: Anti-VEGFB/Vascular endothelial growth factor B/VEGF-B/VEGF-related factor (VRF) therapeutic antibody |
Reflocibart |
VEGFB |
Whole mAb |
 |
| GMP-Bios-INN-1361 |
Pre-Made Remternetug biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP therapeutic antibody |
Remternetug |
APP |
Whole mAb |
 |
| GMP-Bios-INN-1362 |
Pre-Made Remzistotug biosimilar, Whole mAb, Anti-PVRIG/NECTIN2 receptor/CD112R Antibody: Anti-PVRIG/Transmembrane protein PVRIG/CD112 receptor (CD112R)/Poliovirus receptor-related immunoglobulin domain-containing protein therapeutic antibody |
Remzistotug |
PVRIG/NECTIN2 receptor/CD112R |
Whole mAb |
 |
| GMP-Bios-INN-1363 |
Pre-Made Renvistobart biosimilar, Whole mAb, Anti-TIGIT/WUCAM/VSTM3 Antibody: Anti-TIGIT/T-cell immunoreceptor with Ig and ITIM domains/V-set and immunoglobulin domain-containing protein 9/V-set and transmembrane domain-containing protein 3 therapeutic antibody |
Renvistobart |
TIGIT/WUCAM/VSTM3 |
Whole mAb |
 |
| GMP-Bios-INN-1364 |
Pre-Made Reozalimab biosimilar, Bispecific mAb, Anti-PDCD1/CD279/PD1;PDL1/CD274 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Reozalimab |
PDCD1/CD279/PD1;PDL1/CD274 |
Bispecific mAb |
 |
| GMP-Bios-INN-1365 |
Pre-Made Resugosbart biosimilar, Whole mAb, Anti-SOST Antibody: Anti-CDD/DAND6/SOST1/VBCH therapeutic antibody |
Resugosbart |
SOST |
Whole mAb |
 |
| GMP-Bios-INN-1366 |
Pre-Made Retavibart biosimilar, Whole mAb: Anti-RSV gpF therapeutic antibody |
Retavibart |
RSV gpF |
Whole mAb |
 |
| GMP-Bios-INN-1367 |
Pre-Made Rezetamig biosimilar, Bispecific (half G4-kappa_G4(VH-h-CH2-CH3)), Anti-CD3;SIGLEC2/CD22 Antibody: Anti-CD3/CD3E/CD3e/T-cell surface glycoprotein CD3 epsilon chain therapeutic antibody |
Rezetamig |
CD3;SIGLEC2/CD22 |
Bispecific (half G4-kappa_G4(VH-h-CH2-CH3)) |
 |
| GMP-Bios-INN-1368 |
Pre-Made Rezorstobart biosimilar, Whole mAb, Anti-KLRB1 Antibody: Anti-CD161/KLRB1/Killer cell lectin-like receptor subfamily B member 1/C-type lectin domain family 5 member B therapeutic antibody |
Rezorstobart |
KLRB1 |
Whole mAb |
 |
| GMP-Bios-INN-1369 |
Pre-Made Riliprubart biosimilar, Whole mAb, Anti-C1S Antibody: Anti-C1S/Complement C1s subcomponent/C1 esterase/Complement component 1 subcomponent s therapeutic antibody |
Riliprubart |
C1S |
Whole mAb |
 |
| GMP-Bios-INN-1370 |
Pre-Made Rilogrotug biosimilar, Whole mAb, Anti-GDF15/MIC1/MIC-1/NAG1/NAG-1/PTGFB Antibody: Anti-GDF15/Growth/differentiation factor 15/GDF-15 therapeutic antibody |
Rilogrotug |
GDF15/MIC1/MIC-1/NAG1/NAG-1/PTGFB |
Whole mAb |
 |
| GMP-Bios-INN-1371 |
Pre-Made Riltovetbart biosimilar, Whole mAb, Anti-IL31 (Canine) Antibody: Anti-IL-31 therapeutic antibody |
Riltovetbart |
IL31 (Canine) |
Whole mAb |
 |
| GMP-Bios-INN-1372 |
Pre-Made Rilvegostomig biosimilar, Bispecific mAb, Anti-PDCD1/CD279/PD1;TIGIT/WUCAM/VSTM3 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Rilvegostomig |
PDCD1/CD279/PD1;TIGIT/WUCAM/VSTM3 |
Bispecific mAb |
 |
| GMP-Bios-INN-1373 |
Pre-Made Rinatabart biosimilar, Whole mAb, Anti-FOLR1 Antibody: Anti-FOLR1/Folate receptor alpha/FR-alpha/Adult folate-binding protein (FBP) therapeutic antibody |
Rinatabart |
FOLR1 |
Whole mAb |
 |
| GMP-Bios-INN-1374 |
Pre-Made Roconkibart biosimilar, Whole mAb, Anti-IL17A Antibody: Anti-IL-17A/IL17A/IL17/Interleukin-17A therapeutic antibody |
Roconkibart |
IL17A |
Whole mAb |
 |
| GMP-Bios-INN-1375 |
Pre-Made Rolistobart biosimilar, Whole mAb, Anti-LILRB4/CD85K Antibody: Anti-LILRB4/ILT-3/CD85k/Leukocyte immunoglobulin-like receptor subfamily B member 4 therapeutic antibody |
Rolistobart |
LILRB4/CD85K |
Whole mAb |
 |
| GMP-Bios-INN-1376 |
Pre-Made Rosnilimab biosimilar, Whole mAb, Anti-PDCD1/CD279/PD1 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Rosnilimab |
PDCD1/CD279/PD1 |
Whole mAb |
 |
| GMP-Bios-INN-1377 |
Pre-Made Ruxoprubart biosimilar, Whole mAb, Anti-CFB/BFD Antibody: Anti-Complement factor B/CFB/C3/C5 convertase therapeutic antibody |
Ruxoprubart |
CFB/BFD |
Whole mAb |
 |
| GMP-Bios-INN-1378 |
Pre-Made Ruzaltatug biosimilar, Whole mAb ADC, Anti-ERBB3/HER3 Antibody: Anti-ERBB3/ErbB3/HER3/Erbb-3 therapeutic antibody |
Ruzaltatug |
ERBB3/HER3 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1379 |
Pre-Made Sabestomig biosimilar, Bispecific mAb, Anti-PDCD1/CD279/PD1;HAVCR2/TIM3 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Sabestomig |
PDCD1/CD279/PD1;HAVCR2/TIM3 |
Bispecific mAb |
 |
| GMP-Bios-INN-1380 |
Pre-Made Sabirnetug biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP therapeutic antibody |
Sabirnetug |
APP |
Whole mAb |
 |
| GMP-Bios-INN-1381 |
Pre-Made Safimestomig biosimilar, Bispecific Whole mAb, Anti-IAP/CD47;PDL1/CD274 Antibody: Anti-CD47/Leukocyte surface antigen CD47/Antigenic surface determinant protein OA3/Integrin-associated protein (IAP) therapeutic antibody |
Safimestomig |
IAP/CD47;PDL1/CD274 |
Bispecific Whole mAb |
 |
| GMP-Bios-INN-1382 |
Pre-Made Samatatug biosimilar, Whole mAb, Anti-F3/CD142 Antibody: Anti-F3/Tissue Factor/Coagulation Factor III/CD142 therapeutic antibody |
Samatatug |
F3/CD142 |
Whole mAb |
 |
| GMP-Bios-INN-1383 |
Pre-Made Semzuvolimab biosimilar, Whole mAb, Anti-CD4 Antibody: Anti-CD4/T-cell surface glycoprotein CD4/T-cell surface antigen T4/Leu-3 therapeutic antibody |
Semzuvolimab |
CD4 |
Whole mAb |
 |
| GMP-Bios-INN-1384 |
Pre-Made Seniprutug biosimilar, Whole mAb: Anti-TRBV9 therapeutic antibody |
Seniprutug |
TRBV9 |
Whole mAb |
 |
| GMP-Bios-INN-1385 |
Pre-Made Sigvotatug biosimilar, Whole mAb, Anti-ITGB6 Antibody: Anti-Integrin beta 6/Integrin beta-6/ITGB6/AI1H therapeutic antibody |
Sigvotatug |
ITGB6 |
Whole mAb |
 |
| GMP-Bios-INN-1386 |
Pre-Made Silevimig biosimilar, Bispecific ((G1_L-kappa)_scFv-G1(h-CH2-CH3)): Anti-Rabies Lyssavirus Glycoprotein G epitope III;Rabies Lyssavirus Glycoprotein G epitope I therapeutic antibody |
Silevimig |
Rabies Lyssavirus Glycoprotein G epitope III;Rabies Lyssavirus Glycoprotein G epitope I |
Bispecific ((G1_L-kappa)_scFv-G1(h-CH2-CH3)) |
 |
| GMP-Bios-INN-1387 |
Pre-Made Siltartoxatug biosimilar, Whole mAb: Anti-Clostridium tetani tetanus toxin (TeNT) therapeutic antibody |
Siltartoxatug |
Clostridium tetani tetanus toxin (TeNT) |
Whole mAb |
 |
| GMP-Bios-INN-1388 |
Pre-Made Simaravibart biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Simaravibart |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1389 |
Pre-Made Sipavibart biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Sipavibart |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1390 |
Pre-Made Solabafusp biosimilar, Antibody Fusion Protein targeting PDL1/CD274: Recombinant therapeutic protein targeting PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 |
Solabafusp |
PDL1/CD274 |
Antibody Fusion Protein |
 |
| GMP-Bios-INN-1391 |
Pre-Made Solnerstotug biosimilar, Whole mAb, Anti-VSIR/VISTA/B7H5/PD1H/SISP1 Antibody: Anti-VISTA/VSIR/V-type immunoglobulin domain-containing suppressor of T-cell activation/Platelet receptor Gi24 therapeutic antibody |
Solnerstotug |
VSIR/VISTA/B7H5/PD1H/SISP1 |
Whole mAb |
 |
| GMP-Bios-INN-1392 |
Pre-Made Solrikitug biosimilar, Whole mAb, Anti-TSLP Antibody: Anti-TSLP/Thymic stromal lymphopoietin therapeutic antibody |
Solrikitug |
TSLP |
Whole mAb |
 |
| GMP-Bios-INN-1393 |
Pre-Made Sonavibart biosimilar, Whole mAb: Anti-Influenza A HA therapeutic antibody |
Sonavibart |
Influenza A HA |
Whole mAb |
 |
| GMP-Bios-INN-1396 |
Pre-Made Sonesitatug biosimilar, Whole mAb, Anti-CLDN18 Antibody: Anti-SFTA5/SFTPJ therapeutic antibody |
Sonesitatug |
CLDN18 |
Whole mAb |
 |
| GMP-Bios-INN-1397 |
Pre-Made Sotiburafusp biosimilar, Fusion Protein (whole mAb with protein) targeting VEGFR-1: Recombinant therapeutic protein targeting VEGFR-1/FLT-1/VEGFR1/FLT1 |
Sotiburafusp |
VEGFR-1 |
Fusion Protein (whole mAb with protein) |
 |
| GMP-Bios-INN-1398 |
Pre-Made Sovipostobart biosimilar, Whole mAb, Anti-CTLA4/CD152 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Sovipostobart |
CTLA4/CD152 |
Whole mAb |
 |
| GMP-Bios-INN-1399 |
Pre-Made Spevatamig biosimilar, Bispecific Whole mAb, Anti-IAP/CD47;CLDN18 Antibody: Anti-CD47/Leukocyte surface antigen CD47/Antigenic surface determinant protein OA3/Integrin-associated protein (IAP) therapeutic antibody |
Spevatamig |
IAP/CD47;CLDN18 |
Bispecific Whole mAb |
 |
| GMP-Bios-INN-1400 |
Pre-Made Stapokibart biosimilar, Whole mAb, Anti-IL4R/CD124 Antibody: Anti-IL-4RA/CD124/IL4R/Interleukin-4 receptor subunit alpha therapeutic antibody |
Stapokibart |
IL4R/CD124 |
Whole mAb |
 |
| GMP-Bios-INN-1401 |
Pre-Made Surovatamig biosimilar, Bispecific Mixed Domains ((H-gamma4_L-kappa)_VH-G4(h-CH2-CH3)), Anti-CD3D&CD3E;CD19 Antibody: Anti-CD3 Delta/CD3D/CD3d/T-cell surface glycoprotein CD3 delta chain therapeutic antibody |
Surovatamig |
CD3D&CD3E;CD19 |
Bispecific Mixed Domains ((H-gamma4_L-kappa)_VH-G4(h-CH2-CH3)) |
 |
| GMP-Bios-INN-1402 |
Pre-Made Sutacimig biosimilar, Bispecific Whole mAb, Anti-F7a/F7A/FVIIa/FVIIA;TREML1/GLTL1825/PRO3438/TLT-1/TLT1 Antibody: Anti-TREML1/Trem-like transcript 1 protein/TLT-1/Triggering receptor expressed on myeloid cells-like protein 1 therapeutic antibody |
Sutacimig |
F7a/F7A/FVIIa/FVIIA;TREML1/GLTL1825/PRO3438/TLT-1/TLT1 |
Bispecific Whole mAb |
 |
| GMP-Bios-INN-1403 |
Pre-Made Suvemcitug biosimilar, Whole mAb, Anti-VEGFA Antibody: Anti-VEGFA/Vascular endothelial growth factor A/long form/L-VEGF therapeutic antibody |
Suvemcitug |
VEGFA |
Whole mAb |
 |
| GMP-Bios-INN-1404 |
Pre-Made Suvonstobart biosimilar, Whole mAb, Anti-CD24 Antibody: Anti-CD24/Signal transducer CD24/Small cell lung carcinoma cluster 4 antigen/CD24A therapeutic antibody |
Suvonstobart |
CD24 |
Whole mAb |
 |
| GMP-Bios-INN-1405 |
Pre-Made Tabirafusp biosimilar, Antibody Fusion Protein targeting IL6: Recombinant therapeutic protein targeting BSF-2/BSF2/CDF/HGF |
Tabirafusp |
IL6 |
Antibody Fusion Protein |
 |
| GMP-Bios-INN-1406 |
Pre-Made Tacatuzumab biosimilar, Whole mAb ADC: Anti-Alpha Ferroprotein therapeutic antibody |
Tacatuzumab |
Alpha Ferroprotein |
Whole mAb ADC |
 |
| GMP-Bios-INN-1407 |
Pre-Made Tanruprubart biosimilar, Whole mAb, Anti-C1q Antibody: Anti-C1qB/C1QB/C1Q/Complement C1q subcomponent subunit B therapeutic antibody |
Tanruprubart |
C1q |
Whole mAb |
 |
| GMP-Bios-INN-1408 |
Pre-Made Tarperprumig biosimilar, Bispecific Single Domains (VH-VH'), Anti-ALB;CFP Antibody: Anti-Albumin/ALB/HSA/FDAHT therapeutic antibody |
Tarperprumig |
ALB;CFP |
Bispecific Single Domains (VH-VH') |
 |
| GMP-Bios-INN-1409 |
Pre-Made Tazlestobart biosimilar, Whole mAb, Anti-CTLA4/CD152 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Tazlestobart |
CTLA4/CD152 |
Whole mAb |
 |
| GMP-Bios-INN-1410 |
Pre-Made Tecotabart biosimilar, Whole mAb, Anti-CLDN18 Antibody: Anti-SFTA5/SFTPJ therapeutic antibody |
Tecotabart |
CLDN18 |
Whole mAb |
 |
| GMP-Bios-INN-1411 |
Pre-Made Tegoprubart biosimilar, Whole mAb, Anti-CD40LG/CD154 Antibody: Anti-CD40LG/CD154/CD40 ligand/CD40-L therapeutic antibody |
Tegoprubart |
CD40LG/CD154 |
Whole mAb |
 |
| GMP-Bios-INN-1412 |
Pre-Made Telikibart biosimilar, Whole mAb, Anti-IL4R/CD124 Antibody: Anti-IL-4RA/CD124/IL4R/Interleukin-4 receptor subunit alpha therapeutic antibody |
Telikibart |
IL4R/CD124 |
Whole mAb |
 |
| GMP-Bios-INN-1413 |
Pre-Made Temtokibart biosimilar, Whole mAb, Anti-IL22RA1 Antibody: Anti-IL-22RA1/IL22RA1/Interleukin-22 receptor subunit alpha-1/IL-22 receptor subunit alpha-1 therapeutic antibody |
Temtokibart |
IL22RA1 |
Whole mAb |
 |
| GMP-Bios-INN-1414 |
Pre-Made Tilatamig biosimilar, Bispecific mAb, Anti-MET/HGFR;EGFR/ERBB1/HER1 Antibody: Anti-c-Met/MET/Hepatocyte growth factor receptor/HGF receptor therapeutic antibody |
Tilatamig |
MET/HGFR;EGFR/ERBB1/HER1 |
Bispecific mAb |
 |
| GMP-Bios-INN-1415 |
Pre-Made Tilrekimig biosimilar, Trispecific Mixed mAbs, Anti-IL13;IL4;TSLP Antibody: Anti-IL-13/P600/BCGF-1/BCGF1 therapeutic antibody |
Tilrekimig |
IL13;IL4;TSLP |
Trispecific Mixed mAbs; Bispecific entry |
 |
| GMP-Bios-INN-1417 |
Pre-Made Timcevibart biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Timcevibart |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1418 |
Pre-Made Tixentamig biosimilar, Bispecific Mixed Domains (H-gamma1_L-kappa)_scFvhh-G1(h-CH2-CH3), Anti-CD3E;CLDN18 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Tixentamig |
CD3E;CLDN18 |
Bispecific Mixed Domains (H-gamma1_L-kappa)_scFvhh-G1(h-CH2-CH3) |
 |
| GMP-Bios-INN-1419 |
Pre-Made Tixestobart biosimilar, Whole mAb, Anti-TNFRSF7/CD27 Antibody: Anti-CD27/CD27 antigen/CD27L receptor/T-cell activation antigen CD27 therapeutic antibody |
Tixestobart |
TNFRSF7/CD27 |
Whole mAb |
 |
| GMP-Bios-INN-1420 |
Pre-Made Tizetatug biosimilar, Whole mAb, Anti-TACSTD2/TROP2/EGP1 Antibody: Anti-TACSTD2/TROP2/Tumor-associated calcium signal transducer 2/Cell surface glycoprotein Trop-2 therapeutic antibody |
Tizetatug |
TACSTD2/TROP2/EGP1 |
Whole mAb |
 |
| GMP-Bios-INN-1421 |
Pre-Made Tobemstomig biosimilar, Bispecific mAb with Domain Crossover, Anti-PDCD1/CD279/PD1;LAG3/CD223 Antibody: Anti-PD-1/CD279/PDCD1/Programmed cell death protein 1 therapeutic antibody |
Tobemstomig |
PDCD1/CD279/PD1;LAG3/CD223 |
Bispecific mAb with Domain Crossover |
 |
| GMP-Bios-INN-1422 |
Pre-Made Tobevibart biosimilar, Whole mAb: Anti-Human Papillomavirus Envelope Protein therapeutic antibody |
Tobevibart |
Human Papillomavirus Envelope Protein |
Whole mAb |
 |
| GMP-Bios-INN-1423 |
Pre-Made Torvutatug biosimilar, Whole mAb ADC, Anti-FOLR1 Antibody: Anti-FOLR1/Folate receptor alpha/FR-alpha/Adult folate-binding protein (FBP) therapeutic antibody |
Torvutatug |
FOLR1 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1424 |
Pre-Made Tovecimig biosimilar, Bispecific Mixed mAb and scFv, Anti-VEGFA Antibody: Anti-VEGFA/Vascular endothelial growth factor A/long form/L-VEGF therapeutic antibody |
Tovecimig |
VEGFA |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1425 |
Pre-Made Trabikibart biosimilar, Whole mAb, Anti-CSF2RB/CD131/IL3RB/IL5RB Antibody: Anti-IL-3RB/CD131/CSF2RB/Cytokine receptor common subunit beta therapeutic antibody |
Trabikibart |
CSF2RB/CD131/IL3RB/IL5RB |
Whole mAb |
 |
| GMP-Bios-INN-1426 |
Pre-Made Traxivitug biosimilar, Whole mAb: Anti-BK Polyomavirus Major Capsid Protein VP1 therapeutic antibody |
Traxivitug |
BK Polyomavirus Major Capsid Protein VP1 |
Whole mAb |
 |
| GMP-Bios-INN-1427 |
Pre-Made Trevotamig biosimilar, Bispecific Mixed Domains (H-gamma1_L-kappa-scFvhl), Anti-EPCAM/CD326;CD3E Antibody: Anti-EPCAM/CD326/Epithelial cell adhesion molecule/Ep-CAM therapeutic antibody |
Trevotamig |
EPCAM/CD326;CD3E |
Bispecific Mixed Domains (H-gamma1_L-kappa-scFvhl) |
 |
| GMP-Bios-INN-1428 |
Pre-Made Trontinemab biosimilar, Bispecific Mixed Format with Domain Crossover, Anti-APP Abeta 1-40/42;TFRC/CD71 Antibody: Anti-CD71/TFRC/Transferrin receptor protein 1/TR therapeutic antibody |
Trontinemab |
APP Abeta 1-40/42;TFRC/CD71 |
Bispecific Mixed Format with Domain Crossover |
 |
| GMP-Bios-INN-1429 |
Pre-Made Trosunilimab biosimilar, Whole mAb, Anti-ITGA4B7 Antibody: Anti-Integrin Alpha 4/Integrin alpha-4/ITGA4/CD49d therapeutic antibody |
Trosunilimab |
ITGA4B7 |
Whole mAb |
 |
| GMP-Bios-INN-1430 |
Pre-Made Trovostobart biosimilar, Whole mAb, Anti-VSIR/VISTA/B7H5/PD1H/SISP1 Antibody: Anti-VISTA/VSIR/V-type immunoglobulin domain-containing suppressor of T-cell activation/Platelet receptor Gi24 therapeutic antibody |
Trovostobart |
VSIR/VISTA/B7H5/PD1H/SISP1 |
Whole mAb |
 |
| GMP-Bios-INN-1431 |
Pre-Made Tucotuzumab biosimilar, Whole mAb ADC, Anti-EPCAM/CD326 Antibody: Anti-EPCAM/CD326/Epithelial cell adhesion molecule/Ep-CAM therapeutic antibody |
Tucotuzumab |
EPCAM/CD326 |
Whole mAb ADC |
 |
| GMP-Bios-INN-1432 |
Pre-Made Tulisokibart biosimilar, Whole mAb, Anti-TNFSF15/TL1A/VEGI Antibody: Anti-TNFSF15/Tumor necrosis factor ligand superfamily member 15/TNF ligand-related molecule 1/Vascular endothelial cell growth inhibitor therapeutic antibody |
Tulisokibart |
TNFSF15/TL1A/VEGI |
Whole mAb |
 |
| GMP-Bios-INN-1433 |
Pre-Made Tuparstobart biosimilar, Whole mAb: Anti-LAG3/CD223 therapeutic antibody |
Tuparstobart |
LAG3/CD223 |
Whole mAb |
 |
| GMP-Bios-INN-1434 |
Pre-Made Turenkibart biosimilar, Whole mAb, Anti-IL17A Antibody: Anti-IL-17A/IL17A/IL17/Interleukin-17A therapeutic antibody |
Turenkibart |
IL17A |
Whole mAb |
 |
| GMP-Bios-INN-1435 |
Pre-Made Ubletamig biosimilar, Bispecific mAb, Anti-MUC16/CA125;CD28 Antibody: Anti-CA125/CD28/T-cell-specific surface glycoprotein CD28/TP44 therapeutic antibody |
Ubletamig |
MUC16/CA125;CD28 |
Bispecific mAb |
 |
| GMP-Bios-INN-1436 |
Pre-Made Ucenprubart biosimilar, Whole mAb, Anti-MOX2R/CD200R1 Antibody: Anti-CD200R1/Cell surface glycoprotein CD200 receptor 1/CD200 cell surface glycoprotein receptor/Cell surface glycoprotein OX2 receptor 1 therapeutic antibody |
Ucenprubart |
MOX2R/CD200R1 |
Whole mAb |
 |
| GMP-Bios-INN-1437 |
Pre-Made Ulviprubart biosimilar, Whole mAb, Anti-KLRG1 Antibody: Anti-KLRG1/Killer cell lectin-like receptor subfamily G member 1/C-type lectin domain family 15 member A/ITIM-containing receptor MAFA-L therapeutic antibody |
Ulviprubart |
KLRG1 |
Whole mAb |
 |
| GMP-Bios-INN-1438 |
Pre-Made Umesolerbart biosimilar, Whole mAb: Anti-Bet v 1 therapeutic antibody |
Umesolerbart |
Bet v 1 |
Whole mAb |
 |
| GMP-Bios-INN-1439 |
Pre-Made Umikibart biosimilar, Whole mAb, Anti-HGF Antibody: Anti-HGF/Hepatocyte growth factor/Hepatopoietin-A/Scatter factor (SF) therapeutic antibody |
Umikibart |
HGF |
Whole mAb |
 |
| GMP-Bios-INN-1440 |
Pre-Made Umizortamig biosimilar, Tetraspecific scFv-IgG-scFv-scFv (Bispecific entry 1), Anti-EGFRvIII;CD3E;PDL1/CD274;TNFRSF9/CD137/4-1BB Antibody: Anti-EGFR vIII/Epidermal growth factor receptor/Proto-oncogene c-ErbB-1/Receptor tyrosine-protein kinase erbB-1 therapeutic antibody |
Umizortamig |
EGFRvIII;CD3E;PDL1/CD274;TNFRSF9/CD137/4-1BB |
Tetraspecific scFv-IgG-scFv-scFv (Bispecific entry 1) |
 |
| GMP-Bios-INN-1442 |
Pre-Made Uprevstobart biosimilar, Whole mAb, Anti-NT5E/CALJA/CD73 Antibody: Anti-CD73/NT5E/5'-nucleotidase/5'-NT therapeutic antibody |
Uprevstobart |
NT5E/CALJA/CD73 |
Whole mAb |
 |
| GMP-Bios-INN-1443 |
Pre-Made Upinitatug biosimilar, Whole mAb, Anti-SLC34A2 Antibody: Anti-SLC34A2/Sodium-dependent phosphate transport protein 2B/Sodium-phosphate transport protein 2B/Na(+)-dependent phosphate cotransporter 2B therapeutic antibody |
Upinitatug |
SLC34A2 |
Whole mAb |
 |
| GMP-Bios-INN-1444 |
Pre-Made Usilnetug biosimilar, Whole mAb, Anti-APP Abeta N3pGlu Antibody: Anti-APP/Beta Amyloid/Amyloid-beta precursor protein/ABPP therapeutic antibody |
Usilnetug |
APP Abeta N3pGlu |
Whole mAb |
 |
| GMP-Bios-INN-1445 |
Pre-Made Vamikibart biosimilar, Whole mAb, Anti-IL6 Antibody: Anti-BSF-2/BSF2/CDF/HGF therapeutic antibody |
Vamikibart |
IL6 |
Whole mAb |
 |
| GMP-Bios-INN-1446 |
Pre-Made Varokibart biosimilar, Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF therapeutic antibody |
Varokibart |
IL5 |
Whole mAb |
 |
| GMP-Bios-INN-1447 |
Pre-Made Vebanvibart biosimilar, Whole mAb: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Vebanvibart |
SARS-CoV-2 Spike RBD |
Whole mAb |
 |
| GMP-Bios-INN-1448 |
Pre-Made Vecantoxatug biosimilar, Whole mAb: Anti-Clostridium tetani tetanus toxin (TeNT) therapeutic antibody |
Vecantoxatug |
Clostridium tetani tetanus toxin (TeNT) |
Whole mAb |
 |
| GMP-Bios-INN-1449 |
Pre-Made Velaprumig biosimilar, Bispecific Mixed mAb and scFv, Anti-ALB;CD40LG/CD154 Antibody: Anti-Albumin/ALB/HSA/FDAHT therapeutic antibody |
Velaprumig |
ALB;CD40LG/CD154 |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1450 |
Pre-Made Veligrotug biosimilar, Whole mAb, Anti-IGF1R/CD221 Antibody: Anti-IGF1R/CD221/Insulin-like growth factor 1 receptor/Insulin-like growth factor I receptor (IGF-I receptor) therapeutic antibody |
Veligrotug |
IGF1R/CD221 |
Whole mAb |
 |
| GMP-Bios-INN-1451 |
Pre-Made Velinotamig biosimilar, Bispecific Whole mAb, Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E Antibody: Anti-TNFRSF17/BCMA/CD269/Tumor necrosis factor receptor superfamily member 17 therapeutic antibody |
Velinotamig |
TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E |
Bispecific Whole mAb |
 |
| GMP-Bios-INN-1452 |
Pre-Made Venanprubart biosimilar, Whole mAb, Anti-BTLA/CD272 Antibody: Anti-BTLA/CD272/B- and T-lymphocyte attenuator/B- and T-lymphocyte-associated protein therapeutic antibody |
Venanprubart |
BTLA/CD272 |
Whole mAb |
 |
| GMP-Bios-INN-1453 |
Pre-Made Vensobafusp biosimilar, Fusion Protein (whole mAb with protein) targeting C5: Recombinant therapeutic protein targeting C5/CO5/Complement C5/C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4 |
Vensobafusp |
C5 |
Fusion Protein (whole mAb with protein) |
 |
| GMP-Bios-INN-1454 |
Pre-Made Verekitug biosimilar, Whole mAb, Anti-CRLF2 Antibody: Anti-CRLF2/Cytokine receptor-like factor 2/Cytokine receptor-like 2/IL-XR therapeutic antibody |
Verekitug |
CRLF2 |
Whole mAb |
 |
| GMP-Bios-INN-1455 |
Pre-Made Verenafusp biosimilar, Fab Fusion Protein targeting INSR/CD220: Recombinant therapeutic protein targeting INSR/CD220/Insulin receptor/IR |
Verenafusp |
INSR/CD220 |
Fab Fusion Protein |
 |
| GMP-Bios-INN-1456 |
Pre-Made Verzistobart biosimilar, Whole mAb, Anti-HAVCR2/TIM3 Antibody: Anti-TIM3/CD366/KIM-3/SPTCL therapeutic antibody |
Verzistobart |
HAVCR2/TIM3 |
Whole mAb |
 |
| GMP-Bios-INN-1457 |
Pre-Made Vilamakitug biosimilar, Whole mAb, Anti-IL1A Antibody: Anti-IL1/IL-1A/IL1F1/IL1-ALPHA therapeutic antibody |
Vilamakitug |
IL1A |
Whole mAb |
 |
| GMP-Bios-INN-1458 |
Pre-Made Vilastobart biosimilar, Whole mAb, Anti-CTLA4/CD152 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Vilastobart |
CTLA4/CD152 |
Whole mAb |
 |
| GMP-Bios-INN-1459 |
Pre-Made Vipalanebart biosimilar, Whole mAb, Anti-ADCYAP1/PACAP Antibody: Anti-ADCYAP1/PACAP-38/Pituitary adenylate cyclase-activating polypeptide/PACAP therapeutic antibody |
Vipalanebart |
ADCYAP1/PACAP |
Whole mAb |
 |
| GMP-Bios-INN-1460 |
Pre-Made Vislarafusp biosimilar, Fusion Protein targeting SIRPA: Recombinant therapeutic protein targeting SIRP Alpha/CD172a/SIRPA/Tyrosine-protein phosphatase non-receptor type substrate 1 |
Vislarafusp |
SIRPA |
Fusion Protein |
 |
| GMP-Bios-INN-1461 |
Pre-Made Visugromab biosimilar, Whole mAb, Anti-GDF15/MIC1/MIC-1/NAG1/NAG-1/PTGFB Antibody: Anti-GDF15/Growth/differentiation factor 15/GDF-15 therapeutic antibody |
Visugromab |
GDF15/MIC1/MIC-1/NAG1/NAG-1/PTGFB |
Whole mAb |
 |
| GMP-Bios-INN-1462 |
Pre-Made Vixticibart biosimilar, Whole mAb, Anti-NPR1/ANPRA/ANPa/GUC2A/GUCY2A/NPRA Antibody: Anti-NPR1/Atrial natriuretic peptide receptor 1/Atrial natriuretic peptide receptor type A (ANP-A/ANPR-A therapeutic antibody |
Vixticibart |
NPR1/ANPRA/ANPa/GUC2A/GUCY2A/NPRA |
Whole mAb |
 |
| GMP-Bios-INN-1463 |
Pre-Made Vobramitamab biosimilar, Whole mAb, Anti-B7H3/CD276 Antibody: Anti-B7-H3/CD276/CD276 antigen/4Ig-B7-H3 therapeutic antibody |
Vobramitamab |
B7H3/CD276 |
Whole mAb |
 |
| GMP-Bios-INN-1464 |
Pre-Made Volrustomig biosimilar, Bispecific mAb, Anti-CTLA4/CD152;PDCD1/CD279/PD1 Antibody: Anti-CTLA-4/CD152/CTLA4/Cytotoxic T-lymphocyte protein 4 therapeutic antibody |
Volrustomig |
CTLA4/CD152;PDCD1/CD279/PD1 |
Bispecific mAb |
 |
| GMP-Bios-INN-1465 |
Pre-Made Vonsetamig biosimilar, Bispecific mAb, Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E Antibody: Anti-TNFRSF17/BCMA/CD269/Tumor necrosis factor receptor superfamily member 17 therapeutic antibody |
Vonsetamig |
TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E |
Bispecific mAb |
 |
| GMP-Bios-INN-1466 |
Pre-Made Vopikitug biosimilar, Whole mAb, Anti-IL2RA/CD25 Antibody: Anti-CD25/IL-2RA/IL2RA/Interleukin-2 receptor subunit alpha therapeutic antibody |
Vopikitug |
IL2RA/CD25 |
Whole mAb |
 |
| GMP-Bios-INN-1467 |
Pre-Made Xaluritamig biosimilar, Bispecific Mixed mAb and scFv, Anti-STEAP1;CD3 Antibody: Anti-STEAP1/STEAP1 protein/Six-transmembrane epithelial antigen of prostate 1/STEAP therapeutic antibody |
Xaluritamig |
STEAP1;CD3 |
Bispecific Mixed mAb and scFv |
 |
| GMP-Bios-INN-1468 |
Pre-Made Xirestomig biosimilar, Bispecific (G1-scFv_L2 dimer), Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB Antibody: Anti-PD-L1/CD274/Programmed cell death 1 ligand 1/PDCD1 ligand 1 therapeutic antibody |
Xirestomig |
PDL1/CD274;TNFRSF9/CD137/4-1BB |
Bispecific (G1-scFv_L2 dimer) |
 |
| GMP-Bios-INN-1469 |
Pre-Made Zadoprubart biosimilar, Whole mAb, Anti-BTLA/CD272 Antibody: Anti-BTLA/CD272/B- and T-lymphocyte attenuator/B- and T-lymphocyte-associated protein therapeutic antibody |
Zadoprubart |
BTLA/CD272 |
Whole mAb |
 |
| GMP-Bios-INN-1470 |
Pre-Made Zaltenibart biosimilar, Whole mAb, Anti-MASP3 Antibody: Anti-MASP1/Mannan-binding lectin serine protease 1/Complement factor MASP-3/Complement-activating component of Ra-reactive factor therapeutic antibody |
Zaltenibart |
MASP3 |
Whole mAb |
 |
| GMP-Bios-INN-1471 |
Pre-Made Zamubafusp biosimilar, Antibody Fusion Protein: Recombinant therapeutic protein targeting Human variable immunoglobulin light chain (N-terminal cryptic neo-epitope) |
Zamubafusp |
Human variable immunoglobulin light chain (N-terminal cryptic neo-epitope) |
Antibody Fusion Protein |
 |
| GMP-Bios-INN-1472 |
Pre-Made Zeleciment biosimilar, Fab, Anti-TFRC/CD71 Antibody: Anti-CD71/TFRC/Transferrin receptor protein 1/TR therapeutic antibody |
Zeleciment |
TFRC/CD71 |
Fab |
 |
| GMP-Bios-INN-1473 |
Pre-Made Zemocimig biosimilar, Bispecific mAb, Anti-F9a;F10 Antibody: Anti-Factor X/F10/Coagulation factor X/Stuart factor therapeutic antibody |
Zemocimig |
F9a;F10 |
Bispecific mAb |
 |
| GMP-Bios-INN-1474 |
Pre-Made Zeripatamig biosimilar, Bispecific mAb, Anti-IAP/CD47;CD19 Antibody: Anti-CD47/Leukocyte surface antigen CD47/Antigenic surface determinant protein OA3/Integrin-associated protein (IAP) therapeutic antibody |
Zeripatamig |
IAP/CD47;CD19 |
Bispecific mAb |
 |
| GMP-Bios-INN-1475 |
Pre-Made Zifibancimig biosimilar, Bispecific mAb, Anti-ANPT2;VEGFA Antibody: Anti-VEGFA/Vascular endothelial growth factor A/long form/L-VEGF therapeutic antibody |
Zifibancimig |
ANPT2;VEGFA |
Bispecific mAb |
 |
| GMP-Bios-INN-1476 |
Pre-Made Zigakibart biosimilar, Whole mAb, Anti-TNFSF13/CD256/APRIL Antibody: Anti-APRIL/TNFSF13/CD256/Tumor necrosis factor ligand superfamily member 13 therapeutic antibody |
Zigakibart |
TNFSF13/CD256/APRIL |
Whole mAb |
 |
| GMP-Bios-INN-1477 |
Pre-Made Zinlirvimab biosimilar, Whole mAb: Anti-HIV-1 gp120 V3 therapeutic antibody |
Zinlirvimab |
HIV-1 gp120 V3 |
Whole mAb |
 |
| GMP-Bios-INN-1478 |
Pre-Made Zovostotug biosimilar, Whole mAb, Anti-CD163 Antibody: Anti-CD163/Scavenger receptor cysteine-rich type 1 protein M130/Hemoglobin scavenger receptor/M130 therapeutic antibody |
Zovostotug |
CD163 |
Whole mAb |
 |
| GMP-Bios-INN-1479 |
Pre-Made Zubotamig biosimilar, Bispecific mAb ((H-gamma1_L-kappa)_(H-gamma1_Llambda2)), Anti-VTCN1/B7H4;CD3E Antibody: Anti-B7‑H4/B7-H4/VTCN1/V-set domain-containing T-cell activation inhibitor 1 therapeutic antibody |
Zubotamig |
VTCN1/B7H4;CD3E |
Bispecific mAb ((H-gamma1_L-kappa)_(H-gamma1_Llambda2)) |
 |